<PAGE>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) January 11, 2000
Commission File Number 0-23252
IGEN INTERNATIONAL, INC.
(Exact name of registrant)
Delaware 94-2852543
(State of organization) (I.R.S. Employer Identification Number)
16020 Industrial Drive, Gaithersburg Maryland 20877
(Address of principal executive offices and zip code)
(301) 869-9800
(Registrant's telephone Number)
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
ITEM 5. OTHER EVENTS
On January 11, 2000, IGEN International, Inc. (the "Company") sold $35 million
in aggregate principal amount of 5% Subordinated Convertible Debentures due
2005. The Company also issued Warrants to purchase up to 282,258 shares of the
Company's common stock, par value $0.001 per share. The Convertible Debentures
are convertible into the Company's common stock at a conversion price of $31 per
share. A copy of the press release announcing the financing and a copy of the
Securities Purchase Agreement pursuant to which the Convertible Debentures and
Warrants were sold are filed herewith as exhibits.
ITEM 7. EXHIBITS
99.1 Press release dated January 12, 2000
99.2 Securities Purchase Agreement, dated as of January 11, 2000,
among IGEN International, Inc. and the Purchasers listed on
Schedule I thereto
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IGEN INTERNATIONAL, INC.
By: /s/ Samuel J. Wohlstadter
------------------------------------
Samuel J. Wohlstadter
Chairman and Chief Executive Officer
Dated: January 12, 2000
<PAGE>
Exhibit 99.1
IGEN INTERNATIONAL, INC.
- --------------------------------------------------------------------------------
<TABLE>
<S> <C>
16020 Industrial Drive, Gaithersburg, Maryland 20877 USA Phone: (301) 984-8000, Fax: (301) 208-3798
FOR IMMEDIATE RELEASE
CONTACT:
George Migausky Trout Group/BMC Com.
Vice President and Jonathan Fassberg (investors), ext. 16
Chief Financial Officer Brad Miles (media), ext. 17
(301) 984-8000 (212) 477-9007
</TABLE>
IGEN SUCCESSFULLY COMPLETES $35 MILLION FINANCING
GAITHERSBURG, MD - JANUARY 12, 2000 - IGEN International, Inc. (NASDAQ: IGEN)
today announced that it has completed a private placement of $35 million
principal amount of 5% Subordinated Convertible Debentures due 2005. The
Debentures are convertible into IGEN common stock at $31 per share, which
represented a 10% premium on the trailing average closing prices for a 25
trading day period prior to the pricing of the financing. As part of this
financing the Company also issued warrants to purchase 282,258 shares of IGEN
common stock at the conversion price.
The Company plans to use the proceeds from this financing to support the
continued launch of the M-SERIES-TM- System, including an increase in assay
development capabilities for genomics target screening, to advance other product
programs, and for capital expenditures and other working capital purposes.
As part of this transaction, IGEN signed a registration rights agreement under
which it will register the shares of common stock issuable upon the conversion
of the Debentures and Warrants. This summary of the terms of the Debentures and
Warrants is not intended to be a complete summary of the terms of such
securities. Copies of the documents related to the financing are being filed
with U.S. Securities and Exchange Commission later today.
Neither the Debentures nor the Warrants have been registered under the
Securities Act of 1933, as amended, or applicable state securities laws, and
unless so registered, may not be offered or sold in the United States, except
pursuant to an applicable exemption from the registration requirements of the
Securities Act of 1933, as amended, and applicable state securities law. This
press release shall not constitute an offer to sell or the solicitation of an
offer to buy the Debentures or Warrants.
STATEMENTS IN THIS RELEASE, INCLUDING THOSE THAT RELATE TO USE OF PROCEEDS, NEW
PRODUCT PLANS, AND BUSINESS PROSPECTS ARE FORWARD-LOOKING STATEMENTS. ACTUAL
RESULTS MIGHT DIFFER MATERIALLY FROM THESE STATEMENTS DUE TO RISKS AND
UNCERTAINTIES, INCLUDING THE IMPACT OF COMPETITIVE PRODUCTS AND PRICING, THE
MARKET ACCEPTANCE OF NEW PRODUCTS AND MARKET CONDITIONS. A MORE DETAILED
DESCRIPTION OF THESE RISKS APPLICABLE TO IGEN APPEARS IN IGEN'S ANNUAL
<PAGE>
REPORT ON FORM 10-K FOR THE YEAR ENDED MARCH 31, 1999, FILED WITH THE SECURITIES
AND EXCHANGE COMMISSION AND AVAILABLE UPON REQUEST FROM IGEN. IGEN DISCLAIMS ANY
INTENT OR OBLIGATION TO UPDATE THESE FORWARD LOOKING STATEMENTS.
IGEN and ORIGEN are registered trademarks of IGEN International, Inc. M-SERIES
is a trademark of IGEN International, Inc.
# # #
<PAGE>
Exhibit 99.2
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES PURCHASE AGREEMENT
Among
IGEN INTERNATIONAL, INC.
and
THE PURCHASERS LISTED ON SCHEDULE I
Dated as of January 11, 2000
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
SECURITIES PURCHASE AGREEMENT
THIS SECURITIES PURCHASE AGREEMENT (this "AGREEMENT") is dated as
of January 11, 2000 among IGEN International, Inc., a Delaware corporation (the
"COMPANY"), and the various purchasers identified and listed on Schedule I
hereto (each referred to herein as a "PURCHASER" and, collectively, the
"PURCHASERS.")
WHEREAS, the Company and the Purchasers are executing and
delivering this Agreement in reliance upon the exemption from securities
registration afforded by Rule 506 under Regulation D as promulgated by the
United States Securities and Exchange Commission (the "COMMISSION") under
Section 4(2) of the Securities Act of 1933, as amended (the "SECURITIES ACT");
WHEREAS, subject to the terms and conditions set forth in this
Agreement, the Company desires to issue and sell to the Purchasers, and the
Purchasers desire to acquire from the Company, an aggregate principal amount of
$35,000,000 of 5% Subordinated Convertible Debentures due January 11, 2005 (the
"Debentures"), in the form of EXHIBIT A annexed hereto and warrants (the
"WARRANTS") to purchase 282,258 shares of the Company's common stock, par value
$0.001 per share (the "COMMON STOCK"), in the form of EXHIBIT B annexed hereto;
and
WHEREAS, contemporaneously with the execution and delivery of this
Agreement, the parties hereto are executing and delivering a Registration Rights
Agreement in the form of EXHIBIT C annexed hereto (the "REGISTRATION RIGHTS
AGREEMENT") pursuant to which the Company has agreed to provide certain
registration rights under the Securities Act and the rules and regulations
promulgated thereunder, and applicable state securities laws.
NOW THEREFORE, in consideration of the promises and mutual
covenants and agreements hereinafter, the Company and the Purchasers hereby
agree as follows:
ARTICLE I.
PURCHASE AND SALE OF THE DEBENTURES AND WARRANTS
1.1 PURCHASE AND SALE. Subject to the terms and conditions set forth
herein, the Company shall issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, shall purchase from the Company on the
Closing Date (as defined below), the principal amount of Debentures as set
forth for such Purchaser on SCHEDULE I.
<PAGE>
1.2 CLOSING.
a. THE CLOSING. The closing of the purchase and sale of the
Debentures and the issuance of the Warrants (the "CLOSING") shall take place
at the offices of Akin, Gump, Strauss, Hauer & Feld, L.L.P., 590 Madison
Avenue, New York, New York 10022, or by transmission by facsimile and
overnight courier, immediately following the execution hereof, or such later
date or different location as the parties shall agree, but not prior to the
date that the conditions set forth in Section 4.1 have been satisfied or
waived by the appropriate party (the "CLOSING DATE"). At the Closing:
Each Purchaser shall deliver, as directed by the Company, its portion of the
purchase price as set forth next to its name on SCHEDULE I in United States
dollars in immediately available funds to an account or accounts designated in
writing by the Company;
The Company shall deliver to each Purchaser a Debenture(s) in the form of
EXHIBIT A hereto representing the principal amount of Debentures purchased by
such Purchaser as set forth on SCHEDULE I hereto;
The Company shall deliver to each Purchaser a Warrant, in the form of EXHIBIT B
hereto, representing the right to acquire the number of shares of Common Stock
as set forth on SCHEDULE I hereto; and
The parties shall execute and deliver each of the documents referred to in
Section 4.1 hereof.
ARTICLE II.
REPRESENTATIONS AND WARRANTIES
2.1 REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE COMPANY. The
Company hereby makes the following representations and warranties to each of
the Purchasers. Any information disclosed in any Schedule hereto shall be
deemed to have been disclosed in all Schedules hereto.
2
<PAGE>
a. ORGANIZATION AND QUALIFICATION. The Company is a
corporation duly incorporated, validly existing and in good standing under
the laws of the State of Delaware, with the requisite corporate power and
authority to own and use its properties and assets and to carry on its
business as currently conducted. Except as set forth on SCHEDULE 2.1(a), the
Company has no subsidiaries (collectively, the "SUBSIDIARIES"). Each of the
Subsidiaries (which for purposes of this Agreement means any entity in which
the Company, directly or indirectly, owns the majority of such entity's
capital stock or holds an equivalent equity or similar interest) is a
corporation duly incorporated, validly existing and in good standing under
the laws of the jurisdiction of its incorporation or organization (as
applicable), with the full corporate power and authority to own and use its
properties and assets and to carry on its business as currently conducted.
Each of the Company and the Subsidiaries is duly qualified to do business as
a foreign corporation and is in good standing as a foreign corporation in
each jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary, except where the failure to
be so qualified or in good standing, as the case may be, would not,
individually or in the aggregate, (x) adversely affect the legality, validity
or enforceability of any of this Agreement or the Transaction Documents (as
defined in Section 2.1(b)) or any of the transactions contemplated hereby or
thereby, (y) have or result in a material adverse effect on the results of
operations, assets or financial condition of the Company and its
Subsidiaries, taken as a whole or (z) impair the Company's ability to perform
fully on a timely basis its obligations under any Transaction Document (any
of (x), (y) or (z), being a "MATERIAL ADVERSE EFFECT").
b. AUTHORIZATION; ENFORCEMENT. Subject to the receipt of
written waiver of the Notice of the Special Meeting of the Board of Directors
of the Company held on January 10, 2000: (i) the Company has the requisite
corporate power and authority to enter into and to consummate the
transactions contemplated by this Agreement, the Debentures, the Warrants and
the Registration Rights Agreement (collectively, the "TRANSACTION
DOCUMENTS"), and otherwise to carry out its obligations hereunder and
thereunder, (ii) the execution and delivery of each of this Agreement and the
Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all
necessary corporate action and no further action is required by the Company,
its Board of Directors or its stockholders, and (iii) each of this Agreement
and the Transaction Documents has been duly executed by the Company and, when
delivered in accordance with the terms hereof, will constitute the valid and
binding obligation of the Company, enforceable against the Company in
accordance with its terms, except as such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally the enforcement of,
creditors' rights and remedies or by other equitable principles of general
application, and except that rights to indemnification and contribution may
be limited by Federal or state securities laws or public policy relating
thereto.
3
<PAGE>
c. CAPITALIZATION. As of the date hereof, the authorized
capital stock of the Company is as set forth in SCHEDULE 2.1(c). All of such
outstanding shares of capital stock have been, or upon issuance will be,
validly authorized and issued, fully paid and nonassessable and were issued
in accordance with the registration or qualification provisions of the
Securities Act, or pursuant to valid exemptions therefrom. Except as
disclosed in the SEC Documents or on SCHEDULE 2.1(c), (i) no shares of the
Company's capital stock are subject to preemptive rights or any other similar
rights or any liens or encumbrances suffered or permitted by the Company, nor
is any holder of the Common Stock entitled to preemptive or similar rights
arising out of any agreement or understanding with the Company by virtue of
any Transaction Document, (ii) there are no outstanding options, warrants,
scrip rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into or
exchangeable for, or giving any Person (as defined below) any right to
subscribe for or acquire, any shares of capital stock of the Company or any
of its Subsidiaries, or contracts, commitments, understandings or
arrangements by which the Company or any of its Subsidiaries is or may become
bound to issue additional shares of capital stock of the Company or any of
its Subsidiaries or options, warrants, scrip rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company or any of its
Subsidiaries, (iii) there are no outstanding debt securities of the Company
or any of its Subsidiaries, (iv) there are no agreements or arrangements
under which the Company or any of its Subsidiaries is obligated to register
the sale of any of their securities under the Securities Act (except the
Registration Rights Agreement), (v) there are no outstanding securities of
the Company or any of its Subsidiaries which contain any redemption or
similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any of its Subsidiaries is or may
become bound to redeem a security of the Company or any of its Subsidiaries,
(vi) there are no securities or instruments containing anti-dilution or
similar provisions that will be triggered by the issuance of the Debentures
or Warrants, or upon the conversion of the Debentures or exercise of the
Warrants, (vii) the Company does not have any stock appreciation rights or
"phantom stock" plans or agreements, or any similar plan or agreement and
(viii) except as specifically disclosed in the SEC Documents (as defined in
Section 2.1(k) hereof), to the knowledge of the Company, no Person (as
defined below) or group of related Persons beneficially owns (as determined
pursuant to Rule 13d-3 promulgated under the Securities Exchange Act of 1934,
as amended (the "EXCHANGE ACT")) or has the right to acquire by agreement
with or by obligation binding upon the Company beneficial ownership of in
excess of 5% of the Common Stock. "PERSON" means an individual or
corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or
an agency or subdivision thereof) or other entity of any kind.
d. AUTHORIZATION, VALIDITY AND ISSUANCE OF SHARES. The shares
of Common Stock issuable upon conversion of the Debentures and exercise of
the Warrants (collectively, the "UNDERLYING SHARES") are and will at all
times hereafter continue to be duly authorized and reserved for issuance and
the shares of Common Stock issued upon conversion of the Debentures (the
"DEBENTURE SHARES") and exercise of the Warrants (the "WARRANT SHARES") will
be validly issued, fully paid and non-assessable, free and clear of all
liens, encumbrances and Company rights of first refusal, other than liens and
encumbrances created by the Purchasers (collectively, "LIENS") and will not
be subject to any preemptive or similar rights.
4
<PAGE>
e. NO CONFLICTS. The execution, delivery and performance of
this Agreement and each of the Transaction Documents by the Company and the
consummation by the Company of the transactions contemplated hereby and
thereby (including the issuance of the Underlying Shares) do not and will not
(i) conflict with or violate any provision of the Company's Certificate of
Incorporation as amended and in effect on the date hereof (the "CERTIFICATE
OF INCORPORATION"), the Company's Bylaws, as in effect on the date hereof
(the "BYLAWS") or other organizational documents of the Company or any of the
Subsidiaries, (ii) subject to obtaining the consents referred to in Section
2.1(f), conflict with, or constitute a breach or a default (or an event which
with notice or lapse of time or both would become a default) under, or give
to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture, patent, patent license or instrument
(evidencing a Company or Subsidiary debt or otherwise) to which the Company
or any Subsidiary is a party or by which any property or asset of the Company
or any Subsidiary is bound or affected, or (iii) result in a violation of any
law, rule, regulation, order, judgment, injunction, decree or other
restriction of any court or governmental authority to which the Company or
any Subsidiary is subject (including Federal and state securities laws and
regulations and the rules and regulations of the principal market or exchange
on which the Common Stock is traded or listed) applicable to the Company or
any of its Subsidiaries, or by which any material property or asset of the
Company or any Subsidiary is bound or affected; except in each case where
such occurrence could not reasonably be expected to result in a Material
Adverse Effect.
f. CONSENTS AND APPROVALS. Except as set forth on
SCHEDULE 2.1(f), neither the Company nor any Subsidiary is required to obtain
any consent, waiver, authorization or order of, give any notice to, or make any
filing or registration with, any court or other federal, state, local or
other governmental authority, regulatory or self regulatory agency, or other
Person in connection with the execution, delivery and performance by the
Company of this Agreement or the Transaction Documents, other than (i) the
filing of a registration statement with the Commission, which shall be filed
in accordance with and in the time periods set forth in the Registration
Rights Agreement, (ii) the application(s) or any letter(s) acceptable to the
National Market System of Nasdaq Stock Market ("NASDAQ") for the listing of
the Underlying Shares with Nasdaq (and with any other national securities
exchange or market on which the Common Stock is then listed), which shall be
filed in accordance with, and in the time periods set forth in, Section
3.6(b) hereof, and (iii) any filings, notices or registrations under
applicable state securities laws (together with the consents, waivers,
authorizations, orders, notices and filings referred to on SCHEDULE 2.1(f),
the "REQUIRED APPROVALS").
g. LITIGATION; PROCEEDINGS. Except as set forth in the SEC
Documents or on SCHEDULE 2.1(g), there is no action, suit, notice of
violation, proceeding or investigation pending or, to the knowledge of the
Company or any of its Subsidiaries, threatened against or affecting the
Company or any of its Subsidiaries or any of their respective properties or
assets before or by any court, governmental or administrative agency or
regulatory authority (federal, state, county, local or foreign) which (i)
adversely affects or challenges the legality, validity or enforceability of
any of this Agreement or the Transaction Documents or (ii) could reasonably
be expected to, individually or in the aggregate, have a Material Adverse
Effect.
5
<PAGE>
h. NO DEFAULT OR VIOLATION. Neither the Company nor any
Subsidiary (i) is in default under or in violation of any indenture, loan or
other credit agreement or any other agreement or instrument to which it is a
party or by which it or any of its properties or assets is bound, (ii) is in
violation of any order of any court, arbitrator or governmental body
applicable to it, (iii) is in violation of any statute, rule or regulation of
any governmental authority to which it is subject or (iv) is in any material
violation of any of the provisions of its respective certificate of
incorporation, bylaws or other charter documents such that any right of a
holder of the Debentures would be affected. The business of the Company and
its Subsidiaries is not being conducted, and shall not be conducted, in
violation of any law, ordinance, rule or regulation of any governmental
entity, except where such violations have not resulted or would not
reasonably result, individually or in the aggregate, in a Material Adverse
Effect. Neither the Company nor any of its Subsidiaries is in breach of any
agreement where such breach, individually or in the aggregate, would have a
Material Adverse Effect.
i. DISCLOSURE; ABSENCE OF CERTAIN CHANGES. None of this
Agreement, the Schedules to this Agreement, the Transaction Documents or any
other written information, report, financial statement, exhibit, schedule or
document furnished by or on behalf of the Company in connection with the
negotiation of the transactions contemplated hereby contained at the time it
was so furnished or now contains any untrue statement of a material fact or
omitted at such time or now omits to state any material fact necessary in
order to make the statements made herein and therein, in light of the
circumstances under which they were made, not misleading. Except as disclosed
on SCHEDULE 2.1(i) or in SEC Documents filed on EDGAR at least five business
days prior to the date hereof, since September 30, 1999, there has been no
material adverse change and no material adverse development in the business,
properties, operations, financial condition, liabilities or results of
operations of the Company or the Subsidiaries. The Company has not taken any
steps, and does not currently expect to take any steps, to seek protection
pursuant to any bankruptcy law nor does the Company or any of its
Subsidiaries have any knowledge or reason to believe that its creditors
intend to initiate involuntary bankruptcy proceedings.
j. PRIVATE OFFERING. The Company and all Persons acting on
its behalf have not made, directly or indirectly, and will not make, offers
or sales of any securities or solicited any offers to buy any security under
circumstances that would require registration of the Debentures, the
Warrants, the Debenture Shares or the Warrant Shares or the issuance of such
securities under the Securities Act. The offer, sale and issuance of the
Debentures, the Warrants, the Debenture Shares and the Warrant Shares to the
Purchasers will not be integrated with any other offer, sale and issuance of
the Company's securities (past, current, or future) under the Securities Act
in a manner that would require the registration under the Securities Act of
the sale of the Debentures, the Warrants, the Debenture Shares or the Warrant
Shares to any purchaser. Subject to the accuracy and completeness of the
representations and warranties of the respective Purchasers contained in
Section 2.2 hereof, the offer, sale and issuance by the Company to the
Purchasers of the Debentures, the Warrants and the Underlying Shares are
exempt from the registration requirements of the Securities Act.
6
<PAGE>
k. SEC DOCUMENTS; FINANCIAL STATEMENTS. The Common Stock is
registered pursuant to Section 12(g) of the Exchange Act. The Company has
filed all reports, schedules, forms, statements and other documents required
to be filed by it with the Commission pursuant to the reporting requirements
of the Exchange Act, including pursuant to Section 13, 14 or 15(d) thereof
(the foregoing materials and all exhibits included therein and financial
statements and schedules thereto and documents (other than exhibits to such
documents) incorporated by reference therein being collectively referred to
herein as the "SEC DOCUMENTS"), on a timely basis or has received a valid
extension of such time of filing and has filed any such SEC Documents prior
to the expiration of any such extension. As of their respective dates, the
SEC Documents complied in all material respects with the applicable
requirements of the Securities Act and the Exchange Act and the rules and
regulations of the Commission promulgated thereunder, and none of the SEC
Documents, when filed, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under
which they were made, not misleading. As of their respective dates, the
financial statements of the Company included in the SEC Documents complied as
to form in all material respects with applicable accounting requirements and
the published rules and regulations of the Commission with respect thereto as
in effect at the time of filing. Such financial statements have been prepared
in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved, except as may be
otherwise specified in such financial statements or the notes thereto, and
fairly present in all material respects the financial position of the Company
as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to
normal, immaterial year-end audit adjustments.
l. INVESTMENT COMPANY. The Company is not, and is not
controlled by or under common control with an affiliate (an "AFFILIATE") of
an "investment company" within the meaning of the Investment Company Act of
1940, as amended.
m. BROKER'S FEES. No fees or commissions or similar payments
with respect to the transactions contemplated by this Agreement or the
Transaction Documents have been paid or will be payable by the Company to any
broker, financial advisor, finder, investment banker, or bank, other than as
set forth in SCHEDULE 2.1(m). The Company has not entered into any agreement
or undertaken any obligation whereby the Purchasers shall have any obligation
with respect to any fees or with respect to any claims made by or on behalf
of other Persons for fees of a type contemplated in this Section 2.1(m) that
may be due in connection with the transactions contemplated by this Agreement
and the Transaction Documents.
n. FORM S-3 ELIGIBILITY. The Company is, and at the Closing
Date will be, eligible to register securities (including the Underlying
Shares) for resale with the Commission under Form S-3 (or any successor form)
promulgated under the Securities Act.
7
<PAGE>
o. LISTING AND MAINTENANCE REQUIREMENTS COMPLIANCE. The
principal market on which the Common Stock is currently traded is Nasdaq.
Except as disclosed on SCHEDULE 2.1(o), the Company has not in the two years
preceding the date hereof received notice (written or oral) from Nasdaq (or
any stock exchange, market or trading facility on which the Common Stock is
or has been listed (or on which it has been quoted)) to the effect that the
Company is not in compliance with the listing or maintenance requirements of
such market or exchange. The Company is not aware of any facts which would
reasonably be expected to lead to delisting or suspension of the Common Stock
by Nasdaq. After giving effect to the transactions contemplated by this
Agreement and the Transaction Documents, the Company is and will be in
compliance with all such maintenance requirements.
p. INTELLECTUAL PROPERTY RIGHTS. The Company and its
Subsidiaries own, possess, or have the right to acquire adequate rights or
licenses to use all material trademarks, trademark applications, trade names
and service marks, whether or not registered, and all patents, patent
applications, copyrights, inventions, licenses, approvals, governmental
authorizations, trade secrets and intellectual property rights (collectively,
"INTELLECTUAL PROPERTY RIGHTS") which are reasonably necessary for use in
connection with their respective businesses as now conducted and as described
in the SEC Documents, except for such Intellectual Property Rights as the
Company could acquire with commercially reasonable efforts. Except as set
forth in the SEC Documents or on SCHEDULE 2.1(p), none of the Company's
Intellectual Property Rights reasonably necessary for use in connection with
the Company's business as now conducted has expired or terminated, or are
expected to expire or terminate within two years from the date of this
Agreement. Neither the Company nor any of its Subsidiaries has infringed or
is infringing on any of the Intellectual Property Rights of any Person and,
except as set forth in the SEC Documents or on SCHEDULE 2.1(p), there is no
claim, action or proceeding which has been made or brought or alleged
against, or to the Company's knowledge, is being made, brought or threatened
against, the Company or its Subsidiaries regarding the infringement of any of
the Intellectual Property Rights, except where any of the foregoing would not
have a Material Adverse Effect. The Company and its Subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and
value of their material intellectual properties.
q. EMPLOYEE RELATIONS. Neither the Company nor any of its
Subsidiaries is involved in any union labor dispute nor, to the knowledge of
the Company or any of its Subsidiaries, is any such dispute threatened.
Neither the Company nor any of its Subsidiaries is a party to a collective
bargaining agreement, and the Company and its Subsidiaries believe that
relations with their employees are satisfactory. Except as set forth on
SCHEDULE 2.1(q), since September 30, 1999 no executive officer (as defined in
Rule 501(f) under the Securities Act) has notified the Company that such
officer intends to leave the Company or otherwise terminate such officer's
employment with the Company.
8
<PAGE>
r. REGISTRATION RIGHTS; RIGHTS OF PARTICIPATION. Except as
described on SCHEDULE 2.1(r) hereto, (i) the Company has not granted or
agreed to grant to any Person any rights (including "piggy-back" registration
rights) to have any securities of the Company registered with the Commission
or any other governmental authority which has not been satisfied and (ii) no
Person, including, but not limited to, current or former stockholders of the
Company, underwriters, brokers or agents, has any right of first refusal,
preemptive right, right of participation, or any similar right to participate
in the transactions contemplated by this Agreement or any Transaction
Document.
s. TITLE. Except as disclosed on SCHEDULE 2.1(s), the Company
and the Subsidiaries have good and marketable title in fee simple to all real
property and personal property owned by them which is material to the
business of the Company and its Subsidiaries, in each case free and clear of
all Liens, except for Liens that do not materially affect the value of such
property and do not interfere with the use made and proposed to be made of
such property by the Company and the Subsidiaries. Any real property and
facilities held under lease by the Company and the Subsidiaries are held by
them under valid, subsisting and, to the Company's best knowledge,
enforceable leases with such exceptions as are not material and do not
interfere with the use made and proposed to be made of such property and
buildings by the Company and the Subsidiaries.
t. PERMITS. The Company and each of its Subsidiaries possess
all certificates, authorizations, licenses, easements, consents, approvals,
orders and permits necessary to own, lease and operate their respective
properties and to conduct their respective businesses as currently conducted
except such permits as the Company could obtain within 60 days or where the
failure to possess such permits would not, individually or in the aggregate,
have a Material Adverse Effect ("MATERIAL PERMITS"), and there is no
proceeding pending, or, to the knowledge of the Company, threatened, relating
to the revocation, modification, suspension or cancellation of any Material
Permit. Neither the Company nor any of the Subsidiaries is in conflict with
or default or violation of any Material Permit.
u. INSURANCE. The Company and each of its Subsidiaries are
insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as management of the Company believes to
be prudent. Neither the Company nor any such Subsidiary has any reason to
believe that it will not be able to renew its existing insurance coverages as
and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business, at a cost that would
not materially and adversely affect the condition, financial or otherwise, or
the earnings, business or operations of the Company and its Subsidiaries,
taken as a whole.
9
<PAGE>
v. TAX STATUS; FIRPTA. Except as set forth on
SCHEDULE 2.1(w), the Company and each of the Subsidiaries has made or filed all
federal and state income and all other tax returns, reports and declarations
required by any jurisdiction to which it is subject (unless and only to the
extent that the Company and each of its Subsidiaries has set aside on its
books provisions reasonably adequate for the payment of all unpaid and
unreported taxes) and has paid all taxes and other governmental assessments
and charges that are material in amount, shown or determined to be due on
such returns, reports and declarations, except those being contested in good
faith (which are set forth on SCHEDULE 2.1(w) hereof), and has set aside on
its books provisions reasonably adequate for the payment of all taxes for
periods subsequent to the periods to which such returns, reports or
declarations apply. There are no unpaid taxes in any material amount claimed
to be due by the taxing authority of any jurisdiction, and the officers of
the Company know of no basis for any such claim. The Company is not a "United
States real property holding corporation" within the meaning of Section
847(c)(2) of the Internal Revenue Code of 1986, as amended.
w. TRANSACTIONS WITH AFFILIATES. Except as set forth in the
SEC Documents or on SCHEDULE 2.1(x), and other than the granting of stock
options and documents disclosed on SCHEDULE 2.1(c), none of the officers,
directors, or employees of the Company is presently a party to any
transaction with the Company or any of its Subsidiaries (other than for
services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or
by, providing for rental of real or personal property to or from, or
otherwise requiring payments to or from any officer, director or such
employee or, to the knowledge of the Company, any corporation, partnership,
trust or entity in which any officer, director, or any such employee has a
substantial interest or is an officer, director, trustee or partner that is
required to be disclosed in the SEC Documents.
x. APPLICATION TO TAKEOVER PROTECTION. The Company and its
Board of Directors have taken all necessary action, if any, in order to
render inapplicable any control share acquisition, business combination or
other similar anti-takeover provision under the Certificate of Incorporation,
Bylaws or the laws of the state of incorporation which is or could become
applicable to the Purchasers or the Transaction Documents as a result of the
transactions contemplated by this Agreement or the Transaction Documents.
To the best of the Company's knowledge (based solely upon reports under
Section 13 of the Exchange Act filed with respect to the Company's Common Stock
and relying on the accuracy of the Purchasers' representations under
Section 2.2 hereof), none of the transactions contemplated by this Agreement
or the Transaction Documents, including the conversion of the Debentures and
the exercise of the Warrants, will trigger any poison pill provisions of any
of the Company's stockholders' rights or similar agreements.
y. ENVIRONMENTAL LAWS. Except as set forth on
SCHEDULE 2.1(z), the Company and its Subsidiaries (i) are in compliance with
any and all applicable foreign, federal, state and local laws and regulations
relating to the protection of human health and safety, the environment or
hazardous or toxic substances or wastes, pollutants or contaminants
("ENVIRONMENTAL LAWS"), (ii) have received all permits, licenses or other
approvals required of them under applicable Environmental Laws to conduct
their respective businesses and (iii) are in compliance with all terms and
conditions of any such permits, licenses or other approvals except where the
failure of any of the foregoing would not result in a Material Adverse Effect.
10
<PAGE>
z. FOREIGN CORRUPT PRACTICES. Neither the Company, nor any
of its Subsidiaries, nor any director, officer, agent, employee or other person
acting on behalf of the Company or any of its Subsidiaries has, in the course of
its actions for, or on behalf of, the Company (i) used any corporate funds for
any unlawful contribution, gift, entertainment or other unlawful expenses
relating to political activity, (ii) made any direct or indirect unlawful
payment to any foreign or domestic government official or employee from
corporate funds, (iii) violated (or is in violation of) any provision of the
U.S. Foreign Corrupt Practices Act of 1977, as amended, or (iv) made any
unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful
payment to any foreign or domestic government official or employee.
aa. SOLICITATION MATERIALS. The Company has not
(i) distributed any offering materials in connection with the offering and
sale of the Debentures or the Warrants, other than the SEC Documents, the
Schedules to this Agreement, any amendments and supplements thereto and the
materials listed on SCHEDULE 2.1(bb), or (ii) solicited any offer to buy or
sell the Debentures or the Warrants by means of any form of general
solicitation or advertising. Neither the Company, nor any of its Affiliates,
nor any Person acting on its or their behalf, has engaged or will engage in
any form of general solicitation or general advertising (within the meaning
of Regulation D under the Securities Act) in connection with the offer or
sale of the Debentures or Warrants.
bb. ACKNOWLEDGEMENT OF DILUTION. The Company acknowledges
that its obligation to issue Debenture Shares and Warrant Shares upon
conversion of the Debentures or exercise of the Warrants in accordance with
this Agreement, the Debentures and the Warrants is unaffected by any dilutive
effect that such issuance may have on the ownership interests of other
stockholders of the Company.
cc. ACKNOWLEDGEMENT REGARDING PURCHASERS' PURCHASE OF
DEBENTURES. The Company acknowledges and agrees that the Purchasers are
acting solely in the capacity of arm's length purchasers with respect to this
Agreement and the transactions contemplated hereby. The Company further
acknowledges that no Purchaser is acting as a financial advisor or fiduciary
of the Company (or in any similar capacity) with respect to this Agreement
and the transactions contemplated hereby and any statement made by any
Purchaser or any of their respective representatives or agents in connection
with this Agreement and the transactions contemplated hereby is not advice or
a recommendation and is merely incidental to the Purchasers' purchase of the
Debentures. The Company further represents to each Purchaser that the
Company's decision to enter into this Agreement has been based solely on the
independent evaluation of the Company and its representatives.
dd. SOLVENCY. Both before and after giving effect to the
transactions contemplated by this Agreement, (i) the fair value of the
Company's assets is greater than the sum of the Company's debts and (ii) the
Company believes that it has the ability to pay its existing debts as they
mature.
11
<PAGE>
ee. OTHER AGREEMENTS. The Company has not, directly or
indirectly, made any agreements with any Purchasers relating to the terms and
conditions of the transactions contemplated by the Transaction Documents
except as set forth in the Transaction Documents, except for the term sheet
letter, dated December 6, 1999 and as subsequently amended, which the parties
acknowledge shall be terminated and of no force and effect upon the Closing.
2.2 REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS. Each of the
Purchasers, severally and not jointly, hereby represents and warrants to the
Company as follows:
a. ORGANIZATION; AUTHORITY. Such Purchaser is a corporation
or a limited duration company or a limited liability company or limited
partnership duly formed, validly existing and in good standing under the laws
of the jurisdiction of its incorporation or formation with the requisite
power and authority, corporate or otherwise, to enter into and to consummate
the transactions contemplated hereby and by the Transaction Documents and
otherwise to carry out its obligations hereunder and thereunder. The purchase
by such Purchaser of the Debentures and the Warrants hereunder has been duly
authorized by all necessary action on the part of such Purchaser. Each of
this Agreement and the Registration Rights Agreement has been duly executed
and delivered by such Purchaser and constitutes the valid and legally binding
obligation of such Purchaser, enforceable against such Purchaser in
accordance with its terms, subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and similar laws of general
applicability relating to or affecting creditors' rights generally and to
general principles of equity, and except that rights to indemnification and
contribution may be limited by Federal or state securities laws or public
policy relating thereto.
b. INVESTMENT INTENT. Such Purchaser is acquiring the
Debentures and the Warrants for its own account and not with a present view
to or for distributing or reselling the Debentures, the Warrants, the
Debenture Shares or the Warrant Shares or any part thereof or interest
therein in violation of the Securities Act; PROVIDED, HOWEVER, that by making
the representations herein, such Purchaser does not agree to hold any of the
Debentures, the Warrants, the Debenture Shares or the Warrant Shares for any
minimum or other specific term and reserves the right to dispose of the
Debentures at any time in accordance with or pursuant to a registration
statement or an exemption under the Securities Act.
c. PURCHASER STATUS. At the time such Purchaser was offered
the Debentures and the Warrants, and at the Closing Date, (i) it was and will
be an "accredited investor" as defined in Rule 501 under the Securities Act
and (ii) such Purchaser, either alone or together with its representatives,
had and will have such knowledge, sophistication and experience in business
and financial matters so as to be capable of evaluating the merits and risks
of the prospective investment in the Debentures and the Warrants.
d. RELIANCE. Such Purchaser understands and acknowledges that
(i) the Debentures and the Warrants are being offered and sold to such
Purchaser without registration under the Securities Act in a private
placement that is exempt from the registration provisions of the Securities
Act under Section 4(2) of the Securities Act or Regulation D promulgated
thereunder and (ii) the availability of such exemption depends in part on,
and the Company will rely upon the accuracy and truthfulness of, the
representations set forth in this Section 2.2 and such Purchaser hereby
consents to such reliance.
12
<PAGE>
e. INFORMATION. Such Purchaser and its advisors, if any, have
been furnished with all materials relating to the business, finances and
operations of the Company and materials relating to the offer and sale of the
Debentures and Warrants which have been requested by such Purchaser or its
advisors. Such Purchaser and its advisors, if any, have been afforded the
opportunity to ask questions of the Company. Neither such inquiries nor any
other due diligence investigation conducted by Purchaser or any of its
advisors or representatives shall modify, amend or affect Purchaser's right
to rely on the Company's representations and warranties contained in Section
2.1 above or representations and warranties of the Company contained in any
other Transaction Document. Such Purchaser understands that its investment in
the Debentures and Warrants involves a significant degree of risk.
f. GOVERNMENTAL REVIEW. Such Purchaser understands that no
United States federal or state agency or any other government or governmental
agency has passed upon or made any recommendation or endorsement of the
Debentures or Warrants.
g. RESIDENCY. Such Purchaser is a resident of the
jurisdiction set forth immediately below such Purchaser's name on SCHEDULE II
hereto.
h. Such Purchaser is not an Affiliate of, and is not acting in
concert with or as a group (as defined in Rule 13d-3 under the Exchange Act)
with, any reporting person set forth in Amendment No. 2 to Schedule 13D
relating to the Company's Common Stock, filed on February 3, 1999 by, among
others, White Rock Capital, Inc. and, to the best of such Purchaser's
knowledge, upon the Closing, none of such persons will beneficially own any
of the Debentures, Warrants or Underlying Shares.
The Company acknowledges and agrees that the Purchasers make no
representations or warranties with respect to the transactions contemplated
hereby other than those specifically set forth in this Section 2.2.
13
<PAGE>
ARTICLE III.
OTHER AGREEMENTS
3.1 TRANSFER RESTRICTIONS.
a. If any Purchaser should decide to dispose of the
Debentures, the Warrants, the Debenture Shares or the Warrant Shares held by
it, such Purchaser understands and agrees that it may do so only pursuant to
an effective registration statement under the Securities Act, to the Company
or pursuant to an available exemption from the registration requirements of
the Securities Act or Rule 144 promulgated under the Securities Act ("RULE
144"). In connection with any transfer of any Debentures, Warrants, Debenture
Shares or Warrant Shares other than pursuant to an effective registration
statement, Rule 144 or to the Company, the Company may require the transferor
thereof to provide to the Company a written opinion of counsel experienced in
the area of United States securities laws selected by the transferor, the
form and substance of which opinion shall be customary for opinions of
counsel in comparable transactions, to the effect that such transfer does not
require registration of such transferred securities under the Securities Act.
Notwithstanding the foregoing, the Company hereby consents to and agrees to
register any transfer by any Purchaser to an Affiliate of such Purchaser,
provided that the transferee certifies to the Company that it is an
"accredited investor" as defined in Rule 501(a) under the Securities Act and
such Affiliate transferee agrees in writing to be bound by the terms of this
Agreement in which case the transferee shall have the rights of a Purchaser
under this Agreement and the Transaction Documents. If a Purchaser provides
the Company with an opinion of counsel, the form and substance of which
opinion shall be customary for opinions of counsel in comparable
transactions, to the effect that a public sale, assignment or transfer of the
Debentures, the Debenture Shares, the Warrants and the Warrant Shares may be
made without registration under the Securities Act. Notwithstanding the
foregoing or anything else contained herein to the contrary, the securities
may be pledged as collateral in connection with a BONA FIDE margin account or
other lending arrangement; PROVIDED, HOWEVER, that any such pledge shall not
affect the requirements of Section 3.1(b) below.
b. Each Purchaser agrees to the imprinting, so long as is
required by this Section 3.1(b), of the following legend on the Debentures,
the Warrants, the Debenture Shares and the Warrant Shares:
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
WITH THE SECURITIES AND EXCHANGE COMMISSION IN RELIANCE UPON AN
EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR UPON DELIVERY OF AN OPINION
OF COUNSEL THAT THE SECURITIES MAY BE TRANSFERRED PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.
14
<PAGE>
Neither the Debentures, the Warrants, the Debenture Shares nor the
Warrant Shares shall contain the legend set forth above (or any other legend) if
in the written opinion of counsel to the Company experienced in the area of
United States securities laws such legend is not required under applicable
requirements of the Securities Act (including judicial interpretations and
pronouncements issued by the staff of the Commission). The Company agrees that
it will provide each Purchaser, upon request, with a certificate or certificates
representing Securities, Warrants, Debenture Shares or Warrant Shares, free from
such legend at such time as such legend is no longer required hereunder. If such
certificate or certificates had previously been issued with such a legend or any
other legend, the Company shall, upon request and delivery of such certificate
or certificates to the Company by such Purchaser, reissue to such Purchaser such
certificate or certificates free of any legend.
c. Each Purchaser agrees not to transfer any Debentures,
Warrants, Debenture Shares or Warrant Shares in violation of the federal
securities laws or the securities laws of any state.
3.2 STOP TRANSFER INSTRUCTION. The Company may not make any notation on
its records or give instructions to any transfer agent of the Company which
enlarge the restrictions on transfer set forth in Section 3.1.
3.3 FURNISHING OF INFORMATION. As long as any Purchaser owns the
Debentures, the Warrants, the Debenture Shares or the Warrant Shares, the
Company will cause the Common Stock to continue at all times to be registered
under Section 12(g) of the Exchange Act, will timely file (or obtain
extensions in respect thereof and file within the applicable grace period)
all reports required to be filed by the Company after the date hereof
pursuant to Section 13, 14 or 15(d) of the Exchange Act and, unless filed by
EDGAR, promptly furnish, but in no event later than two (2) business days
after the filing thereof with the Commission, the Purchasers with true and
complete copies of all such filings, and will not take any action or file any
document (whether or not permitted by the Exchange Act or the rules
thereunder) to terminate or suspend such reporting and filing obligations. As
long as any Purchaser owns the Debentures, the Warrants, the Debenture Shares
or the Warrant Shares, if the Company is not required to file reports
pursuant to Section 13(a) or 15(d) of the Exchange Act, it will prepare and
furnish to the Purchasers and make publicly available in accordance with Rule
144(c) promulgated under the Securities Act annual and quarterly financial
statements, together with a discussion and analysis of such financial
statements in form and substance substantially similar to those that would
otherwise be required to be included in reports required by Section 13(a) or
15(d) of the Exchange Act, as well as any other information required thereby,
in the time period that such filings would have been required to have been
made under the Exchange Act. The Company also agrees to send the following to
each Purchaser prior to and during the Effectiveness Period (as defined in
the Registration Rights Agreement) copies of any notices and other
information made available or given to the stockholders of the Company
generally, contemporaneously with the making available or giving thereof to
the stockholders. The Company will also include each holder in its
distribution list for press releases by the Company or any of its
Subsidiaries for dissemination in accordance with its general operating
procedures. Upon the request of any such Person, the Company shall deliver to
such Person a written certification of a duly authorized officer as to
whether it has complied with the foregoing requirements. The Company further
covenants that it will take such further action as may be legally required to
enable any holder of
15
<PAGE>
the Debentures, the Warrants, the Debenture Shares or the Warrant Shares to sell
the Debentures, the Warrants, the Debenture Shares, or the Warrant Shares
without registration under the Securities Act within the limitation of the
exemptions provided by Rule 144 promulgated under the Securities Act, including
the legal opinion referenced above in Section 3.1(b).
3.4 BLUE SKY LAWS. In accordance with the Registration Rights
Agreement, during the Effectiveness Period (as defined in the Registration
Rights Agreement) the Company shall (i) qualify the Debenture Shares and the
Warrant Shares under the securities or "blue sky" laws of such jurisdictions
as the Purchasers may request (or to obtain an exemption from such
qualification), (ii) shall provide evidence of any such action so taken to
each Purchaser on or prior to the Closing Date and (iii) shall continue such
qualification at all times through the resale of all Debenture Shares or
Warrant Shares.
3.5 INTEGRATION. The Company shall not sell, offer for sale or solicit
offers to buy or otherwise negotiate in respect of any security (as defined
in Section 2 of the Securities Act) that would be integrated with the offer
or sale of the Debentures, the Warrants, the Debenture Shares or the Warrant
Shares in a manner that would require the registration under the Securities
Act of the sale of the Debentures, the Warrants, the Debenture Shares or the
Warrant Shares to any Purchaser. Notwithstanding the foregoing, each
Purchaser acknowledges that the Company may sell, offer for sale or solicit
offers to buy or otherwise negotiate in respect of any security of the
Company, including the Common Stock, for consideration equal to or less than
the current market value of such security.
3.6 LISTING, REGISTRATION AND RESERVATION OF DEBENTURE SHARES AND
WARRANT SHARES.
a. The Company shall (i) not later than three (3) business
days after the Closing Date prepare and file with Nasdaq an additional shares
listing application or a letter acceptable to Nasdaq covering and listing
1,700,000 shares of Common Stock (the "REQUIRED MINIMUM SHARES"), (ii) take
all commercially reasonable steps necessary to cause the Required Minimum
Shares to be approved for listing on Nasdaq as soon as possible thereafter,
(iii) maintain, so long as any other shares of Common Stock shall be so
listed, such listing of all such Required Minimum Shares on Nasdaq (as well
as on any other national securities exchange or market on which the Common
Stock is then listed), and (iv) provide to the Purchasers evidence of such
listing. Neither the Company nor any of its Subsidiaries shall take any
action which may result in the delisting or suspension of the Common Stock on
Nasdaq. The Company shall pay all fees and expenses in connection with
satisfying its obligations under this Section 3.6(a).
b. The number of shares of Common Stock initially included in
the Initial Registration Statement (as defined in the Registration Rights
Agreement) shall be the Required Minimum Shares.
16
<PAGE>
c. The Company at all times shall reserve the Required Minimum
Shares. If at any time the number of shares of Common Stock authorized and
reserved for issuance is insufficient to cover the number of Debenture Shares
and Warrant Shares issuable upon conversion of the outstanding Debentures and
exercise of the outstanding Warrants (based on the Conversion Price (as
defined in the Debenture) of the Debentures in effect from time to time and
the Exercise Price (as defined in the Warrants) of the Warrants in effect
from time to time) without regard to any limitation on conversions or
exercises, the Company will promptly take all corporate action reasonably
necessary to authorize and reserve such shares pursuant to Section 3(b) of
the Registration Rights Agreement, including, without limitation, calling a
special meeting of stockholders to authorize additional shares to meet the
Company's obligations under this Section 3.6(c), in the case of an
insufficient number of authorized shares, and using commercially reasonable
efforts to obtain stockholder approval of an increase in such authorized
number of shares.
3.7 NOTICE OF BREACHES.
a. The Company and each Purchaser shall give prompt written
notice to the other of any breach by it of any representation, warranty or
other agreement contained in this Agreement or in the Transaction Documents,
as well as any events or occurrences arising after the date hereof and prior
to the Closing Date, which would reasonably be likely to cause any
representation or warranty or other agreement of such party, as the case may
be, contained herein to be incorrect or breached as of the Closing Date;
provided such notice will not constitute material non-public information.
However, no disclosure by either party pursuant to this Section 3.7 shall be
deemed to cure any breach of any representation, warranty or other agreement
contained herein or in the Transaction Documents.
b. Notwithstanding the generality of Section 3.7(a), the
Company shall promptly notify, provided such notification will not constitute
material non-public information, each Purchaser of any notice or claim
(written or oral) that it receives from any lender of the Company or any
Subsidiary with respect to indebtedness in excess of $2,000,000 to the effect
that the consummation of the transactions contemplated hereby and by the
Transaction Documents violates or would violate any written agreement or
understanding between such lender and the Company or any Subsidiary, and the
Company shall promptly furnish by facsimile to the Purchasers a copy of any
written statement in support of or relating to such claim or notice.
c. The default by any Purchaser of any of its obligations,
representations or warranties under this Agreement or the Transaction
Documents shall not be imputed to, and shall have no effect upon, any other
Purchaser or affect the Company's obligations under this Agreement or any
Transaction Document to any non-defaulting Purchaser.
3.8 FORM D. The Company agrees to file a Form D with respect to the
Debentures and Warrants as required by Rule 506 under Regulation D and to
provide a copy thereof to each Purchaser promptly after such filing.
17
<PAGE>
3.9 FUTURE FINANCINGS.
a. Except for issuance of (i) the Underlying Shares,
(ii) shares of Common Stock deemed to have been issued by the Company in
connection with any plan which has been approved by the Board of Directors of
the Company, pursuant to which the Company's securities may be issued to any
employee, officer, director or consultant of the Company, (iii) shares of
Common Stock issuable upon the exercise of any options or warrants
outstanding on the date hereof and listed in SCHEDULE 2.1(c) hereto,
(iv) shares of Common Stock issued or deemed to have been issued as
consideration for an acquisition by the Company of a division, assets or
business (or stock constituting any portion thereof) from another Person,
(v) shares of Common Stock issuable pursuant to any event for which an
adjustment to the Conversion Price is required pursuant to Section 4.5 of the
Debenture, (vi) any other shares of Common Stock issued for which the Company
receives no consideration, or (vii) shares of Common Stock or other securities
convertible into or exchangeable or exercisable for Common Stock issued in an
offering registered under the Securities Act, if the Company agrees to issue
shares of Common Stock or other securities convertible into or exchangeable
or exercisable for Common Stock (the "NEW SECURITY") while any Debentures are
outstanding (a "FUTURE FINANCING"), the Company shall provide to the
Purchasers written notice of the Future Financing containing in reasonable
detail (i) the proposed terms of the Future Financing, (ii) the amount of the
proceeds that will be raised and (iii) the Person with whom such Future
Financing shall be effected, and attached to which shall be a term sheet or
similar document relating thereto (the "FUTURE FINANCING NOTICE"). Upon
receiving the Future Financing Notice, each Purchaser shall have the pro rata
right (based on the principal amount of the Debentures held by such Purchaser
relative to the aggregate principal amount of Debentures outstanding) to
purchase, on the same terms as the Future Financing, that percentage of the
New Securities equal to (i) the sum of (x) the number of shares of Common
Stock which may be purchased upon conversion by the amount of the then
outstanding principal amount of such Purchaser's Security plus (y) the number
of shares of Common Stock underlying the Purchaser's outstanding Warrants
divided by (ii) the aggregate number of shares of Common Stock outstanding on
a fully diluted basis immediately prior to the issuance of the New
Securities. In the event the terms and conditions of a proposed Future
Financing are amended in any respect after delivery of the Future Financing
Notice but prior to the closing of the proposed Future Financing to which
such Future Financing Notice relates, the Company shall deliver a new notice
to each Purchaser describing the amended terms and conditions of the proposed
Future Financing and each Purchaser thereafter shall have an option during
the two (2) Trading Day period following delivery of such new notice to
purchase its pro rata share (in accordance with the terms hereof) of the New
Securities being offered on the same terms as contemplated by such proposed
Future Financing, as amended. The foregoing sentence shall apply to
successive amendments to the terms and conditions of any proposed Future
Financing. Those Purchasers desiring to purchase additional shares of Common
Stock must notify the Company of their intention to do so within five (5)
Trading Days after the Company has informed the Purchasers of their right to
purchase additional shares of Common Stock. Within five (5) Trading Days of
the termination of the final notice period, the transactions contemplated by
this Section 3.9 shall close, subject to the completion of mutually
satisfactory documentation, and the Company shall tender to each Purchaser
certificates representing the New Securities that it agreed to purchase and
the Purchasers shall make payment for the entire purchase price in
immediately available funds at the closing of such sale; PROVIDED, HOWEVER,
that each Purchaser, in lieu of providing cash as consideration for the
purchase price, may retire all or a portion of the outstanding principal
amount of and any interest owing on the Debentures as
18
<PAGE>
payment of the purchase price for the shares of Common Stock that it desires to
purchase pursuant to this Section 3.9. "TRADING DAY" shall mean a day on which
the Nasdaq (or in the event the Common Stock is not traded on Nasdaq, such other
securities market on which the Common Stock is listed) is open for trading.
b. Except as set forth in 3.9(a)(i)-(v) and 3.9(a)(vii) above,
until such time as the Initial Registration Statement (as defined in the
Registration Rights Agreement) shall be declared effective by the Securities
and Exchange Commission the Company shall not offer any equity securities at
a price lower than the Conversion Price (as defined in the Debenture).
3.10 USE OF PROCEEDS. The Company shall use the proceeds from the sale
of the Debentures and the exercise of the Warrants for capital expenditures;
research and development; expansion of sales, customer support and marketing
functions; working capital and possible strategic acquisitions.
3.11 TRANSACTIONS WITH AFFILIATES. So long as any Debentures or
Warrants are outstanding, the Company shall not, and shall cause each of its
Subsidiaries not to, enter into, amend, modify or supplement, or permit any
Subsidiary to enter into, amend, modify or supplement, any agreement,
transaction, commitment or arrangement involving more than $50,000 with any
of its or any Subsidiary's officers, directors, stockholders who beneficially
own 5% or more of the Common Stock, or Affiliates or any individual related
by blood, marriage or adoption to any such individual or with any entity in
which any such entity or individual owns a 5% or more beneficial interest
(each a "RELATED PARTY"), except for (a) customary employment arrangements
and benefit programs on reasonable terms, (b) any agreement, transaction,
commitment or arrangement on an arms-length basis on terms no less favorable
than terms which would have been obtainable from a Person other than such
Related Party, or (c) any agreement, transaction, commitment or arrangement
which is approved by a majority of the disinterested directors of the
Company. "AFFILIATE" for purposes of this section only means, with respect to
any person or entity, another person or entity that, directly or indirectly,
(i) has a 5% or more equity interest in that person or entity, (ii) has 5% or
more common ownership with that person or entity, (iii) controls that person
or entity, or (iv) shares common control with that person or entity.
"CONTROL" or "CONTROLS" for purposes of this section means that a person or
entity has the power, direct or indirect, to conduct or govern the policies
of another person or entity.
3.12 TRANSFER AGENT INSTRUCTIONS. At the Closing the Company shall
issue irrevocable instructions to its transfer agent (and shall issue to any
subsequent transfer agent as required), to issue certificates, registered in
the name of each such Purchaser or its respective nominee(s), for the
Debenture Shares and/or the Warrant Shares in such amounts as specified from
time to time by each Purchaser to the Company in the form attached hereto as
EXHIBIT F (the "IRREVOCABLE TRANSFER AGENT INSTRUCTIONS"). The Company
warrants that no instruction other than the Irrevocable Transfer Agent
Instructions referred to in this Section 3.12, and stop transfer instructions
to give effect to Section 3.1 hereof (in the case of the Debenture Shares and
the Warrant Shares, prior to registration of the Debenture Shares and the
Warrant Shares under the Securities Act) will be given by the Company to its
transfer agent and that the Debentures, the Warrants, the Debenture Shares
and the Warrant Shares shall otherwise be freely transferable on the books
and records of the Company as and to the extent provided in this Agreement
and the
19
<PAGE>
Transaction Documents. The Company acknowledges that a breach by it of its
obligations hereunder will cause irreparable harm to the Purchasers by violating
the intent and purpose of the transactions contemplated hereby. Accordingly, the
Company acknowledges that the remedy at law for a breach of its obligations
under this Section 3.12 will be inadequate and agrees, in the event of a beach
or threatened breach by the Company of the provisions of this Section 3.12, that
the Purchasers shall be entitled, in addition to all other available remedies,
to an order and/or injunction restraining any breach and requiring immediate
issuance and transfer without the necessity of showing economic loss and without
any bond or other security being required.
3.13 ORDINARY COURSE BROKERAGE AND TRADING. Subject to compliance with
all applicable securities laws and Nasdaq regulations, the Company
acknowledges that the Purchasers may engage in ordinary course brokerage and
trading activities in respect of the Company's Common Stock; PROVIDED that
the personnel engaged in such activities have not been involved with the
transactions contemplated hereby and have not been provided with confidential
information with respect to the Company.
3.14 COMMERCIALLY REASONABLE EFFORTS. Each of the parties hereto shall
use all commercially reasonable efforts to satisfy each of the conditions to
be satisfied by it as provided in Article IV of this Agreement.
3.15 NO VIOLATION OF APPLICABLE LAW. Notwithstanding any provision of
this Agreement to the contrary, if the redemption of Debentures or Underlying
Shares otherwise required under this Agreement or the Registration Rights
Agreement would be prohibited by the relevant provisions of the General
Corporation Law of the Stare of Delaware, if applicable, such redemption
shall be effected as soon as it is permitted under such law; provided,
however, that from the fifth (5th) day after such redemption notice until
such redemption price is paid in full, interest on any such unpaid amount
shall accrue and be payable at the rate of 15% per annum in accordance with
the Debentures.
3.16 MATERIAL INFORMATION. The Company covenants that any information
provided by the Company to the Purchasers and their agents or their counsel
which could be deemed to constitute material non-public information will
cease to be material non-public information (either through disclosure by the
Company or otherwise) by the date on which the Initial Registration Statement
(as defined in the Registration Rights Agreement) is declared effective.
ARTICLE IV.
CONDITIONS
4.1 CLOSING CONDITIONS.
a. CONDITIONS PRECEDENT TO THE OBLIGATION OF THE COMPANY TO
SELL. The obligation of the Company to sell the Debentures and the Warrants
hereunder is subject to the satisfaction or waiver (with prior written notice
to each Purchaser) by the Company, at or before the Closing, of each of the
following conditions:
20
<PAGE>
i. ACCURACY OF THE PURCHASERS' REPRESENTATIONS AND WARRANTIES.
The representations and warranties of each Purchaser in this Agreement shall
be true and correct in all material respects as of the date when made as
though made at that time (except for representations and warranties that
speak as of a specific date) and as of the Closing Date;
ii. PERFORMANCE BY THE PURCHASERS. Each Purchaser shall have
performed, satisfied and complied in all material respects with all
covenants, agreements and conditions required by this Agreement to be
performed, satisfied or complied with by such Purchaser at or prior to the
Closing; and
iii. NO INJUNCTION. No statute, rule, regulation, executive
order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent
jurisdiction which prohibits the consummation of any of the transactions
contemplated by this Agreement or the Transaction Documents.
b. CONDITIONS PRECEDENT TO THE OBLIGATION OF THE PURCHASERS TO
PURCHASE. The obligation of each Purchaser hereunder to acquire and pay for
the Debentures and Warrants is subject to the satisfaction or waiver (with
prior written notice to the Company and each other Purchaser) by such
Purchaser, at or before the Closing, of each of the following conditions:
i. ACCURACY OF THE COMPANY'S REPRESENTATIONS AND WARRANTIES.
The representations and warranties of the Company set forth in this Agreement
shall be true and correct in all material respects as of the date when made
as though made at that time (except for representations and warranties that
speak as of a specific date and as of the Closing Date);
ii. PERFORMANCE BY THE COMPANY. The Company shall have
performed, satisfied and complied in all material respects with all
covenants, agreements and conditions required by this Agreement to be
performed, satisfied or complied with by the Company at or prior to the
Closing;
iii. NO INJUNCTION. No statute, rule, regulation, executive
order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent
jurisdiction which prohibits the consummation of any of the transactions
contemplated by this Agreement and the Transaction Documents;
iv. NO SUSPENSIONS OF TRADING IN COMMON STOCK. The trading in
the Common Stock shall not have been suspended by the Commission or on Nasdaq
(except for any suspension of trading of limited duration solely to permit
dissemination of material information regarding the Company);
v. LISTING OF COMMON STOCK. The Common Stock shall have been
at all times since the date hereof, and on the Closing Date shall be, listed
for trading on Nasdaq;
vi. REQUIRED APPROVALS. All Required Approvals shall have
been obtained and copies thereof delivered to such Purchaser;
21
<PAGE>
vii. SHARES OF COMMON STOCK. The Company shall have duly
reserved the number of Underlying Shares required by this Agreement and the
Transaction Documents to be reserved for issuance upon conversion of the
Debentures and the exercise of the Warrants;
viii. CHANGE OF CONTROL. No Change of Control shall have
occurred between the date hereof and the Closing Date. "CHANGE OF CONTROL"
means the occurrence of any of (i) an acquisition after the date hereof by an
individual or legal entity or "group" (as described in Rule 13d-5(b)(1)
promulgated under the Exchange Act), other than the Purchasers or any of
their Affiliates, of in excess of 33% of the voting securities of the
Company, (ii) a replacement of more than one-half of the members of the
Company's Board of Directors which is not approved by those individuals who
are members of the Board of Directors on the date hereof in one or a series
of related transactions, (iii) the merger of the Company with or into another
entity, consolidation or sale of all or substantially all of the assets of
the Company in one or a series of related transactions, (iv) the Involuntary
Termination of Samuel J. Wohlstadter or (vi) the execution by the Company of
an agreement to which the Company is a party or by which it is bound,
providing for any of the events set forth above in (i), (ii) , (iii), (iv) or
(v). The term "Involuntary Termination" shall mean any termination by the
Board of Directors of Samuel J. Wohltstadter's employment as Chief Executive
Officer of the Company except any termination by reason of death, disability,
mutual agreement between Samuel J. Wohltstadter and the Board of Directors or
where the Board of Directors, in the exercise of its fiduciary duties
determines with the advice of counsel that the Involuntary Termination is
necessary or advisable.
ix. TRANSFER AGENT INSTRUCTIONS. The Irrevocable Transfer
Agent Instructions, in a form acceptable to the Purchasers, shall have been
delivered to and acknowledged in writing by the Company's transfer agent with
a copy forwarded to each Purchaser; and
x. RESOLUTIONS. The Board of Directors of the Company shall
have adopted resolutions consistent with Section 2.1(b) (the "RESOLUTIONS").
c. DOCUMENTS AND CERTIFICATES. At the Closing, the Company
shall have delivered to the Purchasers the following in form and substance
reasonably satisfactory to the Purchasers:
i. OPINION. An opinion of the Company's legal counsel in the
form attached hereto as EXHIBIT D dated as of the Closing Date;
ii. SECURITY. A Security(ies) representing the principal
amount of Debentures purchased by such Purchaser as set forth next to such
Purchaser's name on SCHEDULE I, registered in the name of such Purchaser,
each in form satisfactory to the Purchaser;
iii. WARRANT. A Warrant(s) representing the Warrants
purchased by such Purchaser as set forth next to such Purchaser's name on
SCHEDULE I, registered in the name of such Purchaser;
iv. REGISTRATION RIGHTS. The Company shall have executed and
delivered the Registration Rights Agreement;
22
<PAGE>
v. OFFICER'S CERTIFICATE. An Officer's Certificate dated the
Closing Date and signed by an executive officer of the Company confirming the
accuracy of the Company's representations, warranties and covenants as of the
Closing Date and confirming the compliance by the Company with the conditions
precedent set forth in this Section 4.1 as of the Closing Date;
vi. SECRETARY'S CERTIFICATE. A Secretary's Certificate dated
the Closing Date and signed by the Secretary or Assistant Secretary of the
Company certifying (A) that attached thereto is a true and complete copy of
the Certificate of Incorporation of the Company, as in effect on the Closing
Date, (B) that attached thereto is a true and complete copy of the By-laws of
the Company, as in effect on the Closing Date and (C) that attached thereto
is a true and complete copy of the Resolutions duly adopted by the Board of
Directors of the Company authorizing the execution, delivery and performance
of this Agreement and of the Transaction Documents, and that such Resolutions
have not been modified, rescinded or revoked;
vii. CERTIFICATES OF INCORPORATION. The Company shall have
delivered to each of the Purchasers a copy of a certificate evidencing the
incorporation and good standing of the Company and each Subsidiary, in such
corporation's state of incorporation issued by the Secretary of State of such
state of incorporation as of a date within ten days of the Closing Date. The
Company shall have delivered to each of the Purchasers a copy of its
Certificate of Incorporation as certified by the Secretary of State of the
State of Delaware within ten days of the Closing Date;
viii. TRANSFER AGENT LETTER. The Company shall have delivered
to each Purchaser a letter from the Company's transfer agent certifying the
number of shares of Common Stock outstanding as of a date within five days of
the Closing Date;
ix. LOCKUP LETTERS. Chief Executive Officer, Samuel J.
Wohlstadter shall have delivered to the Purchasers a letter in the form of
Exhibit E hereto pursuant to which he agrees not to offer or sell shares of
Common Stock he beneficially owns under certain circumstances as set forth in
such letter; and
x. OTHER DOCUMENTS. The Company shall have delivered to each
Purchaser such other documents relating to the transactions contemplated by
the Transaction Documents as the Purchasers or its counsel may reasonably
request.
ARTICLE V.
INDEMNIFICATION
5.1 INDEMNIFICATION.
23
<PAGE>
a. In addition to all of the Company's other obligations under
this Agreement and the Transaction Documents, the Company shall defend,
protect, indemnify and hold harmless each Purchaser, its past and present
Affiliates and their successors and assigns (in accordance with the
provisions of Section 6.5 hereof), each other permitted transferee of the
Debentures and all of their stockholders, officers, directors, employees and
direct or indirect investors and any of the foregoing Person's agents or
other representatives (including, without limitation, those retained in
connection with the transactions contemplated by this Agreement)
(collectively, the "INDEMNITEES") from and against any and all actions,
causes of action, suits, claims, losses, proceedings, costs (as incurred),
penalties, fees (including legal fees and expenses), liabilities and damages,
and expenses in connection therewith (irrespective of whether any such
Indemnitee is a party to the action for which indemnification hereunder is
sought), and including interest, penalties and attorneys' fees and
disbursements (the "INDEMNIFIED LIABILITIES"), incurred by any Indemnitee as
a result of, or arising out of, or relating to (a) any material
misrepresentation or material breach of any representation or warranty made
by the Company in this Agreement or in the Transaction Documents, or any
other certificate, instrument or document contemplated hereby or thereby, (b)
any material breach of any covenant, agreement or obligation of the Company
contained in this Agreement or the Transaction Documents, or any other
certificate, instrument or document contemplated hereby or thereby, or (c)
any cause of action, suit or claim brought or made or threatened, other than
by the Company, against such Indemnitee and arising out of or resulting from
(i) the execution, delivery, registration, performance or enforcement of this
Agreement or the Transaction Documents, (ii) any transaction financed or to
be financed in whole or in part, directly or indirectly, with the proceeds of
the issuance of the Debentures or Warrants or (iii) solely the status of such
Purchasers or holder of the Debentures, the Debenture Shares, the Warrants or
the Warrant Shares as an investor in the Company. The Company also agrees
that neither the Purchasers nor any such Affiliates, partners, directors,
agents, employees or controlling Persons shall have any liability to the
Company or any Person asserting claims on behalf of or in right of the
Company in connection with or as a result of the consummation of this
Agreement or any of the Transaction Documents except to the extent that any
losses, claims, damages, liabilities or expenses incurred by the Company
result from the gross negligence or willful misconduct of such Purchaser or
entity in connection with the transactions contemplated by this Agreement or
the Transaction Documents. To the extent that the foregoing undertaking by
the Company may be unenforceable for any reason, the Company shall make the
maximum contribution to the payment and satisfaction of each of the
Indemnified Liabilities which is permissible under applicable law.
b. All fees and expenses (including reasonable fees and
expenses to the extent incurred in connection with investigating or preparing
to defend such Proceeding in a manner not inconsistent with this Section) of
the Indemnitees shall be paid to the Indemnitees as incurred, within ten (10)
Business Days of written notice thereof to the Company, which notice shall be
delivered no more frequently than on a monthly basis (regardless of whether
it is ultimately determined that an Indemnitee is not entitled to
indemnification hereunder; PROVIDED, that the Company may require such
Indemnitee to undertake to reimburse all such fees and expenses to the extent
it is finally judicially determined that such Indemnitee is not entitled to
indemnification hereunder).
24
<PAGE>
ARTICLE VI.
MISCELLANEOUS
6.1 ENTIRE AGREEMENT. This Agreement, together with the
Exhibits and Schedules hereto and the Transaction Documents contain the
entire understanding of the parties with respect to the subject matter hereof
and supersede all prior agreements and understandings, oral or written, with
respect to such matters.
6.2 NOTICES. Any notices, consents, waivers or other
communications required or permitted to be given under the terms of this
Agreement must be in writing and will be deemed to have been delivered (i)
upon receipt, when delivered personally; (ii) upon receipt, when sent by
facsimile, provided confirmation of transmission is mechanically or
electronically generated and kept on file by the sending party (if received
by 5:30 p.m. EST where such notice is received) or the first business day
following such delivery (if received after 5:30 p.m. EST where such notice is
received); or (iii) one business day after deposit with a nationally
recognized overnight delivery service; provided that confirmation of the
delivery is generated and kept on file by the sending party, in each case
properly addressed to the party to receive the same. The addresses and
facsimile numbers for such communications shall be:
If to the Company:
IGEN International, Inc.
16020 Industrial Drive
Gaithersburg, MD 20877
Attn: Mr. George V. Migausky
Tel: 301-869-9800
Fax: 301-208-3798
With a copy to:
Wilmer, Cutler & Pickering
2445 M Street, N.W.
Washington, DC 20037
Attn: Meredith B. Cross, Esq.
Tel: 202-663-6000
Fax: 202-663-6363
If to Brown Simpson Strategic Growth Fund, Ltd. to:
152 West 57th Street, 40th Floor
New York, New York 10029
Telephone: (212) 247-8200
Facsimile: (212) 247-1329
Attention: Peter Greene
25
<PAGE>
If to Brown Simpson Strategic Growth Fund, L.P. to:
152 West 57th Street, 40th Floor
New York, New York 10029
Telephone: (212) 247-8200
Facsimile: (212) 247-1329
Attention: Peter Greene
With a copy, in the case of Notice to Brown Simpson
Strategic Growth Fund, Ltd. or Brown Simpson Strategic
Growth Fund, L.P., to:
Akin, Gump, Strauss, Hauer & Feld, L.L.P.
590 Madison Avenue
New York, New York 10022
Telephone: (212) 872-1000
Facsimile: (212) 872-1002
Attention: James Kaye
If to LBI Group Inc. to:
c/o Lehman Brothers, Inc.
3 World Financial Center
New York, New York 10285
Telephone: (212) 526-7255
Facsimile: (212) 526-2198
Attention: Steve Weinstein
Each party shall provide written notice to the other party of any change in
address or facsimile number in accordance with the provisions hereof.
6.3 AMENDMENTS; WAIVERS. No provision of this Agreement may be waived
or amended except in a written instrument signed, in the case of an
amendment, by both the Company and each of the Purchasers or, in the case of
a waiver, by the party against whom a waiver of any such provision is sought.
No waiver of any default with respect to any provision, condition or
requirement of this Agreement shall be deemed to be a continuing waiver in
the future or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of either party to exercise any right
hereunder in any manner impair the exercise of any such right accruing to it
thereafter. Notwithstanding the foregoing, no such amendment shall be
effective to the extent that it applies to less than all of the holders of
the Debentures outstanding. The Company shall not offer or pay any
consideration to a Purchaser for consenting to such an amendment or waiver
unless the same consideration is offered to each Purchaser and the same
consideration is paid to each Purchaser which consents to such amendment or
waiver.
6.4 HEADINGS. The headings herein are for convenience only, do not
constitute a part of this Agreement and shall not be deemed to limit or
affect any of the provisions hereof.
6.5 SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and
inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign
26
<PAGE>
this Agreement or any rights or obligations hereunder without the prior written
consent of each of the Purchasers. The Purchasers may assign this Agreement or
any rights or obligations hereunder without the prior written consent of the
Company, provided, that such assignment is in accordance with Section 3.1 hereof
and that any assignees must make the representations and warranties set forth in
Section 2.2 and otherwise comply with the terms of this Agreement otherwise
applicable to its assignor. This provision shall not limit a Purchaser's right
to transfer securities in accordance with all of the terms of this Agreement and
the other Transaction Documents.
6.6 NO THIRD-PARTY BENEFICIARIES. This Agreement is intended for the
benefit of the parties hereto and their respective permitted successors and
assigns and is not for the benefit of, nor may any provision hereof be
enforced by, any other Person.
6.7 GOVERNING LAW. This Agreement shall be governed by and construed
and enforced in accordance with the internal laws of the State of New York
without regard to the principles of conflicts of law thereof, except with
respect to matters mandatorily governed by the Delaware General Corporation
Law. Each party hereby irrevocably submits to the nonexclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of
Manhattan, for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein, and
hereby irrevocably waives, and agrees not to assert in any suit, action or
proceeding, any claim that it is not personally subject to the jurisdiction
of any such court, that such suit, action or proceeding is improper. Each
party hereby irrevocably waives personal service of process and consents to
process being served in any such suit, action or proceeding by mailing a copy
thereof to such party at the address for such notices to it under this
Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be
deemed to limit in any way any right to serve process in any manner permitted
by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND
AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY
TRANSACTION CONTEMPLATED HEREBY.
6.8 SURVIVAL. The representations and warranties of the Company and the
Purchasers contained in Sections 2.1 and 2.2, the agreements and covenants
set forth in Section 3, and the indemnification provisions set forth in
Section 5, shall survive the Closing and any conversion of the Debentures or
exercise of the Warrants regardless of any investigation made by or on behalf
of the such Purchaser or by or on behalf of the Company until the expiration
of the Effectiveness Period (as defined in the Registration Rights
Agreement). This section shall have no effect on the survival of the
indemnification provisions of the Registration Rights Agreement.
6.9 COUNTERPARTS. This Agreement may be executed in two or more
counterparts, all of which when taken together shall be considered one and
the same agreement and shall become effective when counterparts have been
signed by each party and delivered to the other party, it being understood
that both parties need not sign the same counterpart. In the event that any
signature is delivered by facsimile transmission, such signature shall create
a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) the same with the same force and effect as if
such facsimile signature page were an original thereof.
27
<PAGE>
6.10 PUBLICITY. The Company and the Purchasers shall consult with each
other in issuing any press releases or otherwise making public statements
with respect to the transactions contemplated hereby and neither party shall
issue any such press release or otherwise make any such public statement
without the prior written consent of the other, which consent shall not be
unreasonably withheld or delayed, except that no prior consent shall be
required if such disclosure is required by law, in which such case the
disclosing party shall provide the other party with prior notice of such
public statement.
6.11 SEVERABILITY. In case any one or more of the provisions of this
Agreement shall be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Agreement shall
not in any way be affected or impaired thereby and the parties will attempt
to agree upon a valid and enforceable provision which shall be a reasonable
substitute therefor, and upon so agreeing, shall incorporate such substitute
provision in this Agreement.
6.12 REMEDIES. In addition to being entitled to exercise all rights
provided herein or granted by law, including recovery of damages, the
Purchasers may be entitled to specific performance of the obligations of the
Company under this Agreement or the Transaction Documents. Each of the
Company and the Purchasers (severally and not jointly) agree that monetary
damages may not be adequate compensation for any loss incurred by reason of
any breach of its obligations described in the foregoing sentence.
6.13 INDEPENDENT NATURE OF PURCHASERS' OBLIGATIONS AND RIGHTS. The
obligations of each Purchaser hereunder is several and not joint with the
obligations of the other Purchasers hereunder, and no Purchaser shall be
responsible in any way for the performance of the obligations of any other
Purchaser hereunder. Nothing contained herein or in any other agreement or
document delivered at any closing, and no action taken by any Purchaser
pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a
partnership, an association, a joint venture or any other kind of entity, or
create a presumption that the Purchasers are in any way acting in concert
with respect to such obligations or the transactions contemplated by this
Agreement. The Company and each Purchaser shall be entitled to protect and
enforce its rights, including without limitation the rights arising out of
this Agreement or out of the Transaction Documents, and it shall not be
necessary for any other Purchaser to be joined as an additional party in any
proceeding for such purpose.
6.14 PAYMENT SET ASIDE. To the extent that the Company makes a payment
or payments to the Purchasers hereunder or pursuant to the Transaction
Documents or the Purchasers enforce or exercise their rights hereunder or
thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared
fraudulent or preferential, set aside, recovered from, disgorged by or are
required to be refunded, repaid or otherwise restored to the Company, a
trustee, receiver or any other Person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable
cause of action), then to the extent of any such restoration the obligation
or part thereof originally intended to be satisfied shall be revived and
continued in full force and effect as if such payment had not been made or
such enforcement or setoff had not occurred.
28
<PAGE>
6.15 FURTHER ASSURANCES. Each party shall do and perform, or cause to
be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and
documents, as the other party may reasonably request in order to carry out
the intent and accomplish the purposes of this Agreement and the consummation
of the transactions contemplated hereby.
6.16 FEES AND EXPENSES. Except as set forth in the Registration Rights
Agreement, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses
incurred by such party incident to the negotiation, preparation, execution,
delivery and performance of this Agreement. The Purchasers acknowledge that
the Company has paid an aggregate fee of $45,000 to the Purchasers. The
Company shall pay all stamp and other taxes and duties levied in connection
with the issuance of the Debenture Shares and the Warrant Shares pursuant
hereto.
IN WITNESS WHEREOF, the parties hereto have caused this Securities
Purchase Agreement to be duly executed by their respective authorized persons as
of the date first indicated above.
IGEN INTERNATIONAL, INC.
By: /s/ Samuel J. Wohlstadter
---------------------------
Name: Samuel J. Wohlstadter
Title: Chief Executive Officer
29
<PAGE>
BROWN SIMPSON STRATEGIC
GROWTH FUND, LTD.
By: Brown Simpson Asset Management, LLC
By: /s/ Evan Levine
---------------------------
Name: Evan Levine
Title: Principal
BROWN SIMPSON STRATEGIC
GROWTH FUND, L.P.
By: Brown Simpson Capital, LLC
its general partner
By: /s/ Evan Levine
---------------------------
Name: Evan Levine
Title: Principal
LBI GROUP INC.
By: /s/ Steven Berkenfeld
---------------------------
Name: Steven Berkenfeld
Title: Senior Vice President
30
<PAGE>
SCHEDULE I
<TABLE>
<CAPTION>
Principal Amount of Debenture Shares Warrant Shares
Name of Purchaser Securities At Closing Date At Closing Date At Closing Date
- ----------------- -------------------------- --------------- ---------------
<S> <C> <C> <C>
Brown Simpson Strategic $9,000,000 290,322.6 72,581
Growth Fund, L.P.
Brown Simpson Strategic $16,000,000 516,129 129,032
Growth Fund, Ltd.
LBI Group Inc. $10,000,000 322,580.6 80,645
</TABLE>
<PAGE>
SCHEDULE II
Name of Purchaser Address
- ----------------- -------
Brown Simpson Strategic Growth Fund, Ltd. 152 West 57th Street, 40th Floor
New York, New York 10019
Attn: Peter Greene
Fax: (212) 247-1329
Residence: Grand Cayman,
Cayman Islands
Brown Simpson Strategic Growth Fund, L.P. 152 West 57th Street, 40th Floor
New York, New York 10019
Attn: Peter Greene
Fax: (212) 247-1329
Residence: New York, New York
LBI Group Inc. c/o Lehman Brothers, Inc.
3 World Financial Center
New York, New York 10285
Attention: Steve Weinstein
Facsimile: (212) 526-2198
<PAGE>
EXHIBIT A
5% SUBORDINATED CONVERTIBLE DEBENTURES
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
WITH THE SECURITIES AND EXCHANGE COMMISSION IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), OR QUALIFIED UNDER APPLICABLE STATE SECURITIES OR BLUE SKY LAWS, AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND APPLICABLE STATE SECURITIES OR BLUE SKY
LAWS. THE DEBENTURES AND THE SECURITIES REPRESENTED BY THIS DEBENTURE ARE
SUBJECT TO SUBSTANTIAL RESTRICTIONS ON TRANSFER.
No. __ $__________
IGEN INTERNATIONAL, INC.
5% SUBORDINATED CONVERTIBLE DEBENTURES
DUE JANUARY 11, 2005
IGEN International, Inc., a Delaware corporation (the
"COMPANY"), for value received hereby promises to pay to ___________ or its
registered assigns ("HOLDER") the principal amount of ______ Dollars ($________)
at the Company's office or agency for said purpose in New York, New York on
January 11, 2005 in such coin or currency of the United States of America as at
the time of payment shall be legal tender for the payment of public and private
debts at the address of the Holder (as defined herein) last appearing on the
Register (as defined herein).
This Debenture is one of a duly authorized issue of 5%
Subordinated Convertible Debentures, due January 11, 2005 of the Company (the
"DEBENTURE") issued pursuant to the Securities Purchase Agreement (the "PURCHASE
AGREEMENT"), dated as of January 11, 2005, by and among the Company and the
Purchasers listed on Schedule I thereto. The Debentures are subject to the terms
and conditions of the Purchase Agreement. A Holder may transfer Debentures only
in accordance with the Purchase Agreement and the provisions hereof. The Company
agrees to issue from time to time replacement Debentures in the form hereof to
facilitate any transfers and assignments as are made consistent with the terms
hereof and of the Purchase Agreement. In addition, after delivery of an
indemnity in form and substance reasonably satisfactory to the Company, the
Company also agrees to issue replacement Debentures for securities which have
been lost, stolen, mutilated or destroyed as set forth below.
The Company shall keep at its principal office a register (the
"REGISTER") in which shall be entered the names and addresses of the registered
holders of the Debentures and particulars of the respective Debentures held by
them and of all transfers of such Debentures.
A-1
<PAGE>
References to the "HOLDER" or "HOLDERS" shall mean the Person listed in the
Register as the payee of any Debenture unless the payee shall have presented
such Debenture to the Company for transfer and the transferee shall have been
entered in the Register as a subsequent holder, in which case the term shall
mean such subsequent holder. The ownership of the Debentures shall be proven by
the Register, absent manifest error. For the purpose of paying interest and
principal on the Debentures, the Company shall be entitled to rely on the names
and addresses in the Register.
No provision of this Debenture shall alter or impair the
obligations of the Company to pay the principal of and interest on this
Debenture at the place, times, rate, and in the currency, herein prescribed.
The principal of this Debenture shall bear interest at the
rate of 5% per annum (the "INTEREST RATE") from the later of January 11, 2000 or
the most recent Interest Payment Date on which interest has been paid on this
Debenture and shall be payable semi-annually in arrears on January 15 and July
15 of each year (an "INTEREST PAYMENT DATE"), commencing on July 15, 2000, to
the Holder hereof until the principal amount is paid or made available for
payment. The interest so payable on any Interest Payment Date will be paid in
cash or an equivalent value of the Company's Common Stock calculated based upon
the Average Price (as defined herein) as of such Interest Payment Date, at the
Company's option, subject to certain conditions contained herein, to the Holder
of this Debenture at the close of business on the Record Date for the interest
payable on such Interest Payment Date. The "RECORD DATE" for any interest
payment is the close of business on December 31 or June 30, as the case may be,
whether or not a Business Day, immediately preceding the Interest Payment Date
on which such Interest is payable.
Any amounts that have become due and payable hereunder and
remain unpaid by the Company after expiration of any applicable grace period for
such payment provided herein shall accrue interest thereafter until payment in
full of such amount at the rate of fifteen percent (15%) (the "DEFAULT RATE")
per annum and shall be payable upon demand by the Holder.
Interest, whether at the Interest Rate or the Default Rate,
will be computed on the basis of a fraction, the denominator of which is 365 (or
366 for any leap year) and the numerator of which is the actual number of days
elapsed from the date such interest begins to accrue, in the case of the
Interest Rate, or becomes due and payable, in the case of the Default Rate.
Each of the Interest Rate and the Default Rate shall be
effective both before and after any judgment may be rendered in a court of
competent jurisdiction, PROVIDED, HOWEVER, that if the Default Rate is deemed to
be in excess of the amount permitted to be charged by the Company under
applicable laws, the Holder shall be entitled to collect a Default Rate, as the
case may be, only at the highest rate permitted by law, and any interest
collected by the Holder in excess of such lawful amount shall be deemed a
payment in reduction of the principal amount then outstanding under this
Debenture and shall be so applied.
The principal of, and interest on, this Debenture are payable
in coin or currency of the United States of America as at the time of payment is
legal tender for payment of public or private debts, at the address of the
Holder last appearing on the Register (in the case of interest,
A-2
<PAGE>
as of the Record Date), except that interest due on the principal amount, (but
not interest overdue for more than five days), may, at the Company's option be
paid in shares of Common Stock calculated based upon the Average Price (as
defined herein) as of the applicable Interest Payment Date. It shall be assumed
that the Company shall elect to make all payments of interest in cash unless the
Company shall have given written notice to each Holder not less than five (5)
days prior to the applicable Interest Payment Date of its intention to pay such
interest in shares of Common Stock. Notwithstanding anything to the contrary
contained herein, the Company may not issue shares of Common Stock in payment of
the interest on principal if: (i) the number of shares of Common Stock at the
time authorized, unissued and unreserved for all other purposes is insufficient
to pay interest hereunder in shares of Common Stock or there is an insufficient
number of authorized shares of Common Stock reserved (pursuant to Section 3.6(b)
of the Purchase Agreement) for issue for full conversion of all of the
Debentures issued pursuant to the Purchase Agreement; (ii) such shares are not
either registered for resale pursuant to the Registration Statement (as defined
in the Registration Rights Agreement (as defined herein)) or freely transferable
without volume restrictions pursuant to Rule 144(k) promulgated under the
Securities Act, as determined by counsel to the Company pursuant to a written
opinion letter addressed and in form and substance reasonably acceptable to the
Holder and the transfer agent for such shares, subject to receipt by the Company
and such counsel of a representation from such Holder that it is not an
Affiliate of the Company for purposes of Rule 144 promulgated under the
Securities Act; (iii) such shares are not listed or quoted on the Nasdaq (as
defined herein) or a Subsequent Market (as defined herein); (iv) the issuance of
such shares would result in the recipient thereof beneficially owning more than
4.99% of the issued and outstanding shares of Common Stock as determined in
accordance with Section 4.7 hereof; or (v) an Event of Default has occurred and
is continuing or an event that, with the passage of time or giving of notice or
both would constitute an Event of Default, has occurred and is continuing.
ARTICLE I
DEFINITIONS
1.1 CERTAIN TERMS DEFINED. The following terms (except as
otherwise expressly provided) for all purposes of this Debenture shall have the
respective meanings specified below. All accounting terms used herein and not
expressly defined shall have the meanings given to them in accordance with
generally accepted accounting principles (as defined herein). Capitalized terms
not otherwise defined herein shall have the meanings assigned to them in the
Purchase Agreement. The terms defined in this Section 1.1 include the plural as
well as the singular.
"ACCELERATION NOTICE" has the meaning set forth in Section
3.1.
"AFFILIATE" of any Person means any other Person directly or
indirectly controlling or controlled by or under direct or indirect common
control with such Person. For the purposes of this definition, "control" when
used with respect to any Person means the possession, directly or indirectly, of
the power to direct or cause the direction of the management and policies of
such Person, whether through the ownership of voting securities, by contract or
otherwise; and the terms "controlling" and "controlled" have meanings
correlative to the foregoing.
A-3
<PAGE>
"APPRAISER" shall mean a nationally recognized or major
regional investment banking firm or firm of independent certified public
accountants of recognized standing.
"AUTHORIZATION DATE" has the meaning set forth in Section 4.9.
"AVERAGE PRICE" on any date means (x) the sum of the Per Share
Market Value for the ten (10) Trading Days immediately preceding such date minus
(y) the highest and lowest Per Share Market Value during the ten (10) Trading
Days immediately preceding such date, divided by (z) eight (8).
"BOARD OF DIRECTORS" means either the Board of Directors of
the Company or any committee of such Board duly authorized to act hereunder.
"BUSINESS DAY" means any day except a Saturday, Sunday or
other day on which commercial banks in the City of New York are authorized or
required by law to close.
"CAPITAL STOCK" means, with respect to any Person, any and all
shares, interests, participations or other equivalents (however designated) of
such Person's capital stock whether now outstanding or issued after the Original
Issue Date, including, without limitation, all Common Stock and all Preferred
Stock.
"CHANGE OF CONTROL" means the occurrence of (i) an acquisition
after the date hereof by an individual or legal entity or "group" (as described
in Rule 13d-5(b)(1) promulgated under the Exchange Act), other than the
Purchasers or any of their Affiliates, of in excess of 33% of the voting
securities of the Company, (ii) a replacement of more than one-half of the
members of the Company's Board of Directors which is not approved by those
individuals who are members of the Board of Directors on the date hereof in one
or a series of related transactions, (iii) the merger of the Company with or
into another entity, consolidation or sale of all or substantially all of the
assets of the Company in one or a series of related transactions, (iv) the
Involuntary Termination of Samuel J. Wohlstadter or (vi) the execution by the
Company of an agreement to which the Company is a party or by which it is bound,
providing for any of the events set forth above in (i), (ii) , (iii), (iv) or
(v). The term "Involuntary Termination" shall mean any termination by the Board
of Directors of Samuel J. Wohltstadter's employment as Chief Executive Officer
of the Company except any termination by reason of death, disability, mutual
agreement between Samuel J. Wohltstadter and the Board of Directors or where the
Board of Directors, in the exercise of its fiduciary duties determines with the
advice of counsel that the Involuntary Termination is necessary or advisable.
"CLOSING DATE" has the meaning set forth in the Purchase
Agreement.
"COMMON STOCK" means the common stock, par value $0.001 per
share, of the Company.
"COMPANY" means IGEN International, Inc.
"CONVERSION DATE" has the meaning set forth in Section 4.4(a).
A-4
<PAGE>
"CONVERSION DEFAULT" has the meaning set forth in Section 4.9.
"CONVERSION DEFAULT DATE" has the meaning set forth in Section
4.9.
"CONVERSION DEFAULT PAYMENTS" has the meaning set forth in
Section 4.9.
"CONVERSION EVENT" has the meaning set forth in Section 4.6.
"CONVERSION PRICE" has the meaning set forth in Section 4.2.
"DEBT" of any Person means, at any date, without duplication,
(i) all obligations of such Person for borrowed money, (ii) all obligations of
such Person evidenced by bonds, debentures, notes or other similar instruments,
(iii) all obligations of such Person in respect of letters of credit or bankers'
acceptance or other similar instruments (or reimbursement obligations with
respect thereto), (iv) all obligations of such Person to pay the deferred
purchase price of property or services, (v) all obligations of such Person as
lessee under capitalized leases, (vi) all Debt of others secured by a Lien on
any asset of such Person, whether or not such Debt is assumed by such Person,
provided that for purposes of determining the amount of any Debt of the type
described in this clause, if recourse with respect to such Debt is limited to
such asset, the amount of such Debt shall be limited to the fair market value of
such asset, (vii) all Debt of others guaranteed by such Person, and (viii) all
redeemable stock valued at the greater of its voluntary or involuntary
liquidation preference plus accrued and unpaid dividends.
"DEBENTURE" or "DEBENTURES" has the meaning set forth in the
second paragraph hereof.
"DEBENTURE SHARES" means the shares of Common Stock issuable
upon conversion of the Debentures.
"DEFAULT RATE" has the meaning set forth in the preamble
hereof.
"EVENT OF DEFAULT" has the meaning set forth in Section 3.1.
"EXCESS AMOUNT" has the meaning set forth in Section 4.9.
"EXCESS PRINCIPAL" has the meaning set forth in Section 4.14.
"EXCHANGE ACT" shall mean the Securities Exchange Act of 1934,
as amended.
"FIRST CONVERSION NOTICE" has the meaning set forth in Section
3.1(k).
"GAAP" or "GENERALLY ACCEPTED ACCOUNTING PRINCIPLES" means, at
the Closing Date, United States generally accepted accounting principles,
consistently applied.
"HOLDER" means the registered holder of any Debenture.
"INCURRENCE" means the incurrence, creation, assumption or in
any other manner becoming liable with respect to, or the extension of the
maturity of or becoming responsible for the payment of, any Debt. "Incur" shall
have a comparable meaning.
A-5
<PAGE>
"INTEREST PAYMENT DATE" has the meaning set forth in the
preamble hereof.
"INTEREST RATE" has the meaning set forth in the preamble
hereof.
"ISSUABLE MAXIMUM" has the meaning set forth in Section 4.14.
"LIEN" means, with respect to any asset, any mortgage, lien,
pledge, charge, security interest or encumbrance of any kind in respect of such
asset. For the purposes of this Debenture, the Company shall be deemed to own
subject to a Lien any asset which it has acquired or holds subject to the
interest of a vendor or lessor under any conditional sale agreement, capital
lease or other title retention agreement relating to such asset.
"MANDATORY PREPAYMENT AMOUNT" for any Debenture means, at the
option of the Holder (i) the sum of (x) 100% of the principal amount of the
Debenture to be prepaid and (y) all other amounts, costs, interest, expenses due
in respect of such principal amount or (ii) in the case of an Event of Default
pursuant to Sections 3.1(i) or (k) hereof, the sum of (x) the principal amount
of the Debenture to be prepaid, plus all accrued and unpaid interest thereon,
divided by either of the lesser of the Conversion Price or the Average Price on
the Trading Day immediately prior to the date the Mandatory Prepayment Amount is
paid in full, multiplied by the Per Share Market Value on the Trading Day
immediately prior to the date the Mandatory Prepayment Amount is paid in full,
and (y) all other amounts, costs and interest due in respect of such principal
amount; PROVIDED, HOWEVER, that in the event of the failure of the Company to
have the Initial Registration Statement declared effective by the Securities and
Exchange Commission by the Effectiveness Date (as defined in the Registration
Rights Agreement) the Mandatory Prepayment Amount shall be solely payable
pursuant to subsection (i) hereof if (a) such failure is due solely to delays
caused by comments the Company received from the Securities and Exchange
Commission and (b) the Company responds to such comments in a commercially
reasonable manner within twenty (20) Business Days after the receipt thereof and
otherwise complies with the terms and conditions of the Registration Rights
Agreement; provided further that in the case of an Event of Default pursuant to
Section 3.1(i) hereof, the Mandatory Prepayment amount shall be solely payable
pursuant to subsection (i) hereof if the Company has taken all commercially
reasonable steps to obtain or maintain the effectiveness of the Registration
Statement.
"MATERIAL ADVERSE EFFECT" has the meaning set forth in the
Purchase Agreement.
"MATURITY DATE" means the date on which the principal of a
Debenture becomes due and payable as herein provided, whether on the Stated
Maturity Date or pursuant to acceleration upon an Event of Default.
"NASDAQ" means the Nasdaq National Market.
"NOTICE OF COMPANY REDEMPTION" has the meaning set forth in
Section 5.2.
"NOTICE OF CONVERSION" has the meaning set forth in Section
4.2.
"ORIGINAL ISSUE DATE" means January 11, 2000.
A-6
<PAGE>
"OPTIONAL REDEMPTION" has the meaning set forth in Section
5.1.
"PAYMENT BLOCKAGE NOTICE" has the meaning set forth in Section
6.2.
"PER SHARE MARKET VALUE" means (i) the closing bid price per
share of the Common Stock on such date on the National Market System of the
Nasdaq or other registered national stock exchange on which the Common Stock is
then listed or if there is no such price on such date, then the closing bid
price on such exchange or quotation system on the date nearest preceding such
date, or (ii) if the Common Stock is not listed then on Nasdaq or any Subsequent
Market, the closing bid price for a share of Common Stock in the
over-the-counter market, as reported by the National Quotation Bureau
Incorporated (or similar organization or agency succeeding to its functions of
reporting prices) at the close of business on such date, or (iii) if the Common
Stock is not then publicly traded the fair market value of a share of Common
Stock as determined by an Appraiser selected in good faith by the holder of this
Debenture; PROVIDED, HOWEVER, that the Company, after receipt of the
determination by such Appraiser, shall have the right to select in good faith an
additional Appraiser, in which case, the fair market value shall be equal to the
average of the determinations by each such Appraiser; and PROVIDED, FURTHER that
all determinations of the Per Share Market Value shall be appropriately adjusted
for any stock dividends, stock splits or other similar transactions during such
period.
"PERSON" means an individual, a corporation, a partnership, an
association, a trust or any other entity or organization, including a government
or political subdivision or an agency or instrumentality thereof.
"PREFERRED STOCK" means, with respect to any Person, any and
all shares, interests, participations or other equivalents (however designated)
of such Person's preferred or preference stock whether now outstanding or issued
after the date of this Debenture, and includes, without limitation, all classes
and series of preferred or preference stock.
"PROPERTY" of any Person means all types of real, personal,
tangible, intangible or mixed property owned by such Person whether or not
included in the most recent consolidated balance sheet of such Person under
generally accepted accounting principles.
"PURCHASE AGREEMENT" means that certain Securities Purchase
Agreement dated as of January 11, 2000, by and among the Company and the
Purchasers.
"PURCHASE PRICE" means, with respect to any security, the
purchase price paid to the Company upon issuance of such security.
"PURCHASERS" has the meaning ascribed thereto in the Purchase
Agreement.
"REDEMPTION DATE" has the meaning set forth in Section 5.2.
"REDEMPTION PRICE" has the meaning set forth in Section 5.1.
"REGISTER" has the meaning set forth in the third paragraph
hereof.
A-7
<PAGE>
"REGISTRATION RIGHTS AGREEMENT" means that Registration Rights
Agreement dated as of January 11, 2000, by and among the Company and the
Purchasers.
"RESERVED AMOUNT" has the meaning set forth in Section 4.9.
"SECURITIES ACT" means the Securities Act of 1933, as amended.
"SENIOR INDEBTEDNESS" has the meaning as set forth in Section
6.1.
"SENIOR LENDER" has the meaning as set forth in Section 6.1.
"SHAREHOLDER APPROVAL" has the meaning set forth in Section
4.14.
"STATED MATURITY" means, with respect to any security, the
date specified in such security as the fixed date on which the payment of
principal of such security is due and payable, including pursuant to any
mandatory conversion provision (but excluding any provision providing for the
repurchase of such security at the option of the Holder thereof upon the
happening of any contingency unless such contingency has occurred), and, when
used with respect to any installment of interest on such security, the fixed
date on which such installment of interest is due and payable.
"STATED MATURITY DATE" means January 11, 2005.
"SUBSIDIARY" means, with respect to any Person, any
corporation or other entity of which a majority of the Capital Stock or other
ownership interests having ordinary voting power to elect a majority of the
Board of Directors or other persons performing similar functions are at the time
directly or indirectly owned by such Person.
"SUBSEQUENT MARKET" means the New York Stock Exchange,
American Stock Exchange or Nasdaq Smallcap Market.
"TRADING DAY" means a day on which the Common Stock is traded
on Nasdaq or, if the Common Stock is not then designated on Nasdaq, on such
Subsequent Market on which the Common Stock is then listed or quoted.
"UNDERLYING SHARES" means the shares of Common Stock issuable
upon conversion of the Debentures and exercise of the Warrants.
"VOID REDEMPTION NOTICE" has the meaning set forth in Section
5.3.
"WARRANTS" has the meaning set forth in the Purchase
Agreement.
A-8
<PAGE>
ARTICLE II
PAYMENT; THE SECURITIES
2.1 PAYMENT OF PRINCIPAL AND INTEREST. The Company covenants
and agrees that it will duly and punctually pay or cause to be paid the
principal, interest and interest on overdue principal (in the case of interest
accrued, at the Default Rate, to the extent enforceable under applicable law),
with respect to each of the Debentures at the place or places, at the respective
times and in the manner provided in the Debentures.
2.2 MUTILATED, DEFACED, DESTROYED, LOST AND STOLEN DEBENTURES. In
case any Debenture shall become mutilated, defaced or be apparently destroyed,
lost or stolen, the Company shall execute and deliver a new Debenture, bearing a
number not contemporaneously outstanding, in exchange and substitution for the
mutilated or defaced Debenture. In every case the applicant for a substitute
Debenture shall furnish to the Company such security or indemnity as it may
reasonably require to indemnify and defend and to save it harmless and, in every
case of destruction, loss or theft evidence to the Company's satisfaction of the
apparent destruction, loss or theft of such Debenture and of the ownership
thereof.
Upon the issuance of any substitute Debenture, the Company may
require the payment of a sum sufficient to cover any tax or other governmental
charge that may be imposed in relation thereto and any other expenses connected
therewith. In case any Debenture which has matured or is about to mature, or has
been called for redemption in full, or is being surrendered for conversion in
full shall become mutilated or defaced or be apparently destroyed, lost or
stolen, the Company may, instead of issuing a substitute Debenture, with the
holder's consent, pay or authorize the payment or conversion of the same
(without surrender thereof except in the case of a mutilated or defaced
Debenture), if the applicant for such payment shall furnish to the Company such
security or indemnity as it may reasonably require to save it harmless from all
risks, however remote, and, in every case of apparent destruction, loss or
theft, the applicant shall also furnish to the Company evidence to the Company's
reasonable satisfaction of the apparent destruction, loss or theft of such
Debenture and of the ownership thereof.
Every substitute Debenture issued pursuant to the provisions
of this Section by virtue of the fact that any Debenture is apparently
destroyed, lost or stolen shall constitute an additional contractual obligation
of the Company, whether or not the apparently destroyed, lost or stolen
Debenture shall be at any time enforceable by anyone and shall be entitled to
all the benefits of (but shall be subject to all the limitations of rights set
forth in) this Debenture equally and proportionately with any and all other
Debentures duly authenticated and delivered hereunder. All Debentures shall be
held and owned upon the express condition that, to the extent permitted by law,
the foregoing provisions are exclusive with respect to the replacement or
payment or conversion of mutilated, defaced, or apparently destroyed, lost or
stolen Debentures and shall preclude any and all other rights or remedies
notwithstanding any law or statute existing or hereafter enacted to the contrary
with respect to the replacement or payment of negotiable instruments or other
securities without their surrender.
2.3 CANCELLATION OF DEBENTURES; DESTRUCTION THEREOF. All
Debentures surrendered for payment, redemption, registration of transfer or
exchange shall be delivered to
A-9
<PAGE>
the Company for cancellation, and no Debentures shall be issued in lieu thereof
except as expressly permitted by any of the provisions of this Debenture. The
Company shall destroy canceled Debentures held by it and deliver a certificate
of destruction to the Holder, if requested. If the Company shall acquire any of
the Debentures, such acquisition alone shall not operate as a redemption or
satisfaction of the indebtedness represented by such Debentures unless and until
such indebtedness is satisfied.
ARTICLE III
DEFAULTS
3.1 EVENT OF DEFAULT DEFINED; ACCELERATION OF MATURITY; WAIVER OF
DEFAULT. In case one or more of the following events ("EVENTS OF DEFAULT")
(whatever the reason for such Event of Default and whether it shall be voluntary
or involuntary or be effected by operation of law or pursuant to any judgment,
decree or order of any court or any order, rule or regulation of any
administrative or governmental body) shall have occurred and be continuing:
a. default in the payment of (i) interest on any of the
Debentures, which default shall not have been cured within fifteen (15) Business
Days following the applicable Interest Payment Date or (ii) the principal of any
Debenture, with respect to each of (i) and (ii) as and when the same shall
become due and payable either at maturity, upon any redemption or conversion or
otherwise; or
b. failure on the part of the Company to duly observe or perform
any other of the covenants or agreements on the part of the Company (or the
making by the Company of any announcement, statement or threat that it does not
intend to honor the obligations described in this paragraph) contained in this
Debenture (other than the failure to issue shares of Common Stock upon
conversion because of the Company's non-compliance with applicable Nasdaq rules,
in which case Section 4.14 shall be the sole exclusive remedy of the Holder) the
Purchase Agreement or the Registration Rights Agreement for a period of fifteen
(15) Business Days (other than with respect to an announcement, statement or
threat) after the earlier of (x) the date on which any officer of the Company
shall have obtained actual knowledge of such failure (or such announcement,
statement or threat) or (y) the date on which written notice thereof has been
given to the Company by the Holder; or
c. there shall have occurred with respect to any issue or issues
of Debt of the Company and/or one or more Subsidiaries having an outstanding
principal amount of $2,000,000 or more in the aggregate for all such issues of
all such Persons, whether such Debt now exists or shall hereafter be created, an
event of default which has caused the holder thereof to declare such Debt to be
due and payable prior to its stated maturity and such Debt has not been
discharged in full or such acceleration has not been stayed, rescinded or
annulled within twenty (20) Business Days of such acceleration; or
d. one or more judgments or orders for the payment of money shall
be rendered against the Company or any Subsidiary of the Company in excess of
$5,000,000 in the aggregate (treating any deductibles, self insurance or
retention as not so covered) which judgments or
A-10
<PAGE>
orders are not discharged and remain outstanding for a period of thirty (30)
consecutive days following entry of the judgment or order which causes the
aggregate amount described above to exceed $5,000,000 in which period a stay of
enforcement of such judgment or order, by reason of a pending appeal or
otherwise, shall not be in effect; or
e. a court having jurisdiction in the premises shall enter a
decree or order for relief in respect of the Company or any of its Subsidiaries
in an involuntary case under any applicable bankruptcy, insolvency or other
similar law now or hereafter in effect, or appointing a receiver, liquidator,
assignee, custodian, trustee, sequestrator (or similar official) of the Company
or any of its Subsidiaries or for any substantial part of the property of the
Company or any of its Subsidiaries or ordering the winding up or liquidation of
the affairs of the Company or any of its Subsidiaries, and such decree or order
shall remain unstayed and in effect for a period of sixty (60) consecutive days;
or
f. the Company or any of its Subsidiaries shall commence a
voluntary case under any applicable bankruptcy, insolvency or other similar law
now or hereafter in effect, or consent to the entry of an order for relief in an
involuntary case under any such law, or consent to the appointment or taking
possession by a receiver, liquidator, assignee, custodian, trustee, sequestrator
(or similar official) of the Company or any of its Subsidiaries or for any
substantial part of the property of the Company or any of its Subsidiaries, or
the Company or any of its Subsidiaries shall make any general assignment for the
benefit of creditors; or
g. any representation or warranty made by the Company in the
Purchase Agreement shall prove to have been incorrect in any material respect
when made; or
h. the Common Stock shall be delisted from Nasdaq (or a
Subsequent Market, if applicable) or shall be suspended from trading on Nasdaq
without resuming trading and/or being relisted thereon or on a Subsequent Market
or having such suspension lifted, as the case may be, within fifteen (15)
Business Days; or
i. a Registration Statement for the Underlying Shares shall not
have been declared effective by the Securities and Exchange Commission on or
prior to the 245th day after the Effectiveness Date (as defined in the
Registration Rights Agreement) or after its initial effectiveness at any time
during the Effectiveness Period (as defined in the Registration Rights
Agreement), such Registration Statement lapses in effect or sales of all of the
Registrable Securities (as defined in the Registration Rights Agreement)
otherwise cannot be made thereunder (whether by reason of the Company's failure
to amend or supplement the prospectus included therein in accordance with the
Registration Rights Agreement or otherwise) for more than thirty (30)
consecutive days or sixty (60) days in any twelve (12) month period excluding
(i) any Black-Out Period (as defined in the Registration Rights Agreement) and
(2) any period during which an Objection (as defined in the Registration Rights
Agreement) has been made; or
j. a Change of Control shall occur and the obligations of the
Company under this Debenture shall not have been (i) fully assumed by the
controlling entity that is a publicly traded corporation whose common stock or
other voting securities is listed for trading on the Nasdaq or a Subsequent
Market or (ii) otherwise been fully discharged or accounted; or
A-11
<PAGE>
k. the Company shall fail to issue shares of Common Stock within
twelve (12) Trading Days after the Holder delivers a Notice of Conversion (the
"First Conversion Notice") pursuant to Section 4.2 hereof, provided that a
second Notice of Conversion is delivered by such Holder at least (5) Trading
Days after the First Conversion Notice by a different method of delivery than
the First Conversion Notice, other than (i) the failure to issue shares of
Common Stock because of the Company's non-compliance with applicable Nasdaq
rules, in which case Section 4.14 shall be the sole and exclusive remedy of
Holder or (ii) in accordance with Section 4.7 of this Debenture;
then, in each and every such case (other than an Event of Default specified in
Section 3.1(e) or 3.1(f) hereof), unless the principal shall have already become
due and payable, by notice in writing to the Company (the "ACCELERATION
NOTICE"), a Holder may declare the entire principal amount of the Debentures
owned by such Holder and any interest accrued thereon (and, in lieu thereof, the
aggregate amounts described below) to be due and payable immediately, and upon
any such declaration the same shall become immediately due and payable. If an
Event of Default specified in Section 3.1(e) or 3.1(f) occurs, the principal of
and any accrued interest on the Debentures (and, in lieu thereof, the aggregate
amounts described below) shall become and be immediately due and payable without
any declaration or other act on the part of any Holder.
The aggregate amount payable upon an Event of Default shall be
equal to the sum of (i) the Mandatory Prepayment Amount and (ii) the Holder's
reasonable costs of collection. The Mandatory Prepayment Amount shall be paid in
cash unless the Company determines in good faith that it does not have
sufficient funds to pay such amounts in cash, in which case the Mandatory
Prepayment Amount shall be paid in that number of shares of Common Stock equal
to (i) the Mandatory Prepayment Amount divided by (ii) the lesser of the
Conversion Price or the Average Price on the Trading Day immediately prior to
the date the Mandatory Prepayment Amount is paid in full.
For purposes of this Section 3.1, the principal amount of the
Debentures shall be treated as outstanding until such date as the Holder shall
have been issued Debenture Shares upon a conversion (or attempted conversion)
thereof. Interest shall accrue on the Mandatory Prepayment Amount hereunder from
the day after such amount is due (being the date of an Event of Default) through
the date of payment in full thereof at the Default Rate, accruing daily from the
date of conversion until such amount, plus any interest thereon, if any, is paid
in full. Upon payment of the Mandatory Prepayment Amount pursuant to this
Section 3.1, the Debt evidenced by the Debentures shall be paid in full, retired
and extinguished. Within five (5) Business Days of receipt by the Holder of
payments of amounts due to the Holder, the Holder shall return the Debentures to
the Company. In the event of acceleration relating to the occurrence of an Event
of Default, the Holder need not provide and the Company hereby waives any
presentment, demand, protest or other notice of any kind, and the Holder may
immediately and without expiration of any grace period enforce any and all of
its rights and remedies hereunder and all other remedies available to it under
applicable law. Any demand for payment may be rescinded and annulled by the
Holder at any time prior to payment hereunder. No such rescission or annulment
shall affect any subsequent Event of Default or impair any right consequent
thereon.
Upon delivery of any Acceleration Notice to the Company, the
Company shall provide a copy of such notice to the other Holders, if any, within
three (3) Business Days of the
A-12
<PAGE>
Company's receipt thereof. Failure to deliver such notice shall not affect the
validity of the notice delivered by the Holders in accordance with the
provisions referred to above.
3.2 POWERS AND REMEDIES CUMULATIVE; DELAY OR OMISSION NOT WAIVER
OF DEFAULT. No right or remedy herein conferred upon or reserved to the Holders
is intended to be exclusive of any other right or remedy, and every right and
remedy shall, to the extent permitted by law, be cumulative and in addition to
every other right and remedy given hereunder or now or hereafter existing at law
or in equity or otherwise. The assertion or employment of any right or remedy
hereunder, or otherwise, shall not prevent the concurrent assertion or
employment of any other appropriate right or remedy.
No delay or omission of the Holders to exercise any right or
power accruing upon any Event of Default occurring and continuing as aforesaid
shall impair any such right or power or shall be construed to be a waiver of any
such Event of Default or an acquiescence therein; and every power and remedy
given by the Debentures or by law may be exercised from time to time, and as
often as shall be deemed expedient, by the Holders.
ARTICLE IV
EXCHANGE; CONVERSION
4.1 RIGHT OF HOLDERS TO EXCHANGE DEBENTURES. Subject to and upon
compliance with the provisions of this Section, this Debenture is exchangeable
for an equal principal amount of Debentures of different authorized
denominations, as requested by the Holder surrendering the same; PROVIDED,
HOWEVER, that no exchanges, transfers or assignments shall be made for
Debentures in denominations of less than $2,500,000, and PROVIDED FURTHER that
no conversions shall be made for an aggregate principal amount of less than
$775,000. No service charge will be made for such registration of transfer or
exchange.
4.2 RIGHTS OF HOLDERS TO CONVERT DEBENTURES INTO COMMON STOCK.
a. Subject to the requirements of Rule 4460(i)(1)(D) of the
Nasdaq National Market and upon compliance with the provisions of this Section,
all or any portion of the principal amount of this Debenture, or any portion
thereof (and any accrued but unpaid interest thereon, subject to Section 4.3
hereof), at any time from the date hereof to the close of business on the
Maturity Date, may be converted by the Holder into duly authorized, validly
issued, fully-paid and nonassesable shares of Common Stock at a price per share
equal to $ 31 (the "CONVERSION PRICE").
b. If an adjustment in the Conversion Price and, if applicable, a
change in the securities or other property issuable upon conversion has taken
place pursuant to Article III or IV hereof, then the conversion described in
Section 4.2(a) shall be at the applicable Conversion Price and in such
securities or other property as so adjusted. The Holder desiring to make a
conversion shall deliver to the Company, at any time during usual business hours
at the Company's offices, or, at the Purchaser's option, to the Company's
transfer agent, during its usual business hours, a written notice of election to
convert as provided in the form attached hereto as
A-13
<PAGE>
EXHIBIT A (a "NOTICE OF CONVERSION"), accompanied, if required, by this
Debenture or the Debentures, the principal amount of which is to be converted.
4.3 ADJUSTMENT FOR DIVIDENDS. No payment or adjustment in respect
of this Debenture will be made for dividends on any Common Stock except as
provided herein. On conversion of all or any portion or this Debenture, any
accrued and unpaid interest attributable to the portion of the principal amount
of this Debenture being so converted shall not be canceled, extinguished or
forfeited, but rather shall be paid in full to the Holder thereof, at the option
of the Company (i) by the payment of an amount of shares of Common Stock valued
at the Average Price equal thereto or (ii) by cash payment of such amount. If
the Holder converts more than one Debenture at the same time, the number of
shares of Common Stock issuable upon the conversion shall be based on the total
principal amount of the Debentures converted.
4.4 ISSUANCE OF SHARES UPON CONVERSION.
a. As promptly as practicable, but in any event no later than
three (3) Trading Days after delivery of a Notice of Conversion (subject to the
Company's compliance with the requirements of Rule 4460(i)(1)(D) of the Nasdaq
National Market) and, if required, the surrender, as herein provided, of any
Debenture or securities for conversion, the Company shall deliver or cause to be
delivered to, or upon the written order of, the holder of the Debenture so
surrendered a certificate or certificates representing the number of duly
authorized, validly issued, fully-paid and nonassesable shares of Common Stock,
into which such Debenture or Debentures may be converted in accordance with the
provisions of this Article IV. Such conversion shall be deemed to have been made
at the time and on the date the Notice of Conversion is delivered to the Company
(the "CONVERSION DATE"), PROVIDED, THAT, if required, the Debenture or
Debentures being converted shall promptly be delivered to the Company. The
rights of the Holder of such Debenture or Debentures as a Holder (subject to the
Company's satisfaction of its obligations hereunder with respect to such
conversion) shall cease as of the Conversion Date with respect to the converted
Debentures and the Person or Persons entitled to receive the shares of Common
Stock upon conversion of such Debenture or Debentures shall be treated for all
purposes as having become the record holder or holders of such shares of Common
Stock at such time, and such conversion shall be at the Conversion Price in
effect at such time. Subject to paragraph 4.4(b), in the case of any Debenture
which is converted in part only, upon such conversion the Company shall execute
and deliver to the holder thereof, as requested by such holder, a new Debenture
or securities of authorized denominations in aggregate principal amount equal to
the unconverted portion of such Debenture. Without in any way limiting the
Holder's right to pursue other remedies, including actual damages and/or
equitable relief, the parties hereto agree that in the event that the Company
fails to deliver the shares of Common Stock required to be issued upon the
conversion of such Debenture or Debentures pursuant to this Section 4.4 within
two Trading Days after the three (3) Trading Day period referred above, the
Company shall pay to the Holder upon demand an amount of cash (at the Holder's
option) equal to the product of (w) the number of shares of Common Stock
required to be issued upon the conversion of the Debenture or Debentures, (x)
the Per Share Market Value of such shares on the Conversion Date, (y) the number
of days after such 5-day period that such shares are not delivered to the
Holder, and (z) 0.000411.
A-14
<PAGE>
b. Notwithstanding anything to the contrary set forth herein,
upon conversion of a Debenture in accordance with the terms thereof, the Holder
shall not be required to physically surrender the Debenture to the Company
unless the entire unpaid principal amount of the Debenture is so converted. The
Holder and the Company shall maintain records showing the principal amount so
converted and the dates of such conversions or shall use such other method,
reasonably satisfactory to the Holder and the Company, so as not to require
physical surrender of the Debenture upon each such conversion. In the event of
any dispute or discrepancy, such records of the Company shall be controlling and
determinative in the absence of manifest error. Notwithstanding the foregoing,
if any portion of the Debenture is converted as aforesaid, the Holder may not
transfer the Debenture unless the Holder first physically surrenders the
Debenture to the Company, whereupon the Company shall forthwith issue and
deliver upon the order of the Holder a new Debenture of like tenor, registered
as the Holder (upon payment by the Holder of any applicable transfer taxes) may
request, representing in the aggregate the remaining unpaid principal amount of
the Debenture. The Holder and any assignee, by acceptance of the Debenture,
acknowledge and agree that, by reason of the provisions of this paragraph,
following conversion of a portion of a Debenture, the unpaid and unconverted
principal amount of such Debenture represented by such Debenture may be less
than the amount stated on the face thereof.
c. In lieu of delivering physical certificates representing the
Debenture Shares, provided the Company's transfer agent is participating in the
Depositary Trust Company Fast Automated Debentures Transfer program, upon
request of the Holder and in compliance with the provisions of Sections 4.1, 4.2
and 4.4, the Company shall use all commercially reasonable efforts to cause its
transfer agent to electronically transmit the shares of Common Stock issuable
upon conversion of the Debenture to the Holder by crediting the account of the
Holder's Prime Broker with DTC through its Deposit Withdrawal Agent Commission
system. The time period for delivery described in the immediately preceding
paragraph shall apply to the electronic transmittals described herein.
d. In addition to any other rights available to the Holder, if
the Company fails to deliver to the Holder such certificate or certificates
pursuant to Section 4.4(a), including for purposes hereof, any shares of Common
Stock to be issued on the Conversion Date on account of accrued but unpaid
interest hereunder, by the third (3rd) trading day after the Conversion Date,
and if after such third (3rd) trading day the Holder purchases (in an open
market transaction or otherwise) Common Stock to deliver in satisfaction of a
sale by such Holder of the Debenture Shares which the Holder was entitled to
receive upon such conversion (a "BUY-IN"), then the Company shall (A) pay in
cash to the Holder (in addition to any remedies available to or elected by the
Holder) the amount by which (x) the Holder's total purchase price (including
brokerage commissions, if any) for the Common Stock so purchased exceeds (y) the
product of (1) the aggregate number of shares of Common Stock that such Holder
was entitled to receive from the conversion at issue multiplied by (2) the Per
Share Market Value on the Conversion Date and (B) at the option of the Holder,
either return the Debentures for which such conversion was not honored or
deliver to such Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its conversion and delivery
obligations under Section 4.4(a). For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to
an attempted conversion of Debentures with respect to which the market price of
the Debenture Shares on the date of conversion totaled $10,000, under clause (A)
of the immediately preceding sentence the
A-15
<PAGE>
Company shall be required to pay the Holder $1,000. The Holder shall provide the
Company written notice indicating the amounts payable to the Holder in respect
of the Buy-In.
4.5 ADJUSTMENT OF CONVERSION PRICE. In addition to any adjustment
to the Conversion Price provided elsewhere in this Debenture, the Conversion
Price in effect at any time shall be subject to adjustment from time to time
upon the happening of certain events, as follows:
a. COMMON STOCK DIVIDENDS; COMMON STOCK SPLITS; REVERSE COMMON
STOCK SPLITS. If the Company, at any time while this Debenture is outstanding,
(a) shall pay a stock dividend on its Common Stock, (b) subdivide outstanding
shares of Common Stock into a larger number of shares, (c) combine outstanding
shares of Common Stock into a smaller number of shares, or (d) issue by
reclassification of shares of Common Stock any shares of Capital Stock of the
Company, the Conversion Price shall be multiplied by a fraction the numerator of
which shall be the number of shares of Common Stock (excluding treasury shares,
if any) outstanding before such event and the denominator of which shall be the
number of shares of Common Stock (excluding treasury shares, if any) outstanding
after such event. Any adjustment made pursuant to this paragraph 4.5(a) shall
become effective immediately after the record date for the determination of
stockholders entitled to receive such dividend or distribution and shall become
effective immediately after the effective date in the case of a subdivision,
combination or re-classification.
b. RIGHTS; OPTIONS; WARRANTS OR OTHER SECURITIES. If the Company,
at any time while this Debenture is outstanding, shall fix a record date for the
issuance of rights, options, warrants or other securities to all of the holders
of Common Stock entitling them to subscribe for or purchase, convert to,
exchange for or otherwise acquire shares of Common Stock for no consideration or
at a price per share less than the Per Share Market Value on the record date for
such issuance, the Conversion Price shall be multiplied by a fraction, the
denominator of which shall be the number of shares of Common Stock (excluding
treasury shares, if any) outstanding on the date of issuance of such rights,
options, warrants or other securities plus the number of additional shares of
Common Stock offered for subscription, purchase, conversion, exchange or
acquisition, as the case may be, and the numerator of which shall be the number
of shares of Common Stock (excluding treasury shares, if any) outstanding on the
date of issuance of such rights, options, warrants or other securities plus the
number of shares which the aggregate offering price of the total number of
shares so offered in such offering would purchase at the Conversion Price. Such
adjustment shall be made whenever such rights, options, warrants or other
securities are issued, and shall become effective immediately after the record
date for the determination of shareholders entitled to receive such rights or
warrants. However, upon the expiration of any rights, options, warrants or other
securities to purchase Common Stock the issuance of which resulted in an
adjustment in the Conversion Price pursuant to this Section 4.5(b), if any such
rights, options, warrants or other securities shall expire and all or any
portion thereof shall not have been exercised, the Conversion Price shall
immediately upon such expiration be re-computed and effective immediately upon
such expiration be increased to the price which it would have been had the
adjustment of the Conversion Price made upon the issuance of such rights,
warrants, options or other securities been made on the basis of the issuance of
only that number of shares of Common Stock (if any) actually purchased upon the
exercise of such rights, options, warrants or other securities actually
exercised.
A-16
<PAGE>
c. ROUNDING. All calculations under this Section 4.5 shall be
made to the nearest cent or the nearest l/l00th of a share, as the case may be.
4.6 CONVERSION EVENT. The following are "CONVERSION EVENTS" under
this Section 4.6: (A) any reclassification of the Common Stock, (B) any Change
of Control or (C) any compulsory share exchange pursuant to which the Common
Stock is converted into other securities, cash or property. After the occurrence
of (A), (B) or (C), the Holder shall have the right at his or its option to
convert the Debenture for shares of stock and other securities, cash and
property receivable upon or deemed to be held by holders of Common Stock
following such Conversion Event; the Holder shall be entitled upon such
conversion of the Debenture to receive such amount of securities, cash or
property as if the Holder had converted the Debenture into shares of Common
Stock immediately prior to such Conversion Event (without taking into account
any limitations or restrictions on the conversion of the Debenture). In the case
of (A), (B) or (C), the Company shall not effect any such Conversion Event
unless, prior to the consummation thereof, each Person (other than the Company)
which may be required to deliver any stock, securities, cash or property upon
the conversion of the Debenture as provided herein shall assume, by written
instrument delivered and reasonably satisfactory to, the Holder, (a) the
obligations of the Company under this Debenture (and if the Company shall
survive the consummation of such transaction, such assumption shall be in
addition to, and shall not release the Company from, any continuing obligations
of the Company under this Debenture), (b) the obligations of the Company under
the Purchase Agreement, the Warrant, the Debenture, and the Registration Rights
Agreement, and (c) the obligation to deliver to the Holder such shares of stock,
securities, cash or property as, in accordance with the foregoing provisions of
this Section 4.6, the Holder may be entitled to receive. Nothing in this Section
4.6 shall be deemed to authorize the Company to enter into any transaction not
otherwise permitted by the Purchase Agreement. This provision shall similarly
apply to successive Conversion Events.
4.7 RESTRICTION ON CONVERSION BY EITHER THE HOLDER OR THE COMPANY.
Notwithstanding anything herein to the contrary, in no event shall any Holder or
the Company have the right or be required to convert any or all of the aggregate
principal amount and interest accrued thereon of this Debenture if as a result
of such conversion the aggregate number of shares of Common Stock beneficially
owned by such Holder and its Affiliates would exceed 4.99% of any class of
voting securities of the Company following such conversion. For purposes of this
Section 4.7, beneficial ownership shall be calculated in accordance with Section
13(d) of the Exchange Act. The provisions of this Section 4.7 may be waived by a
Holder as to itself (and solely as to itself) upon not less than 65 days prior
written notice to the Company, and the provisions of this Section 4.7 shall
continue to apply until such 65th day (or later, if stated in the notice of
waiver), subject to the requirements of Rule 4460(i)(1)(D) of the Nasdaq
National Market, provided approval is obtained, if required, pursuant to 40 P.S.
Section 991.1402.
4.8 OFFICER'S CERTIFICATE. Whenever the Conversion Price or the
number of shares purchasable upon conversion shall be adjusted as required by
the provisions of Section 4.5, the Company shall forthwith file in the custody
of its Secretary or an Assistant Secretary at its principal office and with its
stock transfer agent, if any, an officer's certificate showing the adjusted
number of shares determined as herein provided, setting forth in reasonable
detail the facts requiring such adjustment and the manner of computing such
adjustment. Each such officer's certificate shall be signed by the chairman,
president or chief financial officer of the
A-17
<PAGE>
Company and by the secretary or any assistant secretary of the Company. Each
such officer's certificate shall be made available at all reasonable times for
inspection by any holder of the Debentures and the Company shall, forthwith
after each such adjustment, deliver a copy of such certificate to the each of
the Holders.
4.9 RESERVATION OF SHARES. The Company covenants that it will at
all times reserve and keep available out of its authorized shares of Common
Stock, free from preemptive rights, solely for the purpose of issue upon
conversion of the Debentures as herein provided, such number of shares of the
Common Stock as shall then be issuable upon the conversion of all outstanding
Debentures into Common Stock in accordance with Section 3.6(b) of the Purchase
Agreement (the "RESERVED AMOUNT"). The Company covenants that all shares of the
Common Stock issued upon conversion of the Debenture which shall be so issuable
shall, when issued, be duly and validly issued and fully paid and
non-assessable.
If, at any time a Holder of this Debenture submits a Notice of
Conversion, and the Company does not have sufficient authorized but unissued
shares of Common Stock available to effect such conversion in accordance with
the provisions of this Article IV (a "CONVERSION DEFAULT"), subject to Section
4.14, the Company shall issue to the Holder all of the shares of Common Stock
which are then available to effect such conversion. The portion of this
Debenture which the Holder included in its Conversion Notice and which exceeds
the amount which is then convertible into available shares of Common Stock (the
"EXCESS AMOUNT") shall, notwithstanding anything to the contrary contained
herein, not be convertible into Common Stock in accordance with the terms hereof
until the date additional shares of Common Stock are authorized by the Company
to permit such conversion at which time, if the Holder elects to proceed with
such conversion, by written notice to the Company within twenty (20) Business
Days after the Authorization Notice Date (as defined below) the Conversion Price
in respect thereof shall be the lesser of (i) the Conversion Price on the
Conversion Default Date (as defined below) and (ii) the lowest Per Share Market
Value on any date after the Conversion Default Date and prior to that date which
is five (5) Business Days after the Company provides the Holder with written
notice that additional shares of Common Stock have been authorized by the
Company to permit such conversion in respect thereof (the "AUTHORIZATION NOTICE
DATE"). In addition, the Company shall pay to the Holder payments ("CONVERSION
DEFAULT PAYMENTS") for a Conversion Default equal to the product of (x) the
Excess Amount, (y) .20, and (z) (N/365), where N equals the number of days from
the day the holder submits a Notice of conversion giving rise to a Conversion
Default (the "CONVERSION DEFAULT DATE") to the date (the "AUTHORIZATION DATE")
that the Company authorizes a sufficient number of shares of Common Stock to
effect conversion of the Excess Amount. The Company shall use all commercially
reasonable efforts to authorize a sufficient number of shares of Common Stock as
soon as practicable following the earlier of (i) such time that the Holder
notifies the Company or that the Company otherwise becomes aware that there are
or likely will be insufficient authorized and unissued shares to allow full
conversion thereof and (ii) a Conversion Default. The Company shall send notice
to the Holder of the authorization of additional shares of Common Stock, the
Authorization Date and the amount of Holder's accrued Conversion Default
Payments. The accrued Conversion Default Payments for each calendar month shall
be paid in cash to the Holder by the fifth (5th) Business Day of the month
following the month in which it has accrued. Nothing herein shall limit the
Holder's right to pursue actual damages (to the extent in excess of the
conversion Default Payments) for the Company's failure to maintain a sufficient
number of
A-18
<PAGE>
authorized shares of Common Stock, and each Holder shall have the right to
pursue all remedies available at law or in equity (including degree of specific
performance and/or injunctive relief).
4.10 COMPLIANCE WITH GOVERNMENTAL REQUIREMENTS. The Company
covenants that if any shares of Common Stock required to be reserved for
purposes of conversion of Debentures hereunder require registration with or
approval of any governmental authority under any Federal or state law, or any
national securities exchange, before such shares may be issued upon conversion,
the Company will use all commercially reasonable efforts to cause such shares to
be duly registered or approved, as the case may be.
4.11 FRACTIONAL SHARES. Upon a conversion hereunder, the Company
shall not be required to issue stock certificates representing fractions of
shares of the Common Stock, but may if otherwise permitted, make a cash payment
in respect of any final fraction of a share based on the Per Share Market Value
at such time. If the Company elects not, or is unable, to make such a cash
payment, the holder shall be entitled to receive, in lieu of the final fraction
of a share, one whole share of Common Stock.
4.12 PAYMENT OF TAX UPON ISSUE OR TRANSFER. The issuance of
certificates for shares of the Common Stock on conversion of the Debentures
shall be made without charge to the Holders thereof for any documentary stamp or
similar taxes that may be payable in respect of the issue or delivery of such
certificate, provided that the Company shall not be required to pay any tax that
may be payable in respect of any transfer involved in the issuance and delivery
of any such certificate upon conversion in a name other than that of the Holder
of such Debentures so converted and the Company shall not be required to issue
or deliver such certificates unless or until the Person or Persons requesting
the issuance thereof shall have paid to the Company the amount of such tax or
shall have established to the satisfaction of the Company that such tax has been
paid.
4.13 NOTICES. Any notices, consents, waivers or other
communications required or permitted to be given under the terms of this
Debenture must be in writing and will be deemed to have been delivered (i) upon
receipt, when delivered personally; (ii) upon receipt, when sent by facsimile,
provided confirmation of transmission is mechanically or electronically
generated and kept on file by the sending party (if received by 5:30 p.m. EST
where such notice is received) or the first business day following such delivery
(if received after 5:30 p.m. EST where such notice is received); or (iii) one
business day after deposit with a nationally recognized overnight delivery
service; provided that confirmation of the delivery is generated and kept on
file by the sending party, in each case properly addressed to the party to
receive the same. The addresses and facsimile numbers for such communications
are (i) if to the Company to IGEN International, Inc., 16020 Industrial Drive,
Gaithersburg, MD 20877, Attn: Mr. George V. Migausky, fax no. (301) 208-3798
with copies to Wilmer, Cutler & Pickering, 2445 M Street, N.W., Washington, DC
20037, Attn: Meredith B. Cross, fax no. (202) 663-6363 and (ii) if to any Holder
to the address set forth on Schedule II to the Purchase Agreement with copies to
Akin, Gump, Strauss, Hauer & Feld, L.L.P., 590 Madison Avenue, New York, New
York 10022, Attn: James Kaye, fax no. (212) 872-1002 or such other address as
may be designated in writing hereafter, in the same manner, by such Person.
A-19
<PAGE>
4.14 NASDAQ LIMITATION. If on any date (the "DETERMINATION DATE")
(a) the Common Stock is listed for trading on Nasdaq or the Nasdaq SmallCap
Market, (b) the Conversion Price then in effect is such that the aggregate
number of shares of Common Stock that would then be issuable upon conversion in
full of the then outstanding principal amount of the Debentures as if all such
Debentures were converted on such Determination Date (without regard to any
limitations on conversions) and as payment of interest thereon, as would equal
or exceed 20% of the number of shares of the Common Stock outstanding
immediately prior to the Closing Date (the "ISSUABLE MAXIMUM"), and (c) the
Company shall not have previously obtained the vote of the shareholders of the
Company (the "SHAREHOLDER APPROVAL"), if any, as may be required by the
applicable rules and regulations of Nasdaq (or any successor entity) to approve
the issuance of shares of Common Stock in excess of the Issuable Maximum in a
private placement whereby shares of Common Stock are deemed to have been issued
at a price that is less than the greater of book value or fair market value of
the Common Stock, then with respect to the aggregate principal amount of the
Debentures then held by the Holders for which a conversion in accordance with
the Conversion Price would result in an issuance of shares of Common Stock in
excess of such Holder's pro rata allocation (as described below) of the Issuable
Maximum (the "EXCESS PRINCIPAL"), the Company may elect to prepay cash to the
Holders in an amount equal to the Mandatory Prepayment Amount with respect to
such Excess Principal. Any such election by the Company must be made in writing
to the Holders within two (2) Trading Days after the first such Determination
Date and the payment of such Mandatory Prepayment Amount applicable to such
prepayment must be made in full to the Holders with ten (10) Business Days after
the date such notice is delivered. If the Company does not deliver timely a
notice of its election to prepay under this Section or shall, if it shall have
delivered such a notice, fail to pay the prepayment amount hereunder within ten
(10) Business Days thereafter, then each Holder shall have the option by written
notice to the Company, to, if applicable, declare any such notice given by the
Company, if given, to be null and void and require the Company to either: (i)
use all commercially reasonable efforts to obtain the Shareholder Approval
applicable to such issuance as soon as is possible, but in any event not later
than the 60th day after such request unless the Company has previously used all
commercially reasonable efforts to, but has failed to, obtain such approval
(provided, that if the Company shall fail to obtain the Shareholder Approval
during such 60-day period, the Holder may demand the cash payment set forth in
Section 4.14(ii) herein), (ii) use all commercially reasonable efforts to obtain
an exemption from Nasdaq or (iii) pay cash to such Holder, within five (5)
Business Days of such Holder's notice, in an amount equal to the Mandatory
Prepayment Amount for such Holder's portion of the Excess Principal. The payment
of the Mandatory Prepayment Amount to each Holder pursuant to this Section shall
be determined on a pro rata basis upon the principal amount of the Debentures
held by such Holder on the Determination Date which is in excess of the pro rata
allocation of the Issuable Maximum. If the Company fails to pay the Mandatory
Prepayment Amount in full pursuant to this Section within five (5) Business Days
after the date payable, the Company will pay interest thereon at a rate of 10%
per annum to the converting Holder, accruing interest daily from the date of
conversion until such amount, plus all such interest thereon, if any, is paid in
full. Until the Company has received the Shareholder Approval no Holder of the
Debentures shall be issued, upon conversion of Debentures, shares of Common
Stock in an amount greater than such Holder's allocated portion of the Issuable
Maximum pursuant to Section 4.14. In no event shall the Company be required to
issue shares
A-20
<PAGE>
of Common Stock upon conversion of the Debentures if such issuance would violate
the rules of Nasdaq.
4.15 ALLOCATION OF RESERVED AMOUNT. The Reserved Amount shall be
allocated pro rata among the Purchasers based on the principal amount of
Debentures issued to each Purchaser pursuant to the Purchase Agreement. Each
increase to the Reserved Amount shall be allocated pro rata among the Purchasers
based on the principal amount of Debentures held by each Purchaser at the time
of the increase in the Reserved Amount. In the event a Purchaser shall sell or
otherwise transfer any of such Purchaser's Debentures, each transferee shall be
allocated a pro rata portion of such transferor's Reserved Amount. Any portion
of the Reserved Amount which remains allocated to any person or entity which
does not hold any Debentures shall be allocated to the remaining Purchasers, pro
rata, based on the principal amount of such Debentures then held by such
Purchasers.
ARTICLE V
OPTIONAL REDEMPTION
5.1 OPTIONAL REDEMPTION. Subject to Article VI, the Debentures
will be redeemable in whole or in part at the option of the Company at any time
after January 11, 2003 (an "OPTIONAL REDEMPTION") at a price equal to the
principal, plus accrued and unpaid interest (if any) to the Redemption Date (the
"REDEMPTION PRICE").
5.2 MECHANICS OF REDEMPTION. The Company shall exercise its right
to redeem by delivering written notice by facsimile and overnight courier
("NOTICE OF COMPANY REDEMPTION") to each Holder. Such Notice of Company
Redemption shall indicate (A) the maximum, if any, aggregate dollar amount of
Redemption Price which the Company will pay for any Optional Redemption, (B)
each Holder's pro rata allocation of such maximum amount, (C) the Redemption
Price, and (D) confirm the date ("REDEMPTION DATE") the Company shall effect the
Optional Redemption, which date shall be not less than five (5) Business Days
and not more than sixty (60) calendar days after the Redemption Notice Date. If
the Company elects not to redeem all the Debentures outstanding, the Company
shall allocate for redemption from each Holder an amount of the Redemption Price
equal to such Holder's pro rata amount (based on the principal amount of the
Debenture held by such Holder on the date of the Notice of Company Redemption
relative to the total principal of the Debentures outstanding on such date).
Notwithstanding anything in this Section 5.2, the Company shall convert any
Debenture pursuant to Article IV if the Conversion Notice for a Debenture
submitted for conversion is delivered before the Redemption Date.
5.3 PAYMENT OF REDEMPTION PRICE. The Company shall pay the
applicable Redemption Price to the Holder of the Debentures being redeemed in
cash on the Redemption Date. If the Company shall fail to pay the applicable
Redemption Price to such Holder on the Redemption Date, in addition to any
remedy such Holder may have under this Debenture and the Purchase Agreement,
such unpaid amount shall bear interest at the rate of 2.0% per month until the
earlier of the date on which the Redemption Price is paid in full or the receipt
of a Void Redemption Notice. Until the Company pays such unpaid applicable
Redemption Price in full to
A-21
<PAGE>
each Holder, each Holder of Debentures submitted for redemption pursuant to this
Article V and for which the applicable Redemption Price has not been paid, shall
have the option, in lieu of redemption, (A) to require the Company to promptly
return to such Holder all of the Debentures that were submitted for redemption
by such Holder under this Article V and for which the applicable Redemption
Price has not been paid or (B) to convert those Debentures for which the
applicable Redemption Price has not been paid at the Conversion Price in effect
on the Redemption Date. Upon the Company's receipt of written notice thereof to
the Company via facsimile (the "VOID REDEMPTION NOTICE") requesting the return
of the Debentures and prior to payment of the full applicable Redemption Price
to each Holder, (i) the redemption shall be null and void with respect to those
Debentures submitted for redemption and for which the applicable Redemption
Price has not been paid, (ii) the Company shall immediately return any
Debentures submitted to the Company by each Holder for redemption under this
Article V and for which the applicable Redemption Price has not been paid. If
the Company fails to timely effect a redemption in accordance with this Article
V, the Company shall not be allowed to submit another Notice of Company
Redemption without the prior written consent of Holders of at least two-thirds
(2/3) of the principal amount of the Debentures then outstanding.
ARTICLE VI
SUBORDINATION
6.1 DEBENTURES SUBORDINATE TO SENIOR INDEBTEDNESS. The Company
covenants and agrees, and each Holder of a Debenture, by his acceptance thereof,
likewise covenants and agrees, that, to the extent and in the manner hereinafter
set forth in this Article, the payment of the principal of (and premium, if any)
and interest on each and all of the Debentures are hereby expressly made
subordinate and subject in right of payment to the prior payment in full of all
Senior Indebtedness. "SENIOR INDEBTEDNESS" shall mean all Debt of the Company
referred to in the definition of Debt (other than clause vii of such
definition), and including all renewals, extensions, modifications,
refinancings, refundings and amendments of any Debt unless the instrument
creating or evidencing the same or pursuant to which the Debt outstanding
expressly provides that such Debt is not superior in right of payment to the
Debenture, to any Person (each a "SENIOR LENDER"), now existing or hereafter
created.
6.2 NO PAYMENT ON DEBENTURES IN CERTAIN CIRCUMSTANCES.
a. No payment or distribution of cash or property (other than
Common Stock of the Company or other securities of the Company that are
subordinated to Senior Indebtedness to at least the same extent as the
Debentures) of the Company will be made on account of principal of or interest
(if any) on the Debentures, or to defease or acquire any of the Debentures, or
on account of the conversion provisions of the Debentures and no action shall be
taken (judicial or otherwise) to collect any such payment or distribution (i)
upon the maturity of any Senior Indebtedness by lapse of time, acceleration or
otherwise, unless and until all Senior Indebtedness shall first be paid in full
in cash, or such payment duly made in a manner satisfactory to the holders of
such Senior Indebtedness or (ii) in the event that the Company defaults in the
payment of any principal of, premium, if any, or interest on or any other
amounts payable on or due in connection with any Senior Indebtedness when it
becomes due and payable, whether at maturity or at a date fixed for prepayment
or by declaration or otherwise, unless and until such default has
A-22
<PAGE>
been waived in writing by the holders of the Senior Indebtedness. Payments on
the Debentures may and shall be resumed in the case of a payment default only
upon the date on which such default is waived in writing by the holders of the
Senior Indebtedness or their agent.
b. If any default OTHER THAN a default contemplated by Section
6.2(a)(ii) above shall have occurred and be continuing that would permit the
holders of the Senior Indebtedness to accelerate the maturity of Senior
Indebtedness, upon written notice (a "PAYMENT BLOCKAGE NOTICE") of the default
given to the Company by the holders of, or an agent, trustee or other
representative for, such Senior Indebtedness with a copy of the Payment Blockage
Notice given to the Holders by the Company or such agent, trustee or other
representative, then, unless and until such default has been waived in writing,
no payment or distribution of cash or property (other than Common Stock of the
Company or other securities of the Company that are subordinated to Senior
Indebtedness to at least the same extent as the Debentures) shall be made by the
Company with respect to the principal of or interest on the Debentures or on
account of conversion of the Debentures or to acquire or repurchase any of the
Debentures for cash or property other than Common Stock of the Company, and no
action shall be taken (judicial or otherwise) to collect any such payment or
distribution. If such Senior Indebtedness is not declared due and payable within
180 days after written notice of the event of default is given, promptly after
the end of the 180-day period the Company will pay all sums due in respect of
the Debentures and not paid during the 180-day period. During any 360-day
consecutive period, only one such period during which payment with respect to
the Debentures may not be made as the result of a Payment Blockage Notice may
commence and the duration of such period may not exceed 180 days. No nonpayment
default that existed or was continuing on the date of delivery of any Payment
Blockage Notice to the Holders shall be, or be made, the basis for a subsequent
Payment Blockage Notice unless such default shall have been waived for a period
of not less than 90 days.
c. If any payment or distribution of assets of the Company is
received by any Holder in respect of the Debentures at a time when that payment
or distribution should not have been made because of paragraph (a) or (b) of
this Section 6.2, and provided that prior to the Company's disbursement of such
distribution or payment, the Holders shall have received a written notice from
the Company or from an agent or representative for one or more holders of Senior
Indebtedness, such payment or distribution will be received and held and will be
paid over to the holders of Senior Indebtedness (pro rata as to each of such
holders on the basis of the respective amounts of Senior Indebtedness held by
them) until all such Senior Indebtedness has been paid in full, after giving
effect to any concurrent payment or distribution or provision therefor to the
holders of such Senior Indebtedness.
6.3 DEBENTURES SUBORDINATED TO PRIOR PAYMENT OF ALL SENIOR
INDEBTEDNESS ON DISSOLUTION, LIQUIDATION OR REORGANIZATION. Upon any
distribution of assets of the Company upon any dissolution, winding up,
liquidation or reorganization of the Company (whether in bankruptcy, insolvency,
receivership or similar proceedings relating to the Company or its property or
upon an assignment for the benefit of creditors or any marshalling of the
Company's assets or liabilities or otherwise):
a. the holders of all Senior Indebtedness will first be entitled
to receive payment in full of the principal of and interest due on Senior
Indebtedness (including interest accruing
A-23
<PAGE>
after the commencement of a bankruptcy or insolvency) at the rate specified in
the applicable Senior Indebtedness documents and including, without limitation,
in respect of premiums, indemnities or otherwise, before the Holders are
entitled to receive any payment or distribution on account of the principal of
or interest on the Debentures;
b. any payment or distribution of assets of the Company of any
kind or character, whether in cash, property or securities (except that Holders
may receive securities that are subordinated at least to the same extent as the
Debentures to Senior Indebtedness and any securities issued in exchange for
Senior Indebtedness), to which Holders would be entitled except for the
provisions of this Section 6.3 will be paid by the liquidating trustee or agent
or other persons legally empowered to make such a payment or distribution
directly to the holders of Senior Indebtedness (pro rata to such holders on the
basis of the respective amounts of Senior Indebtedness held by such holders) or
their representatives to the extent necessary to make or provide for payment in
full in cash of all Senior Indebtedness remaining unpaid, after giving effect to
any concurrent payment or distribution to the holders of such Senior
Indebtedness or provision for that payment or distribution; and
c. if, notwithstanding the foregoing, any payment or distribution
of assets of the Company of any kind or character, whether in cash, property or
securities (except that Holders may receive securities that are subordinated at
least to the same extent as the Debentures to Senior Indebtedness and any
securities issued in exchange for Senior indebtedness) is received by the
Holders on account of the principal of or interest on the Debentures before all
Senior Indebtedness is paid in full, such payment or distribution will be
received and held in trust for and will be forthwith paid over to the holders of
the Senior Indebtedness remaining unpaid or unprovided for or their
representatives for application (in the cash of cash) to, or as collateral (in
the case of non-cash property or securities) for the payment of such Senior
Indebtedness until all such Senior Indebtedness has been paid in full, after
giving effect to any concurrent payment or distribution or provision therefor to
the holders of such Senior Indebtedness.
The Company will give prompt written notice to the Holders of any
dissolution, winding up, liquidation or reorganization of it or any assignment
for the benefit of its creditors.
6.4 SUBROGATION TO RIGHTS OF HOLDERS OF SENIOR INDEBTEDNESS.
Subject to the payment in full of all Senior Indebtedness, the Holders shall be
subrogated to the rights of the holders of Senior Indebtedness to receive
payments or distributions of cash, property or securities of the Company
applicable to the Senior Indebtedness until all amounts owing on the Debentures
shall be paid in full; and, for the purposes of such subrogation:
a. no payments or distributions to the holders of the Senior
Indebtedness of any cash, property or securities to which the Holders would be
entitled except for the provisions of this Article VI and no payment pursuant to
the provisions of this Article VI to the holders of Senior Indebtedness by the
Holders shall, as between the Company, its creditors (other than holders of
Senior Indebtedness) and the Holders, be deemed to be a payment by the Company
to or on account of the Senior Indebtedness; and
A-24
<PAGE>
b. no payment or distributions of cash, property or securities to
or for the benefit of the Holders pursuant to the subrogation provision of this
Article VI, which would otherwise have been paid to the holders of Senior
Indebtedness, shall be deemed to be a payment by the Company to or for the
account of the Debentures.
6.5 PROVISIONS SOLELY TO DEFINE RELATIVE RIGHTS. The provisions of
this Article are and are intended solely for the purpose of defining the
relative rights of the Holders on the one hand and the holders of Senior
Indebtedness on the other hand. Nothing contained in this Article or elsewhere
in this Debenture or in the Debentures is intended to or shall (a) impair, as
among the Company, its creditors other than holders of Senior Indebtedness and
the Holders of the Debentures, the obligation of the Company, which is absolute
and unconditional to pay to the Holders of the Debentures the principal of (any
premium, if any) and interest on the Debentures as and when the same shall
become due and payable in accordance with their terms; or (b) affect the
relative rights against the Company of the Holders of the Debentures and
creditors of the Company other than the holders of Senior Indebtedness; or (c)
prevent the Holder of any Debenture from exercising all remedies otherwise
permitted by applicable law upon default under this Debentures, subject to the
rights, if any, under this Article VI of the holders of Senior Indebtedness to
receive cash, property and securities otherwise payable or deliverable to the
Holder upon the exercise of any such remedy.
6.6 RIGHT TO FILE PROOF OF CLAIM. In the event of any dissolution,
winding up, liquidation or reorganization of the Company (whether in bankruptcy,
insolvency, receivership, reorganization or similar proceedings or upon any
assignment for the benefit of creditors or otherwise) tending towards
liquidation of the business and assets of the Company, with respect to the
filing of a claim for the unpaid balance of any Holder's Debentures in the form
required in those proceedings, if the Holder does not file a proper claim or
proof of debt in the form required in such proceeding at least thirty (30) days
before the expiration of the time to file such claim or claims, then the holders
of Senior Indebtedness and their agents, trustees, or other representatives are
hereby authorized to have the right to file, and are hereby authorized to file,
an appropriate claim for and on behalf of each such Holder.
6.7 NO WAIVER OF SUBORDINATION PROVISIONS. No right of any present
or future holder of any Senior Indebtedness to enforce subordination as herein
provided shall at any time in any way be prejudiced or impaired by any act or
failure to act on the part of the Company or by any act or failure to act, in
good faith, by any such holder, or by any noncompliance by the Company with the
terms, provisions and covenants of this Debenture, regardless of any knowledge
thereof any such holder may have or be otherwise charged with.
Without in any way limiting the generality of the foregoing
paragraph, the holders of Senior Indebtedness may, at any time and from time to
time, without the consent of or notice to the Holders of the Debentures, without
incurring responsibility to the Holders of the Debentures and without impairing
or releasing the subordination provided in this Article or the obligations
hereunder of the Holders of the Debentures to the holders of Senior
Indebtedness, do any one or more of the following: (i) change the manner, place
or terms of payment or extend the time of payment of, or renew or alter, Senior
Indebtedness, or otherwise amend or supplement in any manner Senior Indebtedness
or any instrument evidencing the same or any agreement under which Senior
Indebtedness is outstanding; (ii) sell, exchange, release or otherwise deal with
any
A-25
<PAGE>
property pledged, mortgaged or otherwise securing Senior Indebtedness; (iii)
release any Person liable in any manner for the collection of Senior
Indebtedness; and (iv) exercise or refrain from exercising any rights against
the Company and any other Person.
6.8 NOTICE TO HOLDERS. The Company shall give prompt written
notice to the Holders of any fact known to the Company which would prohibit the
making of any payment to or by the Holders in respect of the Debentures.
Notwithstanding the provisions of this Article or any other provision of this
Debenture, the Holders shall not be charged with knowledge of the existence of
any facts which would prohibit the making of any payment to the Holders in
respect of the Debentures, unless and until the Holders shall have received
written notice thereof from the Company or a holder of Senior Indebtedness; and,
prior to the receipt of any such written notice, the Holders shall be entitled
in all respects to assume that no such facts exist; PROVIDED, HOWEVER, that if
the Holders shall not have received the notice provided for in this Section at
least two Business Days prior to the date upon which by the terms hereof any
money may become payable for any purpose (including, without limitation, the
payment of the principal of, and premium, if any, or interest on any Debenture),
then, anything herein contained to the contrary notwithstanding, the Holders
shall have full power and authority to receive such money and to apply the same
to the purpose for which such money was received and shall not be affected by
any notice to the contrary which may be received by it within two Business Days
prior to such date.
The Holders shall be entitled to rely on the delivery to them
of a written notice by a Person representing himself to be a holder of Senior
Indebtedness (or a representative thereof) to establish that such notice has
been given by a holder of Senior Indebtedness (or representative thereof). In
the event that the Holders determines in good faith that further evidence is
required with respect to the right of any Person as a holder of Senior
Indebtedness (or a representative thereof) to participate in any payment or
distribution pursuant to this Article, the Holders may request such Person to
furnish evidence to the reasonable satisfaction of the Holders as to the amount
of Senior Indebtedness held by such Person, the extent to which such Person is
entitled to participate in such payment or distribution and any other facts
pertinent to the rights of such Person under this Article, and if such evidence
is not furnished, the Holders may defer any payment to such Person pending
judicial determination as to the right of such Person to receive such payment.
6.9 RELIANCE ON JUDICIAL ORDER OR CERTIFICATE OF LIQUIDATING
AGENT. Upon the payment or distribution of assets of the Company referred to in
this Article, the Holders of the Debentures shall be entitled to rely upon any
order or decree entered by any court of competent jurisdiction in which such
proceeding is pending, or a certificate of the trustee in bankruptcy, receiver,
liquidating trustee, custodian, assignee for the benefit of the creditors, agent
or other Person making such payment or distribution, delivered to the Holders of
Debentures, for the purpose of ascertaining the Persons entitled to participate
in such payment or distribution, the holders of the Senior Indebtedness and
other indebtedness of the Company, the amount thereof or payable thereon, the
amount or amounts paid or distributed thereon and all other facts pertinent
thereto or to this Article VI.
A-26
<PAGE>
6.10 NO ADVERSE MODIFICATION TO DEBENTURE. Neither the Holders nor
the Company shall enter into any modification of the Debentures which is in any
way adverse to the holders of the Senior Indebtedness.
6.11 NOTICE TO HOLDERS OF SENIOR INDEBTEDNESS. The Company will
furnish to the holders of Senior Indebtedness at the time Senior Indebtedness is
initially incurred, when there is a change in the Holders thereof, or at any
time upon request therefor, a true and correct copy of the then most current
register setting forth the names and addresses of the Holders as of such date.
6.12 SUBORDINATION AGREEMENT. The Holder by its acceptance hereof
agrees to execute and deliver to any Senior Lender such subordination agreement
as may be reasonably requested by such Senior Lender, which may deviate in
certain minor respects from the subordination provisions contained herein but
which is commercially reasonable and customary, and to execute, acknowledge,
deliver, file, notarize and register all such further agreements, instruments,
certificates, documents and assurances, and perform such acts as such Senior
Lender shall deem necessary or appropriate to effectuate the purposes of the
subordination provisions contained herein.
ARTICLE VII
MISCELLANEOUS
7.1 MODIFICATION OF DEBENTURES. This Debenture may be modified
without prior notice to any Holder upon the written consent of the Company and
the Holders of more than 90% of the principal amount of the Debentures then
outstanding. The Holders of more than 90% of the principal amount of the
Debentures then outstanding may waive compliance by the Company with any
provision of this Debenture without prior notice to any Holder. However, without
the consent of each Holder affected, an amendment, supplement or waiver may not
(1) reduce the amount of Debentures whose Holders must consent to an amendment,
supplement or waiver, (2) reduce the principal amount of or extend the fixed
maturity of any Debenture or (3) make any Debenture payable in money or property
other than as stated in the Debentures.
7.2 MISCELLANEOUS. This Debenture shall be governed by and
construed and enforced in accordance with the internal laws of the State of New
York without regard to the principles of conflicts of law thereof, except with
respect to matters mandatorily governed by the Delaware General Corporation Law.
Each party hereby irrevocably submits to the nonexclusive jurisdiction of the
state and federal courts sitting in the City of New York, Borough of Manhattan,
for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that
such suit, action or proceeding is improper. The parties hereto, including all
guarantors or endorsers, hereby waive presentment, demand, notice, protest and
all other demands and notices in connection with the delivery, acceptance,
performance and enforcement of this Debenture, except as specifically provided
herein, and assent to extensions of the time of payment, or forbearance or other
indulgence without notice. Any Holder of this
A-27
<PAGE>
Debenture by acceptance of this Debenture agrees to be bound by the provisions
of this Debenture which are expressly binding on such Holder.
7.3 RANK. Except as expressly provided herein, no provision of
this Debenture shall alter or impair the obligation of the Company to pay the
principal of, and interest and liquidated damages (if any) on, this Debenture at
the time, place, and rate, and in the coin or currency (or, as provided herein,
in Common Stock), herein prescribed. This Debenture is a direct obligation of
the Company. Except as otherwise provided herein, the Company may not
voluntarily prepay the outstanding principal amount of the Debenture.
7.4 DEBENTURES OWNED BY COMPANY DEEMED NOT OUTSTANDING. In
determining whether the holders of the requisite aggregate principal amount of
Debentures have concurred in any direction, consent or waiver under this
Debenture, Debentures which are owned by the Company or any other obligor on the
Debentures or by any Person directly or indirectly controlling or controlled by
or under direct or indirect common control with the Company or any other obligor
on the Debentures shall be disregarded and deemed not to be outstanding for the
purpose of any such determination; provided that any Debentures owned by the
Purchasers shall be deemed outstanding for purposes of making such a
determination. Debentures so owned which have been pledged in good faith may be
regarded as outstanding if the pledgee establishes to the satisfaction of the
Company the pledgee's right so to act with respect to such Debentures and that
the pledgee is not the Company or any other obligor upon the Debentures or any
Person directly or indirectly controlling or controlled by or under direct or
indirect common control with the Company or any other obligor on the Debentures.
7.5 NOTICE TO HOLDER PRIOR TO TAKING CERTAIN TYPES OF ACTION;
RECLASSIFICATION, ETC. In case:
a. the Company shall authorize the issuance, at any time from and
after the Original Issue Date, to all holders of any class or series of its
Capital Stock, of rights or warrants to subscribe for or purchase shares of its
capital stock or of any other right;
b. the Company shall authorize, at any time from and after the
Original Issue Date, the distribution to all holders of any class or series of
its Capital Stock, of evidences of its indebtedness or assets;
c. the Company shall declare a dividend (or other distribution)
on its Common Stock or the Company shall declare a special nonrecurring dividend
on or a redemption of its Common Stock;
d. of any subdivision, combination or reclassification of any
class or series of Capital Stock of the Company at any time from and after the
Original Issue Date or of any consolidation or merger to which the Company is a
party and for which approval by the shareholders of the Company is required, or
of the sale or transfer of all or substantially all of the assets of the Company
or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property; or
e. of the voluntary or involuntary dissolution, liquidation or
winding up of the Company;
A-28
<PAGE>
then the Company shall cause to be delivered to the Holder, at least 10
days prior to the applicable record date hereinafter specified, a written notice
stating (i) the date as of which the holders of record of such class or series
of Capital Stock are to be entitled to receive any such rights, warrants or
distribution are to be determined, or (ii) the date on which any such
subdivision, combination, reclassification, consolidation, merger, sale,
transfer, dissolution, liquidation, winding up or other action is expected to
become effective, and the date as of which it is expected that holders of record
of such class or series of Capital Stock record shall be entitled to exchange
their stock for securities or other property, if any, deliverable upon such
subdivision, combination, reclassification, consolidation, merger, sale,
transfer, dissolution, liquidation, winding up or other action.
The failure to give the notice required by this Section 7.5 or any
defect therein shall not affect the legality or validity of any distribution,
right, warrant, subdivision, combination, reclassification, consolidation,
merger, sale, transfer, dissolution, liquidation, winding up or other action, or
the vote upon any of the foregoing.
In the event of any reclassification of the Common Stock or any
compulsory share exchange pursuant to which the Common Stock is converted into
other securities, cash or property, the Holder shall have the right thereafter,
which must be exercised within ten (10) Business Days of receiving written
notice of such reclassification or conversion, to convert the principal amount
of (and any accrued by unpaid interest on) this Debenture into the securities,
cash or property receivable upon or deemed to be held by holders of Common Stock
following such reclassification or compulsory share exchange, and the Holder
shall be entitled upon such event to receive such amount of securities, cash or
property as a holder of the number of shares of Common Stock into which the
principal amount (and any accrued but unpaid interest thereon) of this Debenture
could have been converted immediately prior to such event would have received.
7.6 EFFECT OF HEADINGS. The Section headings herein are for
convenience only and shall not affect the construction hereof.
7.7 NO RIGHTS AS STOCKHOLDER. This Debenture shall not entitle the
Holder to any rights as a stockholder of the Company, including without
limitation, the right to vote, to receive dividends and other distributions,
unless and to the extent converted into shares of Common Stock in accordance
with the terms hereof.
7.8 FAILURE OR INDULGENCE NOT WAIVER. No failure or delay on the
part of the Holder in the exercise of any power, right or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of
any such power, right or privilege preclude other or further exercise thereof or
of any other right, power or privileges. All rights and remedies existing
hereunder are cumulative to, and not exclusive of, any rights or remedies
otherwise available.
A-29
<PAGE>
IN WITNESS WHEREOF, the Company has caused this instrument to be duly
executed as of this 11th day of January , 2000.
IGEN INTERNATIONAL, INC.
By
----------------------
Name:
Title:
A-30
<PAGE>
EXHIBIT A
IGEN INTERNATIONAL, INC.
CONVERSION NOTICE
Reference is made to the Debenture issued by IGEN International, Inc. (the
"DEBENTURE"). In accordance with and pursuant to the Debenture, the undersigned
hereby irrevocably elects to convert the principal amount of the Debenture,
indicated below into shares of Common Stock, par value $.001 per share (the
"COMMON STOCK"), of the Company, by tendering the Debenture specified below as
of the date specified below.
Date of Conversion:
-----------------------------------------------
Aggregate Principal Amount to be converted:
-----------------------
Debenture number(s) of Debenture to be converted:
-----------------
Please confirm the following information:
-------------------------
Conversion Price:
-------------------------------------------------
Number of shares of Common Stock to be issued:
--------------------
Please issue the Common Stock into which the Debenture is being converted and,
if applicable, any check drawn on an account of the Company in the following
name and to the following address:
Issue to:
---------------------------------------------------------
Facsimile Number:
-------------------------------------------------
Authorization: By:
------------------------------------------------
Name:
Title:
Dated:
------------------
Account Number (if electronic book entry transfer):
---------------------------
Transaction Code Number (if electronic book entry transfer):
------------------
A-31
<PAGE>
EXHIBIT B
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED WITH THE SECURITIES
AND EXCHANGE COMMISSION IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM,
OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT. THIS WARRANT AND THE SECURITIES REPRESENTED BY THIS WARRANT ARE
SUBJECT TO SUBSTANTIAL RESTRICTIONS ON TRANSFER.
JANUARY __, 2005
______ shares Warrant No. __
IGEN INTERNATIONAL, INC.
STOCK PURCHASE WARRANT
Registered Owner: _____________
This certifies that, for value received, IGEN International, Inc., a
Delaware corporation, the ("COMPANY") grants the following rights to the
Registered Owner, or permitted assigns, of this Warrant:
1. ISSUE. Upon tender (as defined in Section 5 hereof) to the
Company, the Company, within three (3) Business Days of the date thereof, shall
issue to the Registered Owner, or assigns, up to the number of shares specified
in Section 2 hereof of fully paid and nonassessable shares of Common Stock that
the Registered Owner, or permitted assigns, is otherwise entitled to purchase.
2. NUMBER OF SHARES. The total number of shares of Common
Stock that the Registered Owner, or assigns, of this Warrant is entitled to
receive upon exercise of this Warrant (the "WARRANT SHARES") is ________ shares,
subject to adjustment from time to time as to the number and kind of securities
for which this Warrant is exercisable, all as set forth in Section 6 hereof. The
Company shall at all times reserve and hold available out of its authorized and
unissued shares of Common Stock or other securities, as the case may be,
sufficient shares of Common Stock to satisfy all conversion and purchase rights
represented by outstanding convertible securities, options and warrants,
including this Warrant. The Company covenants and agrees that all shares of
Common Stock or other securities, as the case may be, that may be issued upon
the exercise of this Warrant shall, upon issuance, be duly and validly issued,
fully paid and nonassessable, free from all taxes, liens and charges with
respect to the purchase and the issuance of the shares, and shall not have any
legend or restrictions on resale, except as required by Section 3.1(b) of the
Purchase Agreement.
3. EXERCISE PRICE. The initial per share exercise price of
this Warrant, representing the price per share at which the shares of Common
Stock issuable upon exercise of this Warrant may be purchased, is $31, subject
to adjustment from time to time pursuant to the provisions of Section 6 hereof
(the "EXERCISE PRICE").
B-1
<PAGE>
4. EXERCISE PERIOD. This Warrant may be exercised from the
Closing Date (as defined in the Purchase Agreement) up to and including January
11, 2005 (the "EXERCISE PERIOD"). If not exercised during this period, this
Warrant and all rights granted under this Warrant shall expire and lapse.
5. TENDER; ISSUANCE OF CERTIFICATES.
a. Subject to Section 17 hereof, this Warrant may be
exercised, in whole or in part (for a minimum of 25,000 shares of
Common Stock), by (i) (a) actual delivery of the Exercise Price in cash
and a duly executed Warrant Exercise Form, a copy of which is attached
to this Warrant as EXHIBIT A, properly completed and executed by the
Registered Owner, or assigns, of this Warrant, and (b) by surrender of
this Warrant, or (ii) if the resale of the Warrant Shares by the
Registered Owner is not then registered pursuant to an effective
registration statement under the Securities Act, delivery to the
Company of a written notice of an election to effect a "Cashless
Exercise" (as defined in Section 5(b) below) for the Warrant Shares
specified in the Warrant Exercise Form. The Warrant Shares so purchased
shall be deemed to be issued to the Registered Owner as of the close of
business on the date on which this Warrant shall have been surrendered,
the completed Warrant Exercise Form shall have been delivered and
payment shall have been made for such shares as set forth above. The
payment and Warrant Exercise Form must be delivered to the registered
office of the Company either in person or as set forth in Section 13
hereof.
b. Commencing one hundred twenty (120) days following the
Closing Date (as defined in the Purchase Agreement), if, and only if,
at the time of exercise of this Warrant, the Warrant Shares are not
saleable pursuant to an effective registration statement, then in
addition to the exercise of all or a part of this Warrant by payment of
the Exercise Price in cash as provided above, and in lieu of such
payment, the Registered Owner shall have the right to effect a cashless
exercise (a "CASHLESS EXERCISE") of this Warrant. In the event of a
Cashless Exercise the Registered Owner may pay the aggregate Exercise
Price, in whole or in part, by either
(i) surrendering that number of Warrant Shares
(including Warrant Shares to be delivered upon such Cashless Exercise)
valued at the Per Share Market Value,
(ii) surrendering that number of shares of Common
Stock valued at the Per Share Market Value, or
(iii) reducing the outstanding principal amount of
the Registered Owner's Debentures by an amount equal to the product of
(x) the number of shares as to which this Warrant certificate is being
exercised multiplied by (y) the Exercise Price then in effect.
c. In lieu of physical delivery of the Warrant Shares,
provided the Company's transfer agent is participating in the
Depositary Trust Company ("DTC") Fast
B-2
<PAGE>
Automated Securities Transfer ("FAST") program, upon request of the
Registered Owner and in compliance with the provisions hereof, the
Company shall use its commercially reasonable efforts to cause its
transfer agent to electronically transmit the Warrant Shares to the
Registered Owner by crediting the account of the Registered Owner's
Prime Broker with DTC through its Deposit Withdrawal Agent Commission
system. The time period for delivery described herein shall apply to
the electronic transmittals described herein.
d. Certificates for the Warrant Shares so purchased,
representing the aggregate number of shares specified in the Warrant
Exercise Form, and any cash payments due under Section 16 hereof shall
be delivered to or by, as the case may be, the Registered Owner within
a reasonable time, not exceeding three (3) Business Days, after this
Warrant shall have been so exercised. The certificates so delivered
shall be in such denominations as may be requested by the Registered
Owner and shall be registered in the name of the Registered Owner or
such other name as shall be designated by such Registered Owner. If
this Warrant shall have been exercised only in part, then, unless this
Warrant has expired, the Company shall, at its expense, at the time of
delivery of such certificates, deliver to the Registered Owner a new
Warrant representing the remaining number of shares with respect to
which this Warrant shall not then have been exercised.
6. ADJUSTMENT OF EXERCISE PRICE.
a. COMMON STOCK DIVIDENDS; COMMON STOCK SPLITS; REVERSE COMMON
STOCK SPLITS. If the Company, at any time while this Warrant is
outstanding, (a) shall pay a stock dividend on its Common Stock, (b)
subdivide outstanding shares of Common Stock into a larger number of
shares, (c) combine outstanding shares of Common Stock into a smaller
number of shares or (d) issue by reclassification of shares of Common
Stock any shares of capital stock of the Company, then (i) the Exercise
Price shall be multiplied by a fraction the numerator of which shall be
the number of shares of Common Stock (excluding treasury shares, if
any) outstanding before such event and the denominator of which shall
be the number of shares of Common Stock (excluding treasury shares, if
any) outstanding after such event and (ii) the number of Warrant Shares
shall be multiplied by a fraction, the numerator of which shall be the
number of shares of Common Stock (excluding treasury shares, if any)
outstanding after such event and the denominator of which shall be the
number of shares of Common Stock (excluding treasury shares, if any)
outstanding before such event. Any adjustment made pursuant to this
paragraph (6)(a) shall become effective immediately after the record
date for the determination of shareholders entitled to receive such
dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or
re-classification.
b. RIGHTS; OPTIONS; WARRANTS OR OTHER SECURITIES. If the
Company, at any time while this Warrant is outstanding, shall fix a
record date for the issuance of rights, options, warrants or other
securities to all of the holders of Common Stock entitling them to
subscribe for or purchase, convert to, exchange for or otherwise
acquire shares of
B-3
<PAGE>
Common Stock for no consideration or at a price per share less than the
Per Share Market Value, the Exercise Price shall be multiplied by a
fraction, the denominator of which shall be the number of shares of
Common Stock (excluding treasury shares, if any) outstanding on the
date of issuance of such rights, options, warrants or other securities
plus the number of additional shares of Common Stock offered for
subscription, purchase, conversion, exchange or acquisition and the
numerator of which shall be the number of shares of Common Stock
(excluding treasury shares, if any) outstanding on the date of issuance
of such rights, options, warrants or other securities plus the number
of shares which the aggregate offering price of the total number of
shares so offered would purchase at the Per Share Market Value. Such
adjustment shall be made whenever such rights, options, warrants or
other securities are issued, and shall become effective immediately
after the record date for the determination of shareholders entitled to
receive such rights, options, warrants or other securities. However,
upon the expiration of any rights, options, warrants or other
securities to purchase Common Stock the issuance of which resulted in
an adjustment in the Exercise Price pursuant to this Section 6(b), if
any such rights, options, warrants or other securities shall expire and
all or any portion thereof shall not have been exercised, the Exercise
Price shall immediately upon such expiration be increased to the price
which it would have been had the adjustment of the Exercise Price been
made upon the basis of the issuance of only that number of shares of
Common Stock (if any) actually purchased upon the exercise of such
rights, options, warrants or other securities actually exercised.
c. ADJUSTMENT OF NUMBER OF SHARES. Upon each adjustment of the
Exercise Price as a result of the calculations made in Section 6(b),
this Warrant shall thereafter evidence the right to receive, at the
adjusted Exercise Price, that number of shares of Common Stock
(calculated to the nearest one-hundredth) obtained by dividing (i) the
product of the aggregate number of shares covered by this Warrant
immediately prior to such adjustment and the Exercise Price in effect
immediately prior to such adjustment of the Exercise Price by (ii) the
Exercise Price in effect immediately after such adjustment of the
Exercise Price.
d. ROUNDING. All calculations under this Section 6 shall be
made to the nearest cent or the nearest l/l00th of a share, as the case
may be.
e. REDEMPTION EVENT. The following are "REDEMPTION EVENTS"
under this Section 6(e): (A) any reclassification of the Common Stock,
(B) any Change of Control, or (C) any compulsory share exchange
pursuant to which the Common Stock is converted into other securities,
cash or property. After the occurrence of (A), (B) or (C), the
Registered Owner shall have the right at his or its option, to exercise
the Warrant for shares of stock and other securities, cash and property
receivable upon or deemed to be held by holders of Common Stock
following such Redemption Event; the Registered Owner shall be entitled
upon such exercise to receive such amount of securities, cash or
property as if the Registered Owner had exercised the Warrant for the
shares of Common Stock issuable upon exercise of the Warrant
immediately prior to such Redemption Event (without taking into account
any limitations or restrictions on the exercise of the Warrant). In the
case of (A), (B) or (C), the Company shall not effect any such
B-4
<PAGE>
Redemption Event unless, prior to the consummation thereof, each Person
(other than the Company) which may be required to deliver any stock,
securities, cash or property upon the exercise of the Warrant as
provided herein shall assume, by written instrument delivered and
reasonably satisfactory to, the Registered Owner, (a) the obligations
of the Company under this Warrant (and if the Company shall survive the
consummation of such transaction, such assumption shall be in addition
to, and shall not release the Company from, any continuing obligations
of the Company under this Warrant), (b) the obligations of the Company
under the Purchase Agreement, the Warrant, the Debenture, and the
Registration Rights Agreement, and (c) the obligation to deliver to the
Registered Owner such shares of stock, securities, cash or property as,
in accordance with the foregoing provisions of this Section 6(e), the
Registered Owner may be entitled to receive. Nothing in this Section
6(e) shall be deemed to authorize the Company to enter into any
transaction not otherwise permitted by the Purchase Agreement.
This provision shall similarly apply to successive Redemption Events.
7. NASDAQ LIMITATION. If on any date (the "DETERMINATION
DATE") (a) the Common Stock is listed for trading on Nasdaq or the
Nasdaq SmallCap Market, (b) the Exercise Price then in effect is
such that the aggregate number of shares of Common Stock that would
then be issuable upon exercise in full of the then outstanding
Warrants if all such Warrants were exercised on such Determination
Date (without regard to any limitations on exercise) would equal or
exceed 20% of the number of shares of the Common Stock outstanding
immediately prior to such exercise date (the "ISSUABLE MAXIMUM"),
and (c) the Company shall not have previously obtained any vote of
the shareholders of the Company owning a majority of the outstanding
Common Stock (the "SHAREHOLDER APPROVAL"), if any, as may be
required by the applicable rules and regulations of Nasdaq (or any
successor entity) to approve the issuance of shares of Common Stock
in excess of the Issuable Maximum in a private placement whereby
shares of Common Stock are deemed to have been issued at a price
that is less than the greater of book value or fair market value of
the Common Stock, then with respect to the aggregate number of
shares of Common Stock issuable upon the exercise of the Warrants
then held by the Registered Owners for which an exercise in
accordance with the Exercise Price would result in an issuance of
shares of Common Stock in excess of such Registered Owner's pro rata
allocation (as described below) of the Issuable Maximum (the "EXCESS
AMOUNT"), the Company may elect to pay cash to the Registered Owners
in an amount equal to the product of the Average Price on the
Determination Date multiplied by the number of shares of Common
Stock that would be issued upon the exercise of the Warrants
resulting in the Excess Amount (the "PREPAYMENT AMOUNT"). Any such
election by the Company must be made in writing to the Registered
Owners within two (2) Trading Days after the first such
Determination Date and the payment of such Prepayment Amount shall
be made in full to the Registered Owners with ten (10) Business Days
after the date such notice is delivered. If the Company does not
deliver timely a notice of its election to prepay under this section
or shall, if it shall have delivered such a notice, fail to pay the
Prepayment Amount hereunder within ten (10) Business Days
thereafter, then each Registered Owner shall have the option by
written notice to the Company, to, if applicable, declare any such
notice given by the Company, if given, to be null and void and
require the Company to either: (i) use its commercially
B-5
<PAGE>
reasonable efforts to obtain the Shareholder Approval applicable to
such issuance as soon as is possible, but in any event not later
than the 60th day after such request unless the Company has
previously used its commercially reasonable efforts to, but has
failed to, obtain such approval (provided, that if the Company shall
fail to obtain the Shareholder Approval during such 60-day period,
the Registered Owner may demand the cash payment set forth in
Section 7(ii)) herein, or (ii) use all commercially reasonable
efforts to obtain an exemption from Nasdaq, or (iii) pay cash to
such Registered Owner, within five (5) Business Days of such
Registered Owner's notice, in an amount equal to the Prepayment
Amount for such Registered Owner's portion of the Excess Amount. The
payment of the Prepayment Amount to each Registered Owner pursuant
to this section shall be determined on a pro rata basis upon the
number of shares of Common Stock issuable upon the exercise of the
Warrants held by such Registered Owner on the Determination Date
which is in excess of the pro rata allocation of the Issuable
Maximum. If the Company fails to pay the Prepayment Amount in full
pursuant to this Section 7 within five (5) Business Days after the
date payable, the Company will pay interest thereon at a rate of 10%
per annum to the exercising Registered Owner, accruing interest
daily from the date of exercise until such amount, plus all such
interest thereon, if any, is paid in full. Until the Company has
received the Shareholder Approval no Registered Owner of the
Warrants shall be issued, upon exercise of the Warrants, shares of
Common Stock in an amount greater than such Registered Owner's
allocated portion of the Issuable Maximum.
In no event shall the Company be required to issue shares of Common
Stock upon exercise of the Warrants if such issuance would violate the rules of
Nasdaq.
8. RESTRICTION ON EXERCISE BY EITHER THE REGISTERED OWNER OR
THE COMPANY. Notwithstanding anything herein to the contrary, in no event shall
any Registered Owner or the Company have the right or be required to exercise
this Warrant if as a result of such exercise the aggregate number of shares of
Common Stock beneficially owned by such Registered Owner and its Affiliates
would exceed 4.99% of the outstanding shares of the Common Stock following such
exercise. For purposes of this Section 8, beneficial ownership shall be
calculated in accordance with Section 13(d) of the Securities Exchange Act of
1934, as amended. The provisions of this Section 8 may be waived by a Registered
Owner as to itself (and solely as to itself) upon not less than 65 days prior
written notice to the Company, and the provisions of this Section 8 shall
continue to apply until such 65th day (or later, if stated in the notice of
waiver). Under no circumstances will the provisions of this Section 8 extend the
Exercise Period.
9. OFFICER'S CERTIFICATE. Whenever the Exercise Price, the
number or kind of shares purchasable upon exercise shall be adjusted as required
by the provisions of Section 6, the Company shall forthwith file in the custody
of its Secretary or an Assistant Secretary at its principal office and with its
stock transfer agent, if any, an officer's certificate showing the adjusted
Exercise Price, number of shares or other securities determined as herein
provided, setting forth in reasonable detail the facts requiring such adjustment
and the manner of computing such adjustment. Each such officer's certificate
shall be signed by the chairman, president or chief financial officer of the
Company and by the secretary or any assistant secretary of the Company. Each
such officer's certificate shall be made available at all reasonable times
B-6
<PAGE>
for inspection by any Registered Owner of the Warrants and the Company shall,
forthwith after each such adjustment, deliver a copy of such certificate to the
each of the Registered Owners.
10. DEFINITIONS. Capitalized terms used herein and not
otherwise defined herein shall have the meanings given to such terms in the
Purchase Agreement. As used in this Warrant, the following terms have the
following meanings:
"AFFILIATE" means, with respect to any Person, any other
Person that directly or indirectly controls or is controlled by or under common
control with such Person. For the purposes of this definition, "CONTROL," when
used with respect to any Person, means the possession, direct or indirect, of
the power to direct or cause the direction of the management and policies of
such Person, whether through the ownership of voting securities, by contract or
otherwise; and the terms of "AFFILIATED," "CONTROLLING" and "CONTROLLED" have
meanings correlative to the foregoing.
"APPRAISER" shall mean a nationally recognized or major
regional investment banking firm or firm of independent certified public
accountants of recognized standing.
"BUSINESS DAY" means any day except Saturday, Sunday and any
day which shall be a legal holiday or a day on which banking institutions in the
state of New York generally are authorized or required by law or other
government actions to close.
"CHANGE OF CONTROL" has the meaning set forth in Section 4.1
of the Purchase Agreement.
"CLOSING" has the meaning set forth in Section 1.2 of the
Purchase Agreement.
"COMMON STOCK" means the shares of the Company's Common Stock,
par value $.001 per share.
"COMPANY" means IGEN International, Inc. a Delaware
corporation.
"DEBENTURE(S)" means the Company's 5% Subordinated Convertible
Debentures issued at the Closing.
"DETERMINATION DATE" has the meaning assigned to it in Section
7 hereof.
"EXCESS AMOUNT" has the meaning assigned to it in Section 7
hereof.
"EXERCISE PERIOD" has the meaning assigned to it the Section 4
hereof.
"EXERCISE PRICE" has the meaning assigned to it in Section 3
hereof
"ISSUABLE MAXIMUM" has the meaning assigned to it in Section 7
hereof.
"NASDAQ" means the Nasdaq National Market.
B-7
<PAGE>
"PER SHARE MARKET VALUE" means on any particular date (i) the
closing bid price per share of the Common Stock on such date on the National
Market System of the Nasdaq or other registered national stock exchange on which
the Common Stock is then listed or if there is no such price on such date, then
the closing bid price on such exchange or quotation system on the date nearest
preceding such date, or (ii) if the Common Stock is not listed then on the
Nasdaq or any Subsequent Market, the closing bid price for a share of Common
Stock in the over-the-counter market, as reported by the National Quotation
Bureau Incorporated (or similar organization or agency succeeding to its
functions of reporting prices) at the close of business on such date, or (iii)
if the Common Stock is not then publicly traded the fair market value of a share
of Common Stock as determined by an Appraiser selected in good faith by the
holder of this Warrant; PROVIDED, HOWEVER, that the Company, after receipt of
the determination by such Appraiser, shall have the right to select, in good
faith, an additional Appraiser, in which case the fair market value shall be
equal to the average of the determinations by each such Appraiser; and PROVIDED,
FURTHER that all determinations of the Per Share Market Value shall be
appropriately adjusted for any stock dividends, stock splits or other similar
transactions during such period.
"PREPAYMENT AMOUNT" has the meaning assigned to it in Section
7 hereof.
"PURCHASE AGREEMENT" means that certain Securities Purchase
Agreement, dated January 11, 2000, among the Company and the Purchasers.
"PURCHASER" has the meaning set forth in the Purchase
Agreement.
"REDEMPTION EVENT" has the meaning assigned to it in Section
6(e) hereof.
"REGISTERED OWNER" means the person identified on the face of
this Warrant as the registered owner hereof or such other person as shown on the
records of the Company as being the registered owner of this Warrant or their
assigns.
"REGISTRATION RIGHTS AGREEMENT" means that certain
Registration Rights Agreement, dated January 11, 2000, among the Company and the
Purchasers.
"SHAREHOLDER APPROVAL" has the meaning assigned to it in
Section 8 hereof.
"SUBSEQUENT MARKET" means the New York Stock Exchange,
American Stock Exchange or Nasdaq Smallcap Market.
"TRADING DAY(S)" means any day on which the primary market on
which shares of Common Stock are listed is open for trading.
"UNDERLYING SHARES" has the meaning assigned to it in Section
2.1(d) of the Purchase Agreement.
"WARRANT(S)" means the warrants issuable at the Closing.
B-8
<PAGE>
11. REGISTRATION RIGHTS. The Company will undertake the
registration of the Common Stock into which such Warrants are exercisable at
such times and upon such terms pursuant to the provisions of the Registration
Rights Agreement.
12. RESERVATION OF UNDERLYING SHARES; LISTING. The Company
covenants that it will at all times reserve and keep available out of its
authorized shares of Common Stock, free from preemptive rights, solely for the
purpose of issue upon exercise of the Warrants as herein provided, such number
of shares of the Common Stock as shall then be issuable upon the exercise of all
outstanding Warrants into Common Stock. The Company covenants that all shares of
the Common Stock issued upon exercise of the Warrant shall, when issued, be duly
and validly issued and fully paid and non-assessable. The Company shall promptly
secure the listing of the shares of Common Stock issuable upon exercise of the
Warrant upon each national securities exchange or automated quotation system, if
any, upon which shares of Common Stock are then listed (subject to official
notice of issuance upon exercise of this Warrant) and shall maintain, so long as
any other shares of Common Stock shall be so listed, such listing of all shares
of Common Stock from time to time issuable upon the exercise of this Warrant;
and the Company shall so list on each national securities exchange or automated
quotation system, as the case may be, and shall maintain such listing of, any
other shares of capital stock of the Company issuable upon the exercise of this
Warrant if and so long as any shares of the same class shall be listed on such
national securities exchange or automated quotation system.
13. NOTICES. Any notices, consents, waivers or other
communications required or permitted to be given under the terms of this
Agreement must be in writing and will be deemed to have been delivered (i) upon
receipt, when delivered personally; (ii) upon receipt, when sent by facsimile,
provided confirmation of transmission is mechanically or electronically
generated and kept on file by the sending party (if received by 5:30 p.m. EST
where such notice is received) or the first business day following such delivery
(if received after 5:30 p.m. EST where such notice is received); or (iii) one
business day after deposit with a nationally recognized overnight delivery
service; provided that confirmation of the delivery is generated and kept on
file by the sending party, in each case properly addressed to the party to
receive the same. The addresses and facsimile numbers for such communications
shall be:
If to the Company:
IGEN International, Inc.
16020 Industrial Drive
Gaithersburg, MD 20877
Attn: Mr. George V. Migausky
Tel: 301-869-9800
Fax: 301-208-3798
B-9
<PAGE>
With a copy to:
Wilmer, Cutler & Pickering
2445 M Street, N.W.
Washington, DC 20037
Attn: Meredith B. Cross, Esq.
Tel: 202-663-6000
Fax: 202-663-6363
If to the Registered Owner: to the address set forth on
Schedule II to the Purchase Agreement
With a copy, in the case of Notice to Brown Simpson Strategic
Growth Fund, Ltd. or Brown Simpson Strategic Growth Fund, L.P., to:
Akin, Gump, Strauss, Hauer & Feld, L.L.P.
590 Madison Avenue
New York, New York 10022
Telephone: (212) 872-1000
Facsimile: (212) 872-1002
Attention: James Kaye
Each party shall provide written notice to the other party of any change in
address or facsimile number in accordance with the provisions hereof.
14. COMPLIANCE WITH GOVERNMENTAL REQUIREMENTS. The Company
covenants that if any shares of Common Stock required to be reserved for
purposes of exercise of Warrants hereunder require registration with or approval
of any governmental authority under any Federal or state law, or any national
securities exchange, before such shares may be issued upon exercise, the Company
will use all commercially reasonable efforts to cause such shares to be duly
registered or approved, as the case may be.
15. FRACTIONAL SHARES. Upon any exercise hereunder, the
Company shall not be required to issue stock certificates representing fractions
of shares of the Common Stock, but may if otherwise permitted make a cash
payment in respect of any final fraction of a share based on the Per Share
Market Value at such time. If the Company elects not, or is unable, to make such
a cash payment, the Registered Owner shall be entitled to receive, in lieu of
the final fraction of a share, one whole share of Common Stock.
16. PAYMENT OF TAX UPON ISSUE OF TRANSFER. The issuance of
certificates for shares of the Common Stock upon exercise of the Warrants shall
be made without charge to the Registered Owners thereof for any documentary
stamp or similar taxes that may be payable in respect of the issue or delivery
of such certificate, provided that the Company shall not be required to pay any
tax that may be payable in respect of any transfer involved in the issuance and
delivery of any such certificate upon exercise in a name other than that of the
Registered
B-10
<PAGE>
Owner of such Warrant so converted and the Company shall not be required to
issue or deliver such certificates unless or until the person or persons
requesting the issuance thereof shall have paid to the Company the amount of
such tax or shall have established to the satisfaction of the Company that such
tax has been paid.
17. WARRANTS OWNED BY COMPANY DEEMED NOT OUTSTANDING. In
determining whether the holders of the outstanding Warrants have concurred in
any direction, consent or waiver under this Warrant, warrants which are owned by
the Company or any other obligor on the warrants or by any person directly or
indirectly controlling or controlled by or under direct or indirect common
control with the Company or any other obligor on the warrants shall be
disregarded and deemed not to be outstanding for the purpose of any such
determination; provided that any Warrants owned by the Purchasers (as defined in
the Purchase Agreement) shall be deemed outstanding for purposes of making such
a determination. Warrants so owned which have been pledged in good faith may be
regarded as outstanding if the pledgee establishes to the satisfaction of the
Company the pledgee's right so to act with respect to such warrants and that the
pledgee is not the Company or any other obligor upon the securities or any
Affiliate of the Company or any other obligor on the warrants.
18. EFFECT OF HEADINGS. The section headings herein are for
convenience only and shall not affect the construction hereof.
19. NO RIGHTS AS STOCKHOLDER. This Warrant shall not entitle
the Registered Owner to any rights as a stockholder of the Company, including
without limitation, the right to vote, to receive dividends and other
distributions, or to receive notice of, or to attend, meetings of stockholders
or any other proceedings of the Company, unless and to the extent exercised for
shares of Common Stock in accordance with the terms hereof.
20. CERTAIN ACTIONS PROHIBITED. The Company will at all times
in good faith assist in the carrying out of all the provisions of this Warrant.
21. SUCCESSORS AND ASSIGNS. This Warrant shall be binding upon
and inure to the benefit of the Registered Owners and its assigns, and shall be
binding upon any entity succeeding to the Company by merger or acquisition of
all or substantially all the assets of the Company. The Company may not assign
this Warrant or any rights or obligations hereunder without the prior written
consent of the Registered Owner. The Registered Owner may assign this Warrant in
accordance with the Purchase Agreement without the prior written consent of the
Company.
22. GOVERNING LAW. This Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New
York without regard to the principles of conflicts of law thereof, except with
respect to matters mandatorily governed by the Delaware General Corporation Law.
Each party hereby irrevocably submits to the nonexclusive jurisdiction of the
state and federal courts sitting in the City of New York, Borough of Manhattan,
for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that
such suit, action or proceeding is improper. Each party hereby irrevocably
waives personal service of process and consents to process being served in
B-11
<PAGE>
any such suit, action or proceeding by mailing a copy thereof to such party at
the address for such notices to it under this Warrant and agrees that such
service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY
WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT
OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.
IN WITNESS WHEREOF, the Company has caused this Warrant to be
executed by its duly authorized officer as of the date first set forth above.
IGEN INTERNATIONAL , INC.
By:
------------------------------------
Name:
----------------------------------
Title:
---------------------------------
B-12
<PAGE>
EXHIBIT A
WARRANT EXERCISE FORM
TO: IGEN INTERNATIONAL, INC.
The undersigned hereby: (1) irrevocably subscribes for and offers to
purchase _______ shares of Common Stock of IGEN International, Inc. , pursuant
to Warrant No. ___ heretofore issued to ___________________ on ____________,
2000; (2) encloses either (a) a cash payment of $__________ or (b) _____ Warrant
Shares, valued at the Per Share Market Price of $ _____ on ________, ___, for
these shares at a price of $____ per share (as adjusted pursuant to the
provisions of the Warrant); or (c) ____ shares of Common Stock, valued at the
Per Share Market Price of $ _____ on ________, ___, for these shares at a price
of $____ per share (as adjusted pursuant to the provisions of the Warrant); or
(d) Debentures evidencing $ ______ of the principal amount, for these shares at
a price of $____ per share (as adjusted pursuant to the provisions of the
Warrant) and (3) requests that a certificate for the shares be issued in the
name of the undersigned and delivered to the undersigned at the address
specified below.
Date:
----------------------------------
Investor Name:
----------------------------------
Taxpayer Identification
Number:
----------------------------------
By:
----------------------------------
Printed Name:
----------------------------------
Title:
----------------------------------
Address:
----------------------------------
Note: The above signature should correspond exactly with the
name on the face of this Warrant Certificate or with the name
of the assignee appearing in assignment form below.
AND, if said number of shares shall not be all the shares purchasable under the
within Warrant, a new Warrant Certificate is to be issued in the name of said
undersigned for the balance remaining of the shares purchasable thereunder less
any fraction of a share paid in cash and delivered to the address stated above.
B-13
<PAGE>
EXHIBIT C
REGISTRATION RIGHTS AGREEMENT
This Registration Rights Agreement (this "AGREEMENT") is made
and entered into as of January 11, 2000, among IGEN International, Inc., a
Delaware corporation (the "COMPANY"), and the other parties who have executed
this Agreement and whose names appear on Schedule I hereto (each party listed on
Schedule I hereto is sometimes individually referred to herein as a "PURCHASER"
and all such parties are sometimes collectively referred to herein as the
"PURCHASERS").
This Agreement is made pursuant to the Securities Purchase
Agreement, dated as of the date hereof among the Company and the Purchasers (the
"PURCHASE AGREEMENT").
The Company and the Purchasers hereby agree as follows:
1. DEFINITIONS
Capitalized terms used and not otherwise defined herein shall
have the meanings given such terms in the Purchase Agreement. As used in this
Agreement, the following terms shall have the following meanings:
"ADVICE" has meaning set forth in Section 3(o) hereof.
"AFFILIATE" means, with respect to any Person, any other
Person that directly or indirectly controls or is controlled by or under common
control with such Person. For the purposes of this definition, "CONTROL," when
used with respect to any Person, means the possession, direct or indirect, of
the power to direct or cause the direction of the management and policies of
such Person, whether through the ownership of voting securities, by contract or
otherwise; and the terms "AFFILIATED," CONTROLLING" and "CONTROLLED" have
meanings correlative to the foregoing.
"AMEX" has the meaning set forth in Section 2(d) hereof.
"BUSINESS DAY" means any day except Saturday, Sunday and any
day which shall be a legal holiday or a day on which banking institutions in the
State of New York generally are authorized or required by law or other
government actions to close.
"BLACK-OUT PERIOD" has the meaning set forth in Section 3(q)
hereof.
"CLOSING DATE" shall mean the Closing Date as defined in the
Purchase Agreement.
"COMMISSION" means the Securities and Exchange Commission.
C-1
<PAGE>
"COMMON STOCK" means the Company's Common Stock, par value
$.001 per share.
"EFFECTIVENESS DATE" means the earlier of (i) the tenth
Business Day after the Company has received notice (written or oral) from the
Commission that the Commission Staff will not be reviewing the Registration
Statement or has no further comments on the Registration Statement or (ii) the
120th day following the Closing Date; PROVIDED, HOWEVER, that the Effectiveness
Date shall be extended to up to the 150th day following the Closing Date if the
Initial Registration Statement is not declared effective by the Commission prior
to the 120th day following the Closing Date due to delays which are attributable
to the Commission, so long as the Company responds to any comments received from
the Commission in a commercially reasonably manner and as promptly as
practicable, but in no event later than twenty (20) Business Days from the
receipt thereof.
"EFFECTIVENESS PERIOD" has the meaning set forth in Section
2(a) hereof.
"EXCHANGE ACT" means the Securities Exchange Act of 1934, as
amended.
"EVENT" has the meaning set forth in Section 2(d) hereof.
"FILING DATE" means as soon as practicable but in no event
later than the 30th day following the Closing Date.
"HOLDER" or "HOLDERS" means the holder or holders, as the case
may be, from time to time of Registrable Securities.
"INDEMNIFIED PARTY" has the meaning set forth in Section 5(c)
hereof.
"INDEMNIFYING PARTY" has the meaning set forth in Section 5(c)
hereof.
"INITIAL REGISTRATION DELAY PAYMENT" has the meaning set forth
in Section 2(d) hereof.
"INITIAL REGISTRATION STATEMENT" has the meaning set forth in
Section 2(a) hereof.
"LOSSES" has the meaning set forth in Section 5(a) hereof.
"MAJORITY HOLDERS" means the Holders of at least fifty (50%)
percent of the Registrable Securities.
"NASDAQ" has the meaning set forth in Section 2(d).
"NYSE" has the meaning set forth in Section 2(d).
"OBJECTIONS" has the meaning set forth in Section 3(a).
C-2
<PAGE>
"PERSON" means an individual or a corporation, partnership,
trust, incorporated or unincorporated association, joint venture, limited
liability company, joint stock company, government (or an agency or political
subdivision thereof) or other entity of any kind.
"PROCEEDING" means an action, claim, suit, investigation or
proceeding (including, without limitation, an investigation or partial
proceeding, such as a deposition), whether commenced or threatened.
"PROSPECTUS" means the prospectus included in the Registration
Statement (including, without limitation, a prospectus that includes any
information previously omitted from a prospectus filed as part of an effective
registration statement in reliance upon Rule 430A promulgated under the
Securities Act), as amended or supplemented by any prospectus supplement, with
respect to the terms of the offering of any portion of the Registrable
Securities covered by the Registration Statement, and all other amendments and
supplements to the Prospectus, including post-effective amendments, and all
material incorporated by reference in such Prospectus.
"REGISTRABLE SECURITIES" means the shares of Common Stock
issued or issuable upon (i) conversion of or with respect to the Securities,
(ii) any other payments in respect of the Securities, (iii) exercise of the
Warrants, and (iv) any shares of the Company's capital stock issued with respect
to (i), (ii) or (iii) as a result of any stock split, stock dividend,
recapitalization, exchange or similar event or otherwise.
"REGISTRATION DELAY PAYMENT" means either an Initial
Registration Delay Payment or a Secondary Registration Delay Payment.
"REGISTRATION STATEMENT" means the Initial Registration
Statement and any additional registration statements contemplated by Sections
2(a), 2(b) and 6(d) hereof, including (in each case) the Prospectus, amendments
and supplements to such registration statement or Prospectus, including pre- and
post-effective amendments, all exhibits thereto, and all material incorporated
by reference in such registration statement.
"REQUIRED MINIMUM SHARES" has the meaning set forth in the
Purchase Agreement.
"RULE 144" means Rule 144 promulgated by the Commission
pursuant to the Securities Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the Commission having
substantially the same effect as such Rule.
"RULE 158" means Rule 158 promulgated by the Commission
pursuant to the Securities Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the Commission having
substantially the same effect as such Rule.
C-3
<PAGE>
"RULE 415" means Rule 415 promulgated by the Commission
pursuant to the Securities Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the Commission having
substantially the same effect as such Rule.
"SECONDARY REGISTRATION DELAY PAYMENT" has the meaning set
forth in Section 2(d) hereof.
"SECURITIES" means the Company's 5% Subordinated Convertible
Debentures issuable pursuant to the Purchase Agreement.
"SECURITIES ACT" means the Securities Act of 1933, as amended.
"SPECIAL COUNSEL" means one special counsel to the Holders,
for which the Holders will be reimbursed by the Company pursuant to Section 4
hereof.
"STATED MATURITY" has the meaning assigned it in the
Securities.
"TRADING DAY" means a day on which the Nasdaq (or in the event
the Common Stock is not traded on Nasdaq, such other securities market on which
the Common Stock is listed) is open for trading.
"UNDERLYING SHARES" means the shares of Common Stock issuable
upon conversion of the Securities and exercise of the Warrants.
"UNDERWRITTEN REGISTRATION OR UNDERWRITTEN OFFERING" means a
registration in connection with which securities of the Company are sold to an
underwriter for reoffering to the public pursuant to an effective registration
statement, whether on a firm commitment or best efforts basis.
"WARRANTS" means the warrants issuable pursuant to the
Purchase Agreement.
2. REGISTRATION REQUIREMENTS
(a) FILING AND EFFECTIVENESS OBLIGATIONS. On or prior to the
Filing Date, the Company shall prepare and file with the Commission a
Registration Statement (the "INITIAL REGISTRATION STATEMENT") which shall cover
all Registrable Securities for an offering to be made on a continuous basis
pursuant to a "Shelf" registration statement under Rule 415. The Initial
Registration Statement shall be on Form S-3 or any successor form (except if the
Company is not then eligible to register for resale the Registrable Securities
on Form S-3, in which case such registration shall be on another appropriate
form in accordance herewith, subject to the reasonable consent of the Majority
Holders). The Company shall (i) not permit any securities other than the
Registrable Securities to be included in the Initial Registration Statement and
(ii) use all commercially reasonable efforts to cause the Initial Registration
Statement to be declared effective under the Securities Act as promptly as
possible after the filing thereof, but in any event on or prior to the
Effectiveness Date, and to take all commercially reasonable steps to keep such
Initial Registration Statement continuously effective under the Securities Act,
(except for any
C-4
<PAGE>
delays which are attributable to changes required by the Purchasers in the
Registration Statement with respect to information relating to the Purchasers,
or to the failure of the Purchasers to conduct their review of the Initial
Registration Statement pursuant to Section 3(a), which shall not be deemed to be
a violation of this obligation), until the date which is three years after the
date that such Initial Registration Statement is declared effective by the
Commission or such earlier date when all Registrable Securities covered by such
Initial Registration Statement have been sold or may be sold without volume
restrictions pursuant to Rule 144, without regard to whether the holder of the
Registrable Securities is an affiliate of the Company, as determined by counsel
to the Company pursuant to a written opinion letter, addressed to the Holders
and the Company's transfer agent to such effect (the "EFFECTIVENESS PERIOD").
The number of shares of Common Stock initially included in the Initial
Registration Statement shall be no less than the Required Minimum Shares.
(b) UNDERWRITTEN OFFERING. In addition to the Initial
Registration Statement, at any time when a Registration Statement covering the
Registrable Securities is not effective (during any period in which a
Registration Statement is required to be effective during the Effectiveness
Period), if the Holders of a majority of the Registrable Securities covered by a
Registration Statement so elect by written notice to the Company on or after
July 11, 2000, an offering of Registrable Securities pursuant to such
Registration Statement may be effected on no more than one (1) occasion in the
form of an Underwritten Offering. In such event, and if the managing
underwriters advise the Company and such Holders in writing that in their
opinion the amount of Registrable Securities proposed to be sold in such
Underwritten Offering exceeds the amount of Registrable Securities which can be
sold in such Underwritten Offering, there shall be included in such Underwritten
Offering the amount of such Registrable Securities which in the opinion of such
managing underwriters can be sold, and such amount shall be allocated PRO RATA
among the Holders proposing to sell Registrable Securities in such Underwritten
Offering.
(c) UNDERWRITER. If any of the Registrable Securities are to
be sold in an Underwritten Offering pursuant to Section 2(b) hereof, the
investment banker in interest that will administer the offering will be selected
by the Holders of a majority of the Registrable Securities included in such
offering and be reasonably satisfactory to the Company. No Holder may
participate in any Underwritten Offering hereunder unless such Holder (i) agrees
to sell its Registrable Securities on the basis provided in accordance with any
underwriting agreements approved by the Persons entitled hereunder to approve
such arrangements and (ii) completes and executes all questionnaires, powers of
attorney, indemnities, underwriting agreements and other documents required
under the terms of such arrangements.
(d) PENALTIES. If (i) the Initial Registration Statement
covering all the applicable Registrable Securities and required to be filed by
the Company pursuant to this Agreement is not (A) filed with the Commission on
or before the Filing Date or (B) declared effective by the Commission on or
before the Effectiveness Date or, (ii) on any day after the Registration
Statement has been declared effective by the Commission (A) sales of all the
Registrable Securities required to be included on a Registration Statement
cannot be made pursuant to the Registration Statement (including, without
limitation, because of a failure to keep the Registration Statement effective,
to disclose such information as is necessary for sales to be made pursuant to
the Registration Statement, or to register sufficient shares of Common Stock
C-5
<PAGE>
but excluding any periods during which the Registrable Securities cannot be sold
due to any required update or amendment of the Registration Statement pursuant
to Section 3(b) hereof, provided that each such period shall not exceed twenty
(20) Business Days, or in the event of a Black-Out Period declared by the
Company pursuant to Section 3(q) hereof) or (B) the Common Stock is not listed
or included for quotation on the National Market System of the Nasdaq Stock
Market ("NASDAQ"), the New York Stock Exchange ("NYSE") or the American Stock
Exchange (the "AMEX") after being so listed or included for quotation or (iii)
the Company shall otherwise fail to file a Registration Statement required by
Section 2(a) hereof, (each such event specified in (i), (ii) and (iii) above, an
"EVENT"), then, as partial relief for the damages to any Holder by reason of any
such delay in or reduction of its ability to sell the Registrable Securities
(which remedy shall not be exclusive of any other remedies available at law or
in equity) commencing on the date of the Event, the Company shall pay to each
Holder an amount in cash (a "INITIAL REGISTRATION DELAY PAYMENT") equal to (a)
the then principal amount of the Securities at the stated maturity (and, in the
case of Holders, the principal amount of Securities from which such Registrable
Securities were converted), multiplied by (b) two hundredths (.020) times the
sum of: (i) the number of months (prorated for partial months) after the end of
the Effectiveness Date and prior to the date the Registration Statement is
declared effective by the Commission, PROVIDED, HOWEVER, that there shall be
excluded from such period (A) any delays which are attributable to changes
required by the Purchasers in the Registration Statement with respect to
information relating to the Purchasers, or to the failure of the Purchasers to
conduct their review of the Registration Statement pursuant to Section 3(a) and
(B) any periods during which an Objection has been made and is pending, provided
that each such period shall not exceed twenty (20) Business Days; PROVIDED,
FURTHER, that with respect to Section 2(d)(i)(B) hereof, there shall be excluded
from such period any delays which are attributable to the Commission during the
150-day period following the Filing Date, so long as the Company responds as
promptly as practicable, but in no event later than twenty (20) Business Days,
to any comments received from the Commission, (ii) the number of months
(prorated for partial months) that sales cannot be made pursuant to the
Registration Statement after the Registration Statement has been declared
effective (including, without limitation, when sales cannot be made by reason of
the Company's failure to properly supplement or amend the Prospectus in
accordance with the terms of this Agreement, or otherwise, but excluding (A) any
period when such sales cannot be made solely by reason of any act or omission
attributable to the Purchasers, (B) any periods during which the Registrable
Securities cannot be sold due to any update or amendment of the Registration
Statement pursuant to Section 3(b) hereof, provided that each such period shall
not exceed twenty (20) Business Days, or in the event of a Black-Out Period
declared by the Company pursuant to Section 3(q) hereof and, (C) any periods
during which an Objection has been made and is pending, provided that each such
period shall not exceed twenty (20) Business Days) or (iii) the number of months
(prorated for partial months) that the Common Stock is not listed or included
for quotation on the Nasdaq, NYSE or AMEX or that trading thereon is halted
after the Registration Statement has been declared effective. The Company shall
pay any required Registration Delay Payments to each Holder in cash on the last
Business Day of each month during which an Event has occurred and is continuing.
In addition, if the Initial Registration Statement covering all the
applicable Registrable Securities and required to be filed by the Company
pursuant to this Agreement is not declared effective by the Commission on or
before the 151st day following the Closing Date, in lieu of the
C-6
<PAGE>
Initial Registration Delay Payment, the Company shall pay to each Holder an
amount in cash (the "Secondary Registration Delay Payment") equal to (a) the
then principal amount of the Securities at the stated maturity (and, in the case
of Holders, the principal amount of Securities from which such Registrable
Securities were converted), multiplied by (b) three hundredths (.03) times the
sum of: (i) the number of months (prorated for partial months) after the 150th
day following the Closing Date and prior to the date the Registration Statement
is declared effective by the Commission, PROVIDED, HOWEVER, that there shall be
excluded from such period (A) any delays which are attributable to changes
required by the Purchasers in the Registration Statement with respect to
information relating to the Purchasers, or to the failure of the Purchasers to
conduct their review of the Registration Statement pursuant to Section 3(a) and
(B) any periods during which the Registrable Securities cannot be sold due to
any update or amendment of the Registration Statement pursuant to Section 3(b)
hereof, provided that each such period shall not exceed twenty (20) Business
Days, or in the event of a Black-Out Period declared by the Company pursuant to
Section 3(q) hereof and, (C) any periods during which an Objection has been made
and is pending, provided that each such period shall not exceed twenty (20)
Business Days.
In the event the Company fails to make any Registration Delay Payment
within ten (10) Business Days of the date such Registration Delay Payment is
due, such Registration Delay Payment shall bear interest at the rate of 2.0% per
month (prorated for partial months) until paid in full.
3. REGISTRATION PROCEDURES
In connection with the Company's registration obligations
hereunder, the Company shall:
(a) PREPARATION OF REGISTRATION STATEMENT. Prepare and file
with the Commission on or prior to the Filing Date a Registration Statement on
Form S-3 or its successor form (or if the Company is not then eligible to
register for resale the Registrable Securities on Form S-3 such registration
shall be on another appropriate form in accordance herewith) (which shall
include a Plan of Distribution substantially in the form of EXHIBIT A annexed
hereto, unless in connection with an Underwritten Offering), and cause the
Registration Statement to become effective and remain effective as provided
herein; PROVIDED, HOWEVER, that not less than three (3) Business Days prior to
the filing of the Registration Statement or any related Prospectus or any
amendment or supplement thereto (including any document that would be
incorporated therein by reference, except to the extent that such documents are
otherwise available on EDGAR), the Company shall, if reasonably practicable,
furnish to the Holders, their Special Counsel and any managing underwriters,
copies of all such documents proposed to be filed (including documents
incorporated by reference, except to the extent that such documents are
otherwise available on EDGAR) which documents will be subject to the review of
such Holders, their Special Counsel and such managing underwriters. Such
Registration Statement shall comply with the applicable requirements of Form
S-3, the Securities Act, the Exchange Act and the rules and regulations
thereunder. The Company shall not file the Registration Statement or any such
Prospectus or any amendments or supplements thereto to which the Majority
Holders, their Special Counsel and any managing underwriters shall reasonably
object, and will not request acceleration of such
C-7
<PAGE>
Registration Statement without prior notice to such counsel (an "Objection").
The sections of such Registration Statement covering information with respect to
the Holders, the Holder's beneficial ownership of securities of the Company or
the Holders intended method of disposition of Registrable Securities shall
conform to the information provided to the Company by each of the Holders.
(b) AMENDMENTS. (i) Prepare and file with the Commission such
amendments, including post-effective amendments, to the Registration Statement
as may be necessary to keep the Registration Statement continuously effective
for the Effectiveness Period and prepare and file with the Commission such
additional Registration Statements as are required to be filed hereunder in
order to register for resale under the Securities Act all of the Registrable
Securities, unless the Majority Holders, their Special Counsel and any managing
underwriters shall make an Objection, (ii) cause the related Prospectus to be
amended or supplemented by any required Prospectus supplement, and as so
supplemented or amended to be filed pursuant to Rule 424 (or any similar
provisions then in force) promulgated under the Securities Act, (iii) respond as
promptly as possible to any comments received from the Commission with respect
to the Registration Statement or any amendment thereto and as promptly as
practicable, but in no event later than fifteen (15) Business Days, provide the
Holders true and complete copies of all correspondence from and to the
Commission relating to the Registration Statement, but only to the extent that
such correspondence relates to the Holders' beneficial ownership of securities
of the Company or the Holders intended method of disposition of Registrable
Securities, and (iv) comply in all material respects with the provisions of the
Securities Act and the Exchange Act with respect to the disposition of all
Registrable Securities covered by the Registration Statement during the
applicable period in accordance with the intended methods of disposition by the
Holders thereof set forth in the Registration Statement as so amended or in such
Prospectus as so supplemented. In the event the number of shares available under
a Registration Statement filed pursuant to this Agreement is insufficient to
cover the Registrable Securities issued or issuable upon conversion of the
Securities and exercise of the Warrants, the Company shall amend the
Registration Statement, or file a new Registration Statement (on the short form
available therefore, if applicable), or both, so as to cover the Registrable
Securities, in each case as soon as practicable, but in any event within twenty
(20) Business Days after the necessity therefor arises (based on the Conversion
Price of the Securities and other relevant factors on which the Company
reasonably elects to rely). The Company shall use all commercially reasonable
efforts to cause such amendment and/or new Registration Statement to become
effective as soon as practicable following the filing thereof, but in no event
later than ninety (90) days after the date on which the Company reasonably first
determines (or reasonably should have determined) the need therefor. The
provisions of Section 2(d) shall be applicable with respect to such obligation.
(c) NOTIFICATIONS. Notify the Holders of Registrable
Securities to be sold, their Special Counsel, and any managing underwriters, as
promptly as possible (and, in the case of (i)(a) below, not less than five (5)
days prior to such filing and, in the case of (i)(c) below, not later than the
first Business Day after effectiveness) and (if requested by any such Person)
confirm such notice in writing no later than one (1) Business Day following the
day (i) (a) when a Prospectus or any Prospectus supplement or post-effective
amendment to the Registration Statement is proposed to be filed, (b) when the
Commission notifies the Company whether there
C-8
<PAGE>
will be a "review" of such Registration Statement and whenever the Commission
comments in writing on such Registration Statement and (c) with respect to the
Registration Statement or any post-effective amendment, when the same has become
effective, (ii) of any request by the Commission or any other Federal or state
governmental authority for amendments or supplements to the Registration
Statement or Prospectus or for additional information, (iii) of the issuance by
the Commission of any stop order suspending the effectiveness of the
Registration Statement covering any or all of the Registrable Securities or the
initiation of any Proceedings for that purpose, (iv) of the receipt by the
Company of any notification with respect to the suspension of the qualification
or exemption from qualification of any of the Registrable Securities for sale in
any jurisdiction, or the initiation or threatening of any Proceeding for such
purpose, (v) of the occurrence of any event that makes any statement made in the
Registration Statement or Prospectus or any document incorporated or deemed to
be incorporated therein by reference untrue in any material respect or that
requires any revisions to the Registration Statement, Prospectus or other
documents so that, in the case of the Registration Statement or the Prospectus,
as the case may be, it will not contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were
made, not misleading and (vi) the beginning and end of a Black-Out Period
pursuant to Section 3(q).
(d) SUSPENSIONS. Use all commercially reasonable efforts to
avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order
suspending the effectiveness of the Registration Statement or (ii) any
suspension of the qualification (or exemption from qualification) of any of the
Registrable Securities for sale in any jurisdiction, at the earliest practicable
moment.
(e) SUPPLEMENTS AND POST-EFFECTIVE AMENDMENTS. If requested by
any managing underwriter or the Holders of a majority in interest of the
Registrable Securities to be sold in connection with an Underwritten Offering
(i) promptly incorporate in a Prospectus supplement or post-effective amendment
to the Registration Statement such information regarding the Holders or the plan
of distribution as the Company reasonably agrees should be included therein and
(ii) make all required filings of such Prospectus supplement or such
post-effective amendment as soon as practicable after the Company has received
notification of the matters to be incorporated in such Prospectus supplement or
post-effective amendment; PROVIDED, HOWEVER, that the Company shall not be
required to take any action pursuant to this Section 3(e) that would, in the
written opinion of counsel for the Company (addressed to counsel to the Holder),
violate applicable law.
(f) COPIES OF REGISTRATION STATEMENT. Furnish to each Holder,
their Special Counsel, and any managing underwriters, without charge, at least
one conformed copy of each Registration Statement and each amendment thereto,
including financial statements and schedules, all documents incorporated or
deemed to be incorporated therein by reference, and all exhibits to the extent
requested by such Person (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission.
(g) COPIES OF PROSPECTUS. Promptly deliver to each Holder,
their Special Counsel, and any underwriters, without charge, as many copies of
the Prospectus or Prospectuses
C-9
<PAGE>
(including each form of prospectus) and each amendment or supplement thereto as
such Persons may reasonably request; and the Company hereby consents to the use
of such Prospectus and each amendment or supplement thereto by each of the
selling Holders and any underwriters in connection with the offering and sale of
the Registrable Securities covered by such Prospectus and any amendment or
supplement thereto.
(h) BLUE SKY. Prior to any public offering of Registrable
Securities, use its all commercially reasonable efforts to register or qualify
or cooperate with the selling Holders, any underwriters and their Special
Counsel in connection with the registration or qualification (or exemption from
such registration or qualification) of such Registrable Securities for offer and
sale under the securities or Blue Sky laws of such jurisdictions within the
United States as any Holder or underwriter requests in writing, to keep each
such registration or qualification (or exemption therefrom) effective during the
Effectiveness Period and to do any and all other acts or things necessary or
advisable to enable the disposition in such jurisdictions of the Registrable
Securities covered by a Registration Statement; PROVIDED, HOWEVER, that the
Company shall not be required to qualify generally to do business in any
jurisdiction where it is not then so qualified or to take any action that would
subject it to general service of process in any such jurisdiction where it is
not then so subject or subject the Company to any material tax in any such
jurisdiction where it is not then so subject.
(i) CERTIFICATES. Cooperate with the Holders and any managing
underwriters to facilitate the timely preparation and delivery of certificates
representing Registrable Securities to be sold pursuant to a Registration
Statement, which certificates shall be free, to the extent permitted by
applicable law and the Purchase Agreement, of all restrictive legends, and to
enable such Registrable Securities to be in such denominations and registered in
such names as any such managing underwriters or Holders may request to
facilitate the timely closing of such sales.
(j) SUPPLEMENTS AND AMENDMENTS. Upon the occurrence of any
event contemplated by Section 3(c)(vi), as promptly as possible, prepare a
supplement or amendment, including a post-effective amendment, to the
Registration Statement or a supplement to the related Prospectus or any document
incorporated or deemed to be incorporated therein by reference, and file any
other required document so that, as thereafter delivered, neither the
Registration Statement nor such Prospectus will contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading.
(k) LISTING. Cause all Registrable Securities relating to such
Registration Statement to be listed on Nasdaq and any other securities exchange,
quotation system, market or over-the-counter bulletin board, if any, on which
similar securities issued by the Company are then listed as and when required
pursuant to the Purchase Agreement subject to compliance with Rule 4460(i)(1)(D)
of Nasdaq.
(l) UNDERWRITING AGREEMENT. In the case of an Underwritten
Offering pursuant to Section 2(b), the Company shall enter into such customary
agreements (including underwriting agreements in customary form) to take all
other appropriate actions in order to expedite or facilitate the registration or
the disposition of the Registrable Securities, and in connection therewith, if
an underwriting agreement is entered into cause the same to contain
C-10
<PAGE>
indemnification provisions and procedures substantially identical to those set
forth in Section 5 (or such other provisions and procedures acceptable to the
managing underwriters, if any) with respect to all parties to be indemnified
pursuant to Section 5.
(m) DUE DILIGENCE. Provide each Holder and its representatives
the opportunity to conduct a reasonable inquiry of the Company's financial and
other records during normal business hours and make available its officers,
directors and employees for questions regarding information that such Holder may
reasonably request in order to fulfill any due diligence obligations on its
part.
(n) EARNINGS STATEMENT. Comply in all material respects with
all applicable rules and regulations of the Commission and make generally
available to its securityholders earning statements satisfying the provisions of
Section 11(a) of the Securities Act and Rule 158 not later than 45 days after
the end of any 3-month period (or 90 days after the end of any 12-month period
if such period is a fiscal year) (i) commencing at the end of any fiscal quarter
in which Registrable Securities are sold to underwriters in a firm commitment or
best efforts Underwritten Offering and (ii) if not sold to underwriters in such
an offering, commencing on the first day of the first fiscal quarter of the
Company after the effective date of the Registration Statement, which statement
shall conform to the requirements of Rule 158.
(o) INFORMATION. The Company may require each selling Holder
to furnish to the Company information regarding such Holder and the distribution
of such Registrable Securities as is required by law to be disclosed in the
Registration Statement, and the Company may exclude from such registration the
Registrable Securities of any such Holder who unreasonably fails to furnish such
information within a reasonable time after receiving such request, and such
shall not form the basis for, and shall be excluded from the calculation of,
penalties pursuant to Section 2(d) hereof. Each Holder shall furnish to the
Company information regarding the Holder and the distribution of the Registrable
Securities as is required, in the opinion of counsel to the Holder, by
applicable law to be disclosed in the Registration Statement and Prospectus, and
in the case of the Initial Registration Statement shall provide such information
within 10 days of the Closing Date.
The Company shall hold in confidence and not make any
disclosure of information concerning a Holder provided to the Company unless (i)
disclosure of such information is necessary to comply with federal or state
securities laws, (ii) the disclosure of such information is necessary to avoid
or correct a misstatement or omission in any Registration Statement, (iii) the
release of such information is ordered pursuant to a subpoena or other order
from a court or governmental body of competent jurisdiction, or (iv) such
information has been made generally available to the public other than by
disclosure in violation of this or any other agreement. The Company agrees that
it shall, upon learning that disclosure of such information concerning a Holder
is sought in or by a court or governmental body of competent jurisdiction or
through other means, give prompt notice to such Holder prior to making such
disclosure, and allow the Holder, at its expense, to undertake appropriate
action to prevent disclosure of, or to obtain a protective order for, such
information.
If the Registration Statement refers to any Holder by name or
otherwise as the holder of any securities of the Company, then such Holder shall
have the right to require (if such
C-11
<PAGE>
reference to such Holder by name or otherwise is not required by the Securities
Act or any similar Federal statute then in force) the deletion of the reference
to such Holder in any amendment or supplement to the Registration Statement
filed or prepared subsequent to the time that such reference ceases to be
required.
Each Holder covenants and agrees that (i) it will not sell any
Registrable Securities under the Registration Statement until it has received
copies of the Prospectus as then amended or supplemented as contemplated in
Section 3(g) and notice from the Company that such Registration Statement and
any post-effective amendments thereto have become effective as contemplated by
Section 3(c) and (ii) it and its officers, directors or Affiliates, if any, will
comply with the prospectus delivery requirements of the Securities Act as
applicable to them in connection with sales of Registrable Securities pursuant
to the Registration Statement.
Each Holder agrees by its acquisition of such Registrable
Securities that, upon receipt of a notice from the Company of the occurrence of
any event of the kind described in Section 3(c)(ii), 3(c)(iii), 3(c)(iv),
3(c)(v) or 3(c)(vi) such Holder will forthwith discontinue disposition of such
Registrable Securities under the Registration Statement until such Holder's
receipt of the copies of the supplemented Prospectus and/or amended Registration
Statement contemplated by Section 3(j), or until it is advised in writing (the
"ADVICE") by the Company that the use of the applicable Prospectus may be
resumed, and, in either case, has received copies of any additional or
supplemental filings that are incorporated or deemed to be incorporated by
reference in such Prospectus or Registration Statement. Notwithstanding anything
to the contrary, the Company shall cause its transfer agent to deliver
unlegended shares of Common Stock to a transferee of a Holder in accordance with
the terms of the Securities Purchase Agreement in connection with any sale of
Registrable Securities with respect to which an Holder has entered into a
contract for sale prior to the Holder's receipt of a notice from the Company of
the happening of any event of the kind described in Section 3(c)(ii), 3(c)(iii),
3(c)(iv), 3(c)(v) or 3(c)(vi) and for which the Holder has not yet settled,
provided that the Holder delivers an opinion of Akin, Gump, Strauss, Hauer &
Feld that the delivery of such shares does not violate federal securities laws,
Delaware corporate law or other applicable law.
(p) CONFIRMATION OF EFFECTIVENESS. Within two (2) Business
Days after a Registration Statement which covers applicable Registrable
Securities is ordered effective by the Commission, the Company shall deliver,
and shall cause legal counsel for the Company to deliver, to the transfer agent
for such Registrable Securities (with copies to the Holders whose Registrable
Securities are included in such Registration Statement) confirmation that such
Registration Statement has been declared effective by the Commission.
(q) BLACK-OUT PERIODS. Notwithstanding anything to the
contrary in this Agreement, the Company may delay the filing or effectiveness of
a Registration Statement, other than the Initial Registration Statement, or by
written notice require that the Holders immediately cease sales of Registrable
Securities (for a period not to exceed thirty (30) consecutive days in any one
instance and for a period not to exceed sixty (60) calendar days in any
twelve-month period (a "BLACK-OUT PERIOD")) pursuant to a Registration Statement
at any time that (i) the Company becomes engaged in a business activity or
negotiation which is not disclosed in a Registration Statement (or the
prospectus included therein) which the Company reasonably
C-12
<PAGE>
believes must be disclosed therein under applicable law and which the Company
desires to keep confidential for business purposes, (ii) the Company determines
that a particular disclosure so determined to be required to be disclosed
therein would be premature or would adversely affect the Company or its business
or prospects or (iii) the Registration Statement can no longer be used under the
existing rules and regulations promulgated under the Securities Act (each of
(i), (ii) or (iii), a "MATERIAL CONDITION"). The Company shall not be required
to disclose to the Holders which of the reasons specified in (i), (ii) or (iii)
above is the basis for requiring a suspension of sales due to the occurrence of
a Material Condition. The Company will use all commercially reasonable efforts
to ensure that the use of the Registration Statement (and the prospectus
included therein) may be resumed as soon as it is practicable.
4. REGISTRATION EXPENSES
All fees and expenses, other than underwriting discounts and
commissions, incident to the performance of or compliance with this Agreement by
the Company shall be borne by the Company, whether or not pursuant to an
Underwritten Offering and whether or not the Registration Statement is filed or
becomes effective and whether or not any Registrable Securities are sold
pursuant to the Registration Statement. The fees and expenses referred to in the
foregoing sentence shall include, without limitation, (i) all registration and
filing fees (including, without limitation, reasonable fees and expenses (A)
with respect to filings required to be made with Nasdaq and each other
securities exchange or market on which Registrable Securities are required
hereunder to be listed and (B) in compliance with state securities or Blue Sky
laws (including, without limitation, fees and disbursements of counsel for the
Holders in connection with Blue Sky qualifications of the Registrable Securities
and determination of the eligibility of the Registrable Securities for
investment under the laws of such jurisdictions as the managing underwriters, if
any, or the Holders of a majority of Registrable Securities may designate)),
(ii) printing expenses (including, without limitation, expenses of printing
certificates for Registrable Securities and of printing prospectuses if the
printing of prospectuses is requested by the managing underwriters, if any, or
by the Holders of a majority of the Registrable Securities included in the
Registration Statement), (iii) messenger, telephone and delivery expenses, (iv)
reasonable fees and disbursements of counsel for the Company and Special Counsel
for the Holders, (v) Securities Act liability insurance, if the Company so
desires such insurance, and (vi) fees and expenses of all other Persons retained
by the Company in connection with the consummation of the transactions
contemplated by this Agreement. In addition, the Company shall be responsible
for all of its internal expenses incurred in connection with the consummation of
the transactions contemplated by this Agreement (including, without limitation,
all salaries and expenses of its officers and employees performing legal or
accounting duties), the expense of any annual audit, and the fees and expenses
incurred in connection with the listing of the Registrable Securities on any
securities exchange as required hereunder.
5. INDEMNIFICATION
(a) INDEMNIFICATION BY THE COMPANY. The Company shall,
notwithstanding any termination of this Agreement, indemnify and hold harmless
each Holder, the officers, directors, agents (including any underwriters
retained by such Holder in connection with the offer and sale of Registrable
Securities), brokers (including brokers who offer and sell
C-13
<PAGE>
Registrable Securities as principal as a result of a pledge or any failure to
perform under a margin call of Common Stock), investment advisors and employees
of each of them, each Person who controls any such Holder (within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act) and the
officers, directors, agents and employees of each such controlling Person, to
the fullest extent permitted by applicable law, from and against any and all
joint or several losses, claims, damages, liabilities, costs (including, without
limitation, costs of preparation and attorneys' fees) and expenses
(collectively, together with actions, proceedings or inquiries by any regulatory
or self-regulatory organization, whether commenced or threatened, "LOSSES"), as
incurred, arising out of or relating to (i) any untrue or alleged untrue
statement of a material fact contained in the Registration Statement, any
Prospectus or any form of prospectus or in any amendment or supplement thereto
or in any preliminary Prospectus, or arising out of or relating to any omission
or alleged omission of a material fact required to be stated therein or
necessary to make the statements therein (in the case of any Prospectus or form
of prospectus or supplement thereto, in light of the circumstances under which
they were made) not misleading (in the case of any Prospectus or form of
prospectus or supplement thereto, in light of the circumstances under which they
were made), except to the extent, but only to the extent, that such untrue
statements or omissions are based solely upon and in conformity with information
regarding such Holder furnished in writing to the Company by such Holder
expressly for use therein, or to the extent that such information relates to
such Holder or such Holder's proposed method of distribution of Registrable
Securities and was reviewed and expressly approved in writing by such Holder
expressly for use in the Registration Statement, such Prospectus or such form of
prospectus or in any amendment or supplement thereto (provided that the Company
amended any disclosure with respect to the method of distribution upon written
notice from the Holders that such section of the Prospectus should be revised in
any way) or (ii) any violation or alleged violation by the Company of the
Securities Act, the Exchange Act, any other law, including, without limitation,
any state securities law, or any rule or regulation thereunder relating to the
offer or sale of Registrable Securities. The Company shall not, however, be
liable for any Losses to any Holder with respect to any untrue or alleged untrue
statement of material fact or omission or alleged omission of material fact if
such statement or omission was made in a preliminary Prospectus and such Holder
did not receive a copy of the final Prospectus (or any amendment or supplement
thereto) at or prior to the confirmation of the sale of the Registrable
Securities in any case where such delivery is required by the Securities Act and
the untrue or alleged untrue statement of material fact or omission or alleged
omission of material fact contained in such preliminary Prospectus was corrected
in the final Prospectus (or any amendment or supplement thereto), unless the
failure to deliver such final Prospectus (as amended or supplemented) was a
result of noncompliance by the Company with Section 3(g) of this Agreement. The
Company shall notify the Holders promptly of the institution, threat or
assertion of any Proceeding of which the Company is aware in connection with the
transactions contemplated by this Agreement.
(b) INDEMNIFICATION BY HOLDERS. Each Holder shall, severally
and not jointly, indemnify and hold harmless the Company, the directors,
officers, agents and employees of the Company, each Person who controls the
Company (within the meaning of Section 15 of the Securities Act and Section 20
of the Exchange Act), and the directors, officers, agents or employees of such
controlling Persons, to the fullest extent permitted by applicable law, from and
against all Losses, as incurred, arising solely out of or based solely upon any
untrue
C-14
<PAGE>
statement of a material fact contained in the Registration Statement, any
Prospectus, or any form of prospectus, or in any amendment or supplement thereof
or in any preliminary Prospectus arising solely out of or based solely upon any
omission of a material fact required to be stated therein or necessary to make
the statements therein not misleading to the extent, but only to the extent,
that such untrue statement or omission is contained in any information so
furnished in writing by such Holder to the Company specifically for inclusion in
the Registration Statement or such Prospectus to the extent that such
information relates to such Holder or such Holder's proposed method of
distribution of Registrable Securities and was reviewed and expressly approved
in writing by such Holder expressly for use in the Registration Statement, such
Prospectus or such form of prospectus; PROVIDED, HOWEVER, that the indemnity
agreement contained in this Section 5(b) shall not apply to amounts paid in
settlement of any Losses if such settlement is effected without the prior
written consent of such Holder, PROVIDED, FURTHER, that such Holder agrees its
consent to any such settlement will not be unreasonably withheld if such Holder
will not be liable for any payments or incur any out-of-pocket expenses with
respect to such settlement. In no event shall the liability of any selling
Holder hereunder be greater in amount than the dollar amount of the net proceeds
received by such Holder upon the sale of the Registrable Securities giving rise
to such indemnification obligation.
(c) CONDUCT OF INDEMNIFICATION PROCEEDINGS. If any Proceeding
shall be brought or asserted against any Person entitled to indemnity hereunder
(an "INDEMNIFIED PARTY"), such Indemnified Party promptly shall notify the
Person from whom indemnity is sought (the "INDEMNIFYING PARTY") in writing, and
the Indemnifying Party shall assume the defense thereof, including the
employment of counsel reasonably satisfactory to the Indemnified Party and the
payment of all fees and expenses incurred in connection with defense thereof;
PROVIDED, HOWEVER, that the failure of any Indemnified Party to give such notice
shall not relieve the Indemnifying Party of its obligations or liabilities
pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is
not subject to appeal or further review) that such failure shall have
proximately and materially adversely prejudiced the Indemnifying Party.
An Indemnified Party shall have the right to employ separate
counsel in any such Proceeding and to participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such
Indemnified Party or Parties unless: (i) the Indemnifying Party has agreed in
writing to pay such fees and expenses, or (ii) the Indemnifying Party shall have
failed promptly to assume the defense of such Proceeding and to employ counsel
reasonably satisfactory to such Indemnified Party in any such Proceeding upon
the Indemnifying Party's receipt of notice of the Proceedings, or (iii) the
named parties to any such Proceeding (including any impleaded parties) include
both such Indemnified Party and the Indemnifying Party, and such Indemnified
Party shall have been advised by counsel that a conflict of interest is likely
to exist if the same counsel were to represent such Indemnified Party and the
Indemnifying Party (in which case, if such Indemnified Party notifies the
Indemnifying Party in writing that it elects to employ separate counsel at the
expense of the Indemnifying Party, the Indemnifying Party shall not have the
right to assume the defense thereof and such counsel shall be at the reasonable
expense of the Indemnifying Party). The Indemnifying Party shall not be liable
for any settlement of any such Proceeding effected without its written consent,
which consent shall not be unreasonably withheld. No Indemnifying Party shall,
without the prior written consent of the
C-15
<PAGE>
Indemnified Party, effect any settlement of any pending Proceeding in respect of
which any Indemnified Party is a party, unless such settlement includes an
unconditional release of such Indemnified Party from all liability on claims
that are the subject matter of such Proceeding.
All fees and expenses of the Indemnified Party (including
reasonable fees and expenses to the extent incurred in connection with
investigating or preparing to defend such Proceeding in a manner not
inconsistent with this Section) shall be paid to the Indemnified Party, as
incurred, within ten (10) Business Days of written notice thereof to the
Indemnifying Party, which notice shall be delivered no more frequently than on a
monthly basis (regardless of whether it is ultimately determined that an
Indemnified Party is not entitled to indemnification hereunder; PROVIDED, that
the Indemnifying Party may require such Indemnified Party to undertake to
reimburse all such fees and expenses to the extent it is finally judicially
determined that such Indemnified Party is not entitled to indemnification
hereunder).
(d) CONTRIBUTION. If a claim for indemnification under Section
5(a) or 5(b) is unavailable to an Indemnified Party because of a failure or
refusal of a court of competent jurisdiction to enforce such indemnification in
accordance with its terms (by reason of public policy or otherwise), then each
Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall
contribute to the amount paid or payable by such Indemnified Party as a result
of such Losses, in such proportion as is determined by a court of competent
jurisdiction to reflect the relative fault of the Indemnifying Party and
Indemnified Party in connection with the actions, statements or omissions that
resulted in such Losses as well as any other relevant equitable considerations.
The relative fault of such Indemnifying Party and Indemnified Party shall be
determined by reference to, among other things, whether any action in question,
including any untrue or alleged untrue statement of a material fact or omission
or alleged omission of a material fact, has been taken or made by, or relates to
information supplied by, such Indemnifying Party or Indemnified Party, and the
parties' relative intent, knowledge, access to information and opportunity to
correct or prevent such action, statement or omission. The amount paid or
payable by a party as a result of any Losses shall be deemed to include, subject
to the limitations set forth in Section 5(c), any reasonable attorneys' or other
reasonable fees or expenses incurred by such party in connection with any
Proceeding to the extent such party would have been indemnified for such fees or
expenses if the indemnification provided for in this Section was available to
such party in accordance with its terms. In no event shall any selling Holder be
required to contribute an amount under this Section 5(d) in excess of the net
proceeds received by such Holder upon sale of the Registrable Securities
pursuant to the Registration Statement giving rise to such contribution
obligation.
The parties hereto agree that it would not be just and
equitable if contribution pursuant to this Section 5(d) were determined by pro
rata allocation or by any other method of allocation that does not take into
account the equitable considerations referred to in the immediately preceding
paragraph. No Person guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) shall be entitled to contribution from
any Person who was not guilty of such fraudulent misrepresentation.
The indemnity and contribution agreements contained in this
Section are in addition to any liability that the Indemnifying Parties may have
to the Indemnified Parties.
C-16
<PAGE>
6. MISCELLANEOUS
(a) REMEDIES. In the event of a breach by the Company or by a
Holder of any of their obligations under this Agreement, each Holder or the
Company, as the case may be, in addition to being entitled to exercise all
rights granted by law and under this Agreement, including recovery of damages,
will be entitled to specific performance of its rights under this Agreement. The
Company and each Holder agree that monetary damages would not provide adequate
compensation for any losses incurred by reason of a breach by it of any of the
provisions of this Agreement and hereby further agrees that, in the event of any
action for specific performance in respect of such breach, it shall waive the
defense that a remedy at law would be adequate.
(b) NO INCONSISTENT AGREEMENTS. Neither the Company nor any of
its subsidiaries has, as of the date hereof, nor shall the Company or any of its
subsidiaries, on or after the date of this Agreement, enter into any agreement
with respect to its securities that is inconsistent with the rights granted to
the Holders in this Agreement or otherwise conflicts with the provisions hereof.
Except as disclosed in Schedule 2.1(r) of the Purchase Agreement, neither the
Company nor any of its subsidiaries has previously entered into any agreement
granting any registration rights with respect to any of its securities to any
Person. This Agreement, together with the Purchase Agreement, contain the entire
understanding of the parties with respect to the subject matter hereof and
supersede all prior agreements and understandings, oral or written, with respect
to such matters.
(c) NO PIGGYBACK ON REGISTRATIONS. Except as disclosed on
Schedule 2.1(r) of the Purchase Agreement, neither the Company nor any of its
securityholders (other than the Holders in such capacity pursuant hereto) may
include securities of the Company in the Registration Statements and the Company
shall not after the date hereof enter into any agreement that prohibits or
restricts the obligations of the Company under Sections 2 or 3 hereof.
(d) PIGGY-BACK REGISTRATIONS. Except as provided herein if, at
any time during the Effectiveness Period when there is not an effective
Registration Statement covering the Registrable Securities, the Company shall
determine to prepare and file with the Commission a registration statement
relating to an offering for its own account or the account of others under the
Securities Act of any of its equity securities, other than on Form S-4 or Form
S-8 (each as promulgated under the Securities Act) or their then equivalents
relating to equity securities to be issued solely in connection with any
acquisition of any entity or business or equity securities issuable in
connection with stock option or other employee benefit plans, the Company shall
send to each Holder of Registrable Securities written notice of such
determination and, if within ten (10) days after receipt of such notice, any
such Holder shall so request in writing, (which request shall specify the
Registrable Securities intended to be disposed of by the Holders), the Company
will use reasonable efforts to effect the registration under the Securities Act
of all Registrable Securities which the Company has been so requested to
register by the Holder, to the extent requisite to permit the disposition of the
Registrable Securities so to be registered; PROVIDED, that if at any time after
giving written notice of its intention to register any securities and prior to
the effective date of the registration statement filed in connection with such
C-17
<PAGE>
registration, the Company shall determine for any reason not to register or to
delay registration of such securities, the Company may, at its election, give
written notice of such determination to such Holder and, thereupon, (i) in the
case of a determination not to register, shall be relieved of its obligation to
register any Registrable Securities in connection with such registration (but
not from its obligation to pay expenses in accordance with Section 4 hereof),
and (ii) in the case of a determination to delay registering, shall be permitted
to delay registering any Registrable Securities being registered pursuant to
this Section 6(d) for the same period as the delay in registering such other
securities. The Company shall include in such registration statement all or any
part of such Registrable Securities such Holder requests to be registered;
PROVIDED, HOWEVER, that the Company shall not be required to register any
Registrable Securities pursuant to this Section 6(d) that are eligible for sale
pursuant to Rule 144(k) of the Securities Act. In the case of an underwritten
public offering, if the managing underwriter(s) or underwriter(s) should
reasonably object to the inclusion of the Registrable Securities in such
registration statement, then if the Company after consultation with the
Underwriter's representative should reasonably determine that the inclusion of
such Registrable Securities would materially adversely affect the offering
contemplated in such registration statement, and based on such determination
recommends inclusion in such registration statement of fewer Registrable
Securities then proposed to be sold by the Holders, then (x) the number of
Registrable Securities of the Holders included in such registration statement
shall be reduced pro rata among such Holders (based upon the number of
Registrable Securities requested to be included in the registration) or (y) none
of the Registrable Securities of the Holders shall be included in such
registration statement if the Company, after consultation with the
underwriter(s), recommends the inclusion of none of such Registrable Securities;
PROVIDED, HOWEVER, that if securities are being offered for the account of other
persons or entities as well as the Company, such reduction shall not represent a
greater fraction of the number of Registrable Securities intended to be offered
by the Holders than the fraction of similar reductions imposed on such other
persons or entities (other than the Company).
(e) AMENDMENTS AND WAIVERS. The provisions of this Agreement,
including the provisions of this sentence, may not be amended, modified or
supplemented, and waivers or consents to departures from the provisions hereof
may not be given, unless the same shall be in writing and signed by the Company
and the Majority Holders; PROVIDED, HOWEVER, that for the purposes of this
sentence only, Registrable Securities that are owned, directly or indirectly, by
the Company, or an Affiliate of the Company are not deemed outstanding.
Notwithstanding the foregoing, a waiver or consent to depart from the provisions
hereof with respect to a matter that relates exclusively to the rights of
Holders and that does not directly or indirectly affect the rights of other
Holders may be given by the Majority Holders to which such waiver or consent
relates; PROVIDED, HOWEVER, that the provisions of this sentence may not be
amended, modified, or supplemented except in accordance with the provisions of
the immediately preceding sentence. Any amendment or waiver effected in
accordance with this Section shall be binding upon each Holder, each future
Holder, and the Company. Upon effectiveness of each such amendment or waiver,
the Company shall promptly give written notice thereof to the Holders who have
not previously consented thereto in writing.
(f) NOTICES. Any notices, consents, waivers or other
communications required or permitted to be given under the terms of this
Debenture must be in writing and will be deemed
C-18
<PAGE>
to have been delivered (i) upon receipt, when delivered personally; (ii) upon
receipt, when sent by facsimile, provided confirmation of transmission is
mechanically or electronically generated and kept on file by the sending party
(if received by 5:30 p.m. EST where such notice is received) or the first
business day following such delivery (if received after 5:30 p.m. EST where such
notice is received); or (iii) one business day after deposit with a nationally
recognized overnight delivery service; provided that confirmation of the
delivery is generated and kept on file by the sending party, in each case
properly addressed to the party to receive the same. The addresses for such
communications are (i) if to the Company to IGEN International, Inc., 16020
Industrial Drive, Gaithersburg, MD 20877, Attn: Mr. George V. Migausky, fax no.
(301) 208-3798 with copies to Wilmer, Cutler & Pickering, 2445 M Street, N.W.,
Washington, DC 20037, Attn: Meredith B. Cross, fax no. (202) 663-6363 (ii) if to
any Purchaser to the address set forth on Schedule I hereto with copies to those
specified on the signature pages hereto and to Akin, Gump, Strauss, Hauer &
Feld, L.L.P., 590 Madison Avenue, New York, New York 10022, Attn: James Kaye,
Esq., fax no. (212) 872-1002 or such other address as may be designated in
writing hereafter, in the same manner, by such Person.
(g) SUCCESSORS AND ASSIGNS. This Agreement shall inure to the
benefit of and be binding upon the successors and permitted assigns of each of
the parties and shall inure to the benefit of each Holder. The Company may not
assign its rights or obligations hereunder without the prior written consent of
each Holder. Each Holder may assign its rights hereunder in the manner and to
the Persons as permitted under the Purchase Agreement if: (i) the Holder agrees
in writing with the transferee or assignee to assign such rights, and a copy of
such agreement is furnished to the Company within a reasonable time after such
assignment, (ii) the Company is, within a reasonable time after such transfer or
assignment, furnished with written notice of (a) the name and address of such
transferee or assignee, and (b) the securities with respect to which such
registration rights are being transferred or assigned, (iii) following such
transfer or assignment the further disposition of such securities by the
transferee or assignees is restricted under the Securities Act and applicable
state securities laws, (iv) at or before the time the Company receives the
written notice contemplated by clause (ii) of this Section, the transferee or
assignee agrees in writing with the Company to be bound by all of the provisions
of this Agreement, and (v) such transfer shall have been made in accordance with
the applicable requirements of the Purchase Agreement. The rights to assignment
shall apply to the Holders (and to subsequent) successors and assigns.
(h) COUNTERPARTS. This Agreement may be executed in any number
of counterparts, each of which when so executed shall be deemed to be an
original and all of which taken together shall constitute one and the same
Agreement. In the event that any signature is delivered by facsimile
transmission, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) the same with
the same force and effect as if such facsimile signature were the original
thereof.
(i) GOVERNING LAW. The corporate laws of the State of Delaware
shall govern all issues concerning the relative rights of the Company and the
Purchasers as its stockholders. All other questions concerning the construction,
validity, enforcement and interpretation of this Agreement shall be governed by
and construed in accordance with the laws of the State of New York, without
regard to principles of conflicts of law, except with respect to matters
mandatorily
C-19
<PAGE>
governed by the Delaware General Corporation Law. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in
the City of New York, Borough of Manhattan, for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in
any suit, action or proceeding, any claim that it is not personally subject to
the jurisdiction of any such court, that such suit, action or proceeding is
improper. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by
mailing a copy thereof to such party at the address for such notices to it under
this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law.
(j) CUMULATIVE REMEDIES. The remedies provided herein are
cumulative and not exclusive of any remedies provided by law.
(k) SEVERABILITY. If any term, provision, covenant or
restriction of this Agreement is held by a court of competent jurisdiction to be
invalid, illegal, void or unenforceable, the remainder of the terms, provisions,
covenants and restrictions set forth herein shall remain in full force and
effect and shall in no way be affected, impaired or invalidated, and the parties
hereto shall use their reasonable efforts to find and employ an alternative
means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and
declared to be the intention of the parties that they would have executed the
remaining terms, provisions, covenants and restrictions without including any of
such that may be hereafter declared invalid, illegal, void or unenforceable.
(l) HEADINGS. The headings in this Agreement are for
convenience of reference only and shall not limit or otherwise affect the
meaning hereof.
(m) SHARES HELD BY THE COMPANY. Whenever the consent or
approval of Holders of a specified percentage of Registrable Securities is
required hereunder, Registrable Securities held by the Company shall not be
counted in determining whether such consent or approval was given by the Holders
of such required percentage.
(n) REVISION OF SEC POSITION ON WARRANTS. In the event the
rules and regulations of the Commission or the policies of the staff of the
Commission are modified and as a result thereof the Company and the Company's
counsel determine in good faith that it may be practicable and in the interests
of the Company and the Holders to register the exercise of the Warrants so that
the Warrant Shares may be freely resold without maintaining an effective
registration statement under the Securities Act for resales, the Company and the
Holders agree to cooperate in good faith to effect such amendments to this
Agreement as may be appropriate to provide that the Company may fulfill its
obligations hereunder with respect to the Warrants and the Warrant Shares by
maintaining an effective registration statement under the Securities Act
covering the exercise of the Warrants rather than the resale of the Warrant
Shares.
(o) FUTURE REGISTRATION STATEMENTS. The Company shall not file
any Registration Statement under the Securities Act relating to the offer and
sale of any equity securities of the Company, or offer or sell any equity
C-20
<PAGE>
securities of the Company until such time as the Initial Registration Statement
has become effective, except for: (i) a Registration Statement on Form S-4 or
S-8, (ii) a Registration Statement relating to an offering underwritten by an
investment bank of national standing or (iii) a Registration Statement
registering the resale of securities sold in accordance with Section 3.9 of the
Purchase Agreement.
IN WITNESS WHEREOF, the parties have executed this
Registration Rights Agreement as of the date first written above.
IGEN International, Inc.
By:
------------------------------------
Name:
Title:
C-21
<PAGE>
BROWN SIMPSON STRATEGIC GROWTH
FUND, LTD.
By: Brown Simpson Asset Management, LLC
By:
------------------------------------
Name:
Title:
BROWN SIMPSON STRATEGIC GROWTH FUND,
L.P.
By: Brown Simpson Capital, LLC
its general partner
By:
------------------------------------
Name:
Title:
LBI GROUP INC.
By:
------------------------------------
Name:
Title:
C-22
<PAGE>
SCHEDULE I
COMPANY
IGEN INTERNATIONAL, INC.
16020 Industrial Drive
Gaithersburg, MD 20877
Tel) 301-869-9800
PURCHASERS:
BROWN SIMPSON STRATEGIC GROWTH FUND, L.P.
152 West 57th Street, 40th Floor
New York, New York 10019
Attn: Peter Greene
Fax: (212) 247-1329
BROWN SIMPSON STRATEGIC GROWTH FUND, LTD.
152 West 57th Street, 40th Floor
New York, New York 10019
Attn: Peter Greene
Fax: (212) 247-1329
LBI GROUP INC.
c/o Lehman Brothers, Inc.
3 World Financial Center
New York, New York 10285
Attention: Steve Weinstein
Facsimile: (212) 526-2198
C-23
<PAGE>
EXHIBIT A
PLAN OF DISTRIBUTION
Our company is registering the shares of common stock on
behalf of the selling stockholders. All costs, expenses and fees in connection
with the registration of the shares offered by this prospectus will be borne by
the Company, other than brokerage commissions and similar selling expenses, if
any, attributable to the sale of shares which will be borne by the selling
stockholders. Sales of shares may be effected by selling stockholders from time
to time in one or more types of transactions (which may include block
transactions) on the Nasdaq National Market, in the over-the-counter market, in
negotiated transactions, through put or call options transactions relating to
the shares, through short sales of shares, or a combination of such methods of
sale, at market prices prevailing at the time of sale, or at negotiated prices.
Such transactions may or may not involve brokers or dealers. The selling
stockholders have advised our company that they have not entered into any
agreements, understandings or arrangements with any underwriters or
broker-dealers regarding the sale of their securities, nor is there an
underwriter or coordinated broker acting in connection with the proposed sale of
shares by the selling stockholders.
The selling stockholders may enter into hedging transactions
with broker-dealers or other financial institutions. In connection with such
transactions, broker-dealers or other financial institutions may engage in short
sales of the shares or of securities convertible into or exchangeable for the
shares in the course of hedging positions they assume with selling stockholders.
The selling stockholders may also enter into options or other transactions with
broker-dealers or other financial institutions which require the delivery to
such broker-dealers or other financial institutions of shares offered by this
prospectus, which shares such broker-dealer or other financial institution may
resell pursuant to this prospectus (as amended or supplemented to reflect such
transaction).
The selling stockholders may make these transactions by
selling shares directly to purchasers or to or through broker-dealers, which may
act as agents or principals. Such broker-dealers may receive compensation in the
form of discounts, concessions or commissions from selling stockholders and/or
the purchasers of shares for whom such broker-dealers may act as agents or to
whom they sell as principal, or both (which compensation as to a particular
broker-dealer might be in excess of customary commissions).
The selling stockholders and any broker-dealers that act in
connection with the sale of shares may be "underwriters" within the meaning of
Section 2(a)(11) of the Securities Act, and any commissions received by such
broker-dealers or any profit on the resale of the shares sold by them while
acting as principals might be deemed to be underwriting discounts or commissions
under the Securities Act. The selling stockholders may agree to indemnify any
agent, dealer or broker-dealer that participates in transactions involving sales
of the shares against certain liabilities, including liabilities arising under
the Securities Act.
C-24
<PAGE>
Because selling stockholders may be "underwriters" within the
meaning of Section 2(a)(11) of the Securities Act, the selling stockholders will
be subject to the prospectus delivery requirements of the Securities Act. Our
company has informed the selling stockholders that the anti-manipulative
provisions of Regulation M promulgated under the Exchange Act may apply to their
sales in the market.
Selling stockholders also may resell all or a portion of the
shares in open market transactions in reliance upon Rule 144 under the
Securities Act, provided they meet the criteria and conform to the requirements
of Rule 144.
Upon our company being notified by a selling stockholder that
any material arrangement has been entered into with a broker-dealer for the sale
of shares through a block trade, special offering, exchange distribution or
secondary distribution or a purchase by a broker or dealer, a supplement to this
prospectus will be filed, if required, pursuant to Rule 424(b) under the
Securities Act, disclosing:
- the name of each such selling stockholder and of the
participating broker-dealer(s);
- the number of shares involved;
- the initial price at which such shares were sold;
- the commissions paid or discounts or concessions allowed to
such broker-dealer(s), where applicable;
- that such broker-dealer(s) did not conduct any investigation
to verify the information set out or incorporated by
reference in this prospectus; and
- other facts material to the transactions.
In addition, upon our company being notified by a selling stockholder that a
donee or pledgee intends to sell more than 500 shares, a supplement to this
prospectus will be filed.
C-25
<PAGE>
Exhibit D
Form of Company's Legal Opinion
1. The Company1 is a corporation in good standing under the laws of Delaware,
the jurisdiction of its organization, and is duly qualified and is in good
standing as a foreign corporation in Maryland. The Company has [the
requisite] corporate power to enter into the Agreement.
2. (a) The execution and delivery of the Transaction Documents2 by the Company
and the performance by the Company of the transactions contemplated by the
Transaction Documents have been duly authorized by all necessary corporate
action on the part of the Company. (b) Each of the Transaction Documents has
been duly and validly executed and delivered by the Company. (c) Each of the
Transaction Documents constitutes the valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms,
except as such enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating
to, or affecting generally the enforcement of, creditors' rights and
remedies or by other equitable principles of general application.
3. The execution and delivery of the Transaction Documents by the Company do
not, and the performance by the Company of its transactions contemplated by
the Transaction Documents will not, result in any violation of any law, rule
or regulation of any law, rule, regulation to which the Company is subject
(including Federal and state securities laws and regulations), or by which
any property or asset of the Company is bound or affected (the "Included
Laws").
4. The execution and delivery of the Transaction Documents by the Company do
not, and the performance by the Company of its transactions contemplated by
the Transaction documents will not, result in any violation of any order,
writ, judgment or decree known to us.
5. The execution and delivery of the Transaction Documents by the Company do
not, and the performance by the Company of the transactions contemplated by
the Agreement will not, (a) result in a violation of the Certificate of
Incorporation or By-Laws of the Company, or (b) breach or result in a
default or result in the acceleration of or entitle any party to accelerate
under any agreement or instrument listed on Schedule __ hereto.
6. No authorization or approval or other action by, and no notice to or filing
with, any governmental authority or regulatory body (each, a "FILING") is
required under any of the Included Laws for the due execution and delivery
of the Transaction Documents by the Company and the performance by the
Company of the transactions contemplated by the Transaction Documents,
except (i) routine Filings necessary in connection with the conduct of the
Company's business, (ii) Filings necessary in connection with the exercise
of remedies
- --------
1 The opinion letter should state that capitalized terms not otherwise defined
have the meanings assigned to them in the Purchase Agreement.
2 The term Transaction Documents means the Purchase Agreement, the Registration
Rights Agreement, the Convertible Debenture and the Warrants.
D-1
<PAGE>
under the Transaction Documents, (iii) such other Filings as have been
obtained or made, (iv) Filings required under Federal and state securities
laws as contemplated by the Transaction Documents, (v) Filings related to
environmental matters, ERISA matters, taxes and intellectual property, (vi)
Filings required to maintain corporate and similar standing and existence,
and (vii) the Filings identified on Schedule 2.1(f) to the Agreement.
7. Based on the representations and warranties of the Company set forth in
Section 2.1 of the Purchase Agreement and assuming the accuracy of the
representations and warranties of the Purchasers set forth in Section 2.2 of
the Purchase Agreement, the offer, issuance and sale of the Debentures and
the Warrants to the Purchasers pursuant to the Purchase Agreement are exempt
from the registration requirements of the Securities Act.
8. To our knowledge, the Company has filed all reports required to be filed by
it under the Exchange Act, including pursuant to Section 13(a) or 15(d)
thereof, for the three years preceding the date hereof (the "SEC Documents")
on a timely basis. As of their respective dates, the SEC Documents complied
in all material respects as to form with the requirements of the Securities
Act and the Exchange Act and the rules and regulations of the Securities and
Exchange Commission promulgated thereunder.
9. There is no pending or, to our knowledge, threatened action, suit or
proceeding before any court or governmental agency, authority or body or any
arbitrator involving the Company or any of its Subsidiaries that would be
required to be disclosed in a registration statement under the Securities
Act if filed today that has not been disclosed to the Purchasers.
10. The Company has duly authorized and reserved for issuance such number of
shares of Common Stock as are issuable upon conversion of the Debentures and
exercise of the Warrants (the "Underlying Shares") in accordance with the
terms of the Debentures and the Warrants. When issued by the Company in
accordance with the terms of the Debentures and the Warrants, the Underlying
Shares will be validly issued, fully paid and non-assessable.
D-2
<PAGE>
Exhibit E
January 11, 2000
Each of the Purchasers
Dear Purchasers:
The undersigned, Chief Executive Officer of the Company, understands
that each of the Purchasers proposes to enter into a Securities Purchase
Agreement and a related Registration Rights Agreement (collectively, the
"Agreements") between IGEN International, Inc., a Delaware corporation (the
"Company"), and each of the Purchasers (as defined therein) providing for the
purchase, by the Purchasers, of an aggregate of $35,000,000 principal amount of
the Company's 5% Subordinated Convertible Debentures due 2005 (the
"Debentures"), convertible into shares of the Company's common stock, par value
$0.001 per share ("Common Stock") (the "Purchase"). Each capitalized term not
otherwise defined herein shall have the meaning ascribed to it in the Purchase
Agreement.
To induce the Purchasers to enter into the Purchase Agreement, the
undersigned hereby agrees that: (A) for thirty (30) days following the Closing
Date and (B) during any Black-out Period (as defined in the Registration Rights
Agreement), the undersigned will not, without the prior written consent of the
Purchasers, (1) offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant to purchase, lend, or otherwise transfer or dispose of,
directly or indirectly, any shares of Common Stock or any securities convertible
into or exercisable or exchangeable for Common Stock (excluding bona fide gifts
to donees provided that such donee(s) agree in writing to be bound by the terms
of this letter) or (2) enter into any swap or other arrangement that transfers
to another, in whole or in part, any of the economic consequences of ownership
of Common Stock, whether any such transaction described in clause (1) or (2)
above is to be settled by delivery of Common Stock or such other securities, in
cash or otherwise.
Very truly yours,
---------------------------------------
(Name)
---------------------------------------
(Address)
E-1
<PAGE>
Exhibit F
TRANSFER AGENT INSTRUCTIONS
IGEN INTERNATIONAL, INC.
January 11, 2000
[TRANSFER AGENT]
[ADDRESS]
Attn: _______________
Ladies and Gentlemen:
Reference is made to that certain Securities Purchase Agreement dated
January 11, 2000 by and among IGEN International, Inc., a Delaware corporation
(the "COMPANY"), and the buyers named therein (collectively, the "HOLDERS")
pursuant to which the Company is issuing to the Holders the Company's 5%
Subordinated Convertible Debentures due January 11, 2005 (the "DEBENTURES"),
convertible into shares of the Company's common stock, par value $0.001 per
share (the "COMMON STOCK"), and Warrants (the "WARRANTS") to purchase shares of
the Common Stock. This letter shall serve as our irrevocable authorization and
direction to you (provided that you are the transfer agent of the Company at
such time) to issue shares of Common Stock upon conversion of the Debentures
(the "CONVERSION SHARES") and upon exercise of the Warrants (the "WARRANT
SHARES") to or upon the order of a Holder from time to time upon surrender to
you of a completed and duly executed Conversion Notice or Exercise Notice, as
the case may be, in the form attached as EXHIBIT I and EXHIBIT II, respectively,
which has been acknowledged by the Company as indicated by the signature of a
duly authorized officer of the Company thereon; provided, however, that this
irrevocable authorization and direction to you to issue Conversion Shares and
Warrant Shares shall not apply, and you shall not be authorized to issue any
such Conversion Shares or Warrant Shares, upon receipt of written notice from
the Company stating that (a) the issuance of Conversion Shares or Warrant Shares
would violate applicable law, (b) the aggregate number of shares of Common Stock
beneficially owned by any Holder and its Affiliates would exceed 4.99% of any
class of voting securities of the Company following the issuance of Conversion
Shares or Warrant Shares or (c) the issuance of Conversion Shares or Warrant
Shares would trigger the exercise of a Right (as defined therein) under the
Company Preferred Share Purchase Rights Plan. All of the Conversion Shares and
Warrant Shares, upon issuance shall bear the following legend:
F-1
<PAGE>
"THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED WITH THE
SECURITIES AND EXCHANGE COMMISSION IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR UPON DELIVERY OF AN
OPINION OF COUNSEL THAT THE SECURITIES MAY BE TRANSFERRED PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF, THE SECURITIES ACT.
and; provided, however, that the Conversion Shares and Warrant Shares shall not
bear any legend restricting their transfer if you have received prior to the
issuance of such Conversion Shares or Warrant Shares, as the case may be, a
written opinion of counsel to the Company experienced in the area of U.S.
securities laws that such legend is not required under applicable requirements
of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission).
Please be advised that the Holders are relying upon this letter as an
inducement to enter into the Securities Purchase Agreement and, accordingly,
each Holder is a third party beneficiary to these instructions.
Please execute this letter in the space indicated to acknowledge your
agreement to act in accordance with these instructions. Should you have any
questions concerning this matter, please contact the Company at 16020 Industrial
Drive, Gaithersburg, Maryland 20877, telephone (301)869-9800, fax (301)
208-3798, attention: George Migausky.
Very truly yours,
IGEN INTERNATIONAL, INC.
By:____________________________________
Name:
Title:
ACKNOWLEDGED AND AGREED:
[TRANSFER AGENT]
By:
---------------------------------
Name:
----------------------
Title:
---------------------
Date:
--------------------------------
F-2
<PAGE>
EXHIBIT I
FORM OF CONVERSION NOTICE
NOTICE OF CONVERSION
AT THE ELECTION OF HOLDER
(TO BE EXECUTED BY THE REGISTERED HOLDER IN ORDER
TO CONVERT THE 5% CONVERTIBLE DEBENTURE)
Reference is made to the Debenture issued by IGEN International, Inc. (the
"DEBENTURE"). In accordance with and pursuant to the Debenture, the undersigned
hereby irrevocably elects to convert the principal amount of the Debenture,
indicated below into shares of Common Stock, par value $.001 per share (the
"COMMON STOCK"), of the Company, by tendering the Debenture specified below as
of the date specified below.
Date of Conversion:
------------------------------------------
Aggregate Principal Amount to be converted:
------------------
Debenture number(s) of Debenture to be converted:
------------
Please confirm the following information:
Conversion Price:
-------------------
Number of shares of Common Stock to be issued:__________
Please issue the Common Stock into which the Debenture is being converted and,
if applicable, any check drawn on an account of the Company in the following
name and to the following address:
Issue to:
-----------------------------------------
Facsimile Number:
---------------------------------
Authorization: By:
--------------------------------
Name:
Title:
Dated:
----------------
Account Number (if electronic book entry transfer):
----------------------
F-3
<PAGE>
EXHIBIT II
ARTICLE VII. FORM OF EXERCISE NOTICE
WARRANT EXERCISE FORM
TO: IGEN INTERNATIONAL, INC.
The undersigned hereby: (1) irrevocably subscribes for and offers to
purchase _______ shares of Common Stock of IGEN International, Inc. , pursuant
to Warrant No. ___ heretofore issued to ___________________ on ____________,
2000; (2) encloses either (a) a cash payment of $__________ or (b) _____ Warrant
Shares, valued at the Per Share Market Price of $ _____ on ________, ___, for
these shares at a price of $____ per share (as adjusted pursuant to the
provisions of the Warrant); or (c) ____ shares of Common Stock, valued at the
Per Share Market Price of $ _____ on ________, ___, for these shares at a price
of $____ per share (as adjusted pursuant to the provisions of the Warrant); or
(d) Debentures evidencing $ ______ of the principal amount, for these shares at
a price of $____ per share (as adjusted pursuant to the provisions of the
Warrant) and (3) requests that a certificate for the shares be issued in the
name of the undersigned and delivered to the undersigned at the address
specified below.
Date:
-------------------------------
Investor Name:
-------------------------------
Taxpayer Identification
Number:
-------------------------------
By:
-------------------------------
Printed Name:
-------------------------------
Title:
-------------------------------
Address:
-------------------------------
-------------------------------
-------------------------------
Note: The above signature should correspond exactly with the
name on the face of this Warrant Certificate or with the name
of the assignee appearing in assignment form below.
F-4
<PAGE>
AND, if said number of shares shall not be all the shares purchasable under the
within Warrant, a new Warrant Certificate is to be issued in the name of said
undersigned for the balance remaining of the shares purchasable thereunder less
any fraction of a share paid in cash and delivered to the address stated above.
F-5
<PAGE>
EXHIBIT III
FORM OF NOTICE OF EFFECTIVENESS
OF REGISTRATION STATEMENT
[TRANSFER AGENT]
Attn.:
Re: IGEN International, Inc.
Ladies and Gentlemen:
(i) We are counsel to IGEN International, Inc., a Delaware
corporation (the "Company"), and have represented the Company in
connection with that certain Securities Purchase Agreement dated
January 11, 2000 (the "Purchase Agreement") entered into by and among
the Company and the buyers named therein (collectively, the "Holders")
pursuant to which the Company issued to the Holders its 5% Convertible
Debenture (the "Debenture"), convertible into shares of the Company's
common stock, par value $0.001 per share (the "Common Stock"), and
Warrants (the "Warrants") to acquire shares of Common Stock. Pursuant
to the Purchase Agreement, the Company also has entered into a
Registration Rights Agreement with the Holders (the "Registration
Rights Agreement") pursuant to which the Company agreed, among other
things, to register the Registrable Securities (as defined in the
Registration Rights Agreement), including the shares of Common Stock
issuable upon conversion of the Debenture and exercise of the Warrants,
under the Securities Act of 1933, as amended (the "1933 Act"). In
connection with the Company's obligations under the Registration Rights
Agreement, on _______________, 2000, the Company filed a Registration
Statement on Form S-3 (File No. 333-_____________) (the "Registration
Statement") with the Securities and Exchange Commission (the "SEC")
relating to the Registrable Securities which names each of the Holders
as a selling stockholder thereunder.
F-6
<PAGE>
In connection with the foregoing, we advise you that a member of the
SEC's staff has advised us by telephone that the SEC has entered an order
declaring the Registration Statement effective under the 1933 Act at [ENTER TIME
OF EFFECTIVENESS] on [ENTER DATE OF EFFECTIVENESS] and we have no knowledge,
after telephonic inquiry of a member of the SEC's staff, that any stop order
suspending its effectiveness has been issued or that any proceedings for that
purpose are pending before, or threatened by, the SEC and the Registrable
Securities are available for resale under the 1933 Act pursuant to the
Registration Statement.
Very truly yours,
[ISSUER'S COUNSEL]
CC: [LIST NAMES OF HOLDERS]
F-7
